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Gene orf18, which is situated in the conjugative transposon Tn916 from 
the bacterial pathogen Enterococcus faecalis, encodes a putative ArdA (alleviation 
of restriction of DNA) protein. ArdA from Tn916 may be responsible for the 
apparent immunity of the transposon to DNA restriction and modification 
(R/M) systems and for ensuring that the transposon has a broad host range. The 
orf18 gene was engineered for overexpression in Escherichia coli and the 
recombinant ArdA protein was purified to homogeneity. Biophysical 
characterisation of ArdA demonstrated tight association between ArdA and the 
M.EcoKI. Also, ArdA was shown to efficiently inhibit restriction and 
modification by all four major classes of Type I R/M enzymes in vivo. Thus, 
ArdA can overcome the restriction barrier following conjugation and so helps to 
increase the spread of antibiotic resistance genes by horizontal gene transfer. 
The amino acid sequence of KlcA, from the incompatibility plasmid 
pBP136 from Bordetella pertussis, showed a high degree of similarity with the 
antirestriction protein ArdB from the IncN plasmid pKM101. In this study the 
solution structure of KlcA was solved with high-resolution NMR and its 
antirestriction function demonstrated. The structure of KlcA showed a rigid 
globular molecule with a novel fold. No antimodification function was observed 
for KlcA in vivo and the antirestriction function of KlcA has been successfully 
shown in vivo but not in vitro. Because no direct binding of KlcA to EcoKI was 
observed in vitro, the mechanism of the endonuclease blocking was assumed to 
be different from that of ArdA. Preliminary experiments including 
coimmunoprecipitation assays were conducted in order to elucidate the 
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Chapter 1: Introduction 
 
1.1 Horizontal gene transfer and antibiotic resistance 
 
The natural transfer of genetic material between bacteria in the environment is 
necessary for the generation of genetic diversity and provides the raw material 
for natural selection and evolution. The ability of bacteria to adapt to new 
environments, to be able to overcome selective pressures or to become 
pathogenic is often the result of gene transfer, specifically horizontal gene 
transfer. Horizontal gene transfer between bacterial populations is of particular 
medical importance since genes that confer resistance to antibiotics can pass 
from one bacterium to another.  The discovery of plasmid-mediated antibiotic 
resistance in Shigella in 1959 (Watanabe, 1963) marked the beginning of a series 
of discoveries that showed that plasmids and transposons can be important 
agents for the transfer of antibiotic resistance between bacteria. Antibiotic-
resistant bacterial infections are now becoming increasingly common with the 
appearance of multi-drug resistant strains such as methicilin-resistant 
Staphylococci, vancomycin resistant Enterococci and extended-spectrum 
betalactamase (ESBL) producing Gram- negative bacilli (Dzidic & Bedekovic, 
2003). 
 
1.2 Types of horizontal gene transfer 
 
There are three principal mechanisms that allow the horizontal transfer of 
genes: transformation, transduction and conjugation. In transformation, 
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prokaryotes can take up free (naked) DNA from their surroundings. In 
transduction, bacteriophage particles act as vectors and incorporate genes by 
“injection” into the bacterial chromosome either through the lytic or the 
lysogenic cycle of the phage. Transduction can be generalised where any 
bacterial gene may be transferred, or specialised, where only genes located near 
the site of prophage integration are transferred) (Davison, 1999). The third 
mechanism of horizontal gene transfer is conjugation (or mating), where 
bacteria are capable of attaching to each other for the purpose of transmitting 
DNA from a donor cell to a recipient cell. For this purpose, some bacteria use 
pili (F pilus in E. coli) that adhere to the recipient’s cell surface and DNA transfer 
takes place at the site of contact. Not all bacteria use pili and a notable exception 
is Enterococcus faecalis where the molecules necessary for cell-cell contact 
(adhesins) are located on the cell surface rather than on pili (White, 2007). 
Conjugation, can be of several types (Davison, 1999): a) transfer of a self-
transmissible conjugative plasmid, b) transfer of a nonself-transmissible plasmid 
containing an OriT by the action of a conjugative plasmid (mobilisation), c) a 
non-self-transmissible non-mobilisable plasmid fuses with a self-transmissible 
partner (cointegration) and d) by conjugative transposons. 
 
1.3 Conjugative transposons 
 
Transposable elements, or transposons, are sequences of DNA that can move 
from one site to another within a bacterial genome. Transposition does not 
require extensive regions of DNA homology and this differentiates transposition 
from other forms of genetic recombination. The enzyme transposase acts on a 
specific DNA sequence at each end of the transposon disconnecting it from the 
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flanking DNA and then inserting it into the new target site. Transposons can be 
grouped into three main classes based on their structure and transposition 
mechanisms: a) DNA-only transposons (move as DNA either excising or 
following a replicative pathway), b) Non-retroviral retrotransposons (encode 
reverse transcriptase, move via an RNA intermediate), c) Retroviral-like 
transposons (encode reverse transcriptase, move via an RNA intermediate, 
resemble retroviruses). DNA–only transposable elements can be further 
subdivided into: 
 
• Insertion sequences (simplest form of transposable element, carry no 
information other than that required for transposition itself, move by 
conservative transposition) 
• Composite transposons (comprise two identical, or nearly identical, 
insertion sequences that move by conservative transposition) 
• Type II transposons (move by replicative transposition increasing the 
number of copies of the transposon) 
• Conjugative transposons (form a covalently closed circular intermediate) 
 
Neither replicative nor conservative transposition involves the generation of a 
free transposon molecule in the cell. However, conjugative transposons form a 
circular intermediate that can reinsert into host genomic DNA or it can transfer 
by conjugation to a new host. The transposon is excised from the donor 
molecule, it circularises and inserts itself into a target site in the recipient 
molecule. The following model (Fig. 1) has been proposed for the excision and 
integration of a conjugative transposon (Scott & Churchward, 1995).  
 - 4 -
 
 
Fig. 1 A proposed model for the excision and integration of a conjugative transposon 
according to Scott & Churchward, 1995. The thick lines represent the transposon, the 
thin lines are the DNA adjacent to the transposon and the letters X-Y, Q-R and A-B 
represent hypothetical complementary nucleotide pairs. At first, the transposon is 
excised from the donor molecule. The ends are joined to create an excisant molecule and 
the circularised transposon (A). Semi-conservative replication produces an excisant pair. 
Cuts in the circularised transposon and the new DNA target followed by ligation create 
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a new insertion of the transposon with a heteroduplex at its end. Replication follows, 
which resolves the heteroduplexes (B). 
 
1.3.1 The conjugative transposon Tn916 
 
 
Found in Enterococcus faecalis DS16 (formerly known as Streptococcus faecalis 
DS16), Tn916 was the first conjugative transposon identified (Franke & Clewell, 
1981), the first to have its nucleotide sequence determined (Flannagan et al., 






Fig. 2.  Linear map of Tn916 showing open reading frames (ORFs) represented by 
patterned segments. The assigned number for each ORF is shown above an arrow that 
indicates the direction of transcription and the approximate extent of the ORF. 
Reprinted from Flannagan et al., 1994. 
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Tn916 is located chromosomally. Compared to transposons greater in size than 
50 kb - as for example Tn3705 (>52 kb) in Streptococcus auginosus (Clermont & 
Horaud, 1994), Tn3701 (50 kb) of Streptococcus pyogenes (Le Bouguenec et al., 
1988), and the multiresistance transposon Tn5385 (65 kb) also present in 
Enterococcus faecalis (Rice & Carias, 1998) - Tn916, being 18.3 kilobases long, is a 
relatively small conjugative transposon. Tn916 carries the tet(M) gene which 
provides resistance to both tetracycline-and unlike most other tet genes- to 
minocycline as well. Instead of causing resistance by facilitating the export of 
the antibiotic as is the case with other tet gene products, tet(M) encodes a protein 
that causes the process of protein synthesis to become insensitive to tetracycline 
(Burdett, 1993). Most Tn916-like elements contain tet(M) genes. In some cases, 
however, Tn916-like elements have acquired additional resistance determinants, 
as in the pneumococcal conjugative transpososon Tn1545 which encodes 
kanamycin and erythromycin resistance in addition to tetracycline resistance 
(Courvalin & Carlier 1987). In other instances, Tn916-like elements have been 
discovered incorporated within larger multiresistance elements, such as in the 
Enterococus faecalis transposon Tn5385 that encodes resistance to erythromycin, 
gentamycin, streptomycin, tetracycline and penicillin (Rice & Carias, 1998). 
  
Tn916 has been shown both in vitro and in vivo to transfer readily to a wide 
variety of Gram-positive and Gram-negative bacteria. In one report, Tn916 was 
able to transfer from E. faecalis to Alcaligens eutrophus, Citrobacter freundii and E. 
coli (Bertram et al., 1991). Other examples include the transfer of Tn916 from E. 
faecalis to the Gram-positive Bacillus licheniformis  (Herzog-Velikonja et al, 1994) 
and to the Gram-negative Butyrivibrio fibrisolvens  (Hespell & Whitehead, 1991). 
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1.4 Restriction-Modification (R-M) systems 
 
 
R-M systems are widely believed to have evolved as cellular defense 
mechanisms against infecting foreign DNA identified as alien by lack of cognate 
methylation. They are designated by a three letter acronym derived from the 
name of the organism in which they occur. The first letter comes from the genus 
and the second and third letters come from the species. For example, EcoKI is 
the first restriction enzyme identified in E. coli K-12. R-M systems are classified 
into four major groups on the basis of composition and cofactor requirements, 
cleavage position and target sequence characteristics (Bickle & Kruger, 1993; 
Roberts et al., 2003). 
 
1.4.1 Type I restriction-modification systems 
  
Type I R-M systems are multifunctional enzymes that can catalyse both 
restriction and modification. They are composed of three subunits encoded by 
the genes hsdR, hsdM and hsdS (hsd denotes “host specificity of DNA”) (Glover 
& Colson, 1969). HsdM (~50-60 kDa) and HsdS (~50 kDa) subunits comprise a 
methyltransferase (M2S1) which in association with HsdR forms an 
endonuclease (R2M2S1). The R (~140 kDa) subunits are required for restriction, 
the S subunit specifies the DNA target sequence and the M subunits catalyse the 
methylation reaction.  
 
The S subunit includes two target recognition domains (TRDs) that impart 
target sequence specificity to both the restriction and modification activities of 
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the complex. The M subunit includes the binding site of the cofactor and methyl 
donor SAM (S-adenosyl-L-methionine) and the active site for DNA methylation.  
Methylation occurs at the N6 position of adenine yielding N6-methyladenine. 
The R subunits include the active site for ATP hydrolysis and other sequences 
essential for DNA translocation and endonuclease activity. The restriction 
reaction requires SAM, ATP and Mg2+. Depending upon the methylation state of 
the DNA, the R-M complex can function as either a REase or an MTase. If the 
target sequence is hemi-methylated, DNA is targeted for further methylation. 
Fully methylated DNA is immune to restriction. If the target sequence is 
unmodified (unmethylated) then it is targeted for restriction. The enzyme, while 
bound to its target site, is believed to translocate, or pull, the DNA towards itself 
simultaneously in both directions in an ATP-dependent manner. DNA 
translocation allows the cleavage to occur several hundreds to thousands of base 
pairs away from the recognition sequence. DNA cleavage occurs when 
translocation is impeded, either by collision with another translocating complex 
or by the topology of the DNA substrate (Murray, 2000). Recent atomic force 
microscopy measurements revealed that the EcoKI enzyme goes through an 
additional dimerisation stage before the onset of translocation (Neaves et al., 
2009).  The new model (Fig. 3) suggests the following mode of action of EcoKI: 
an EcoKI monomer binds to DNA at a random sequence and then through 
linear diffusion it finds its target sequence. A second monomer of EcoKI then 
binds to the first one. The dimer that is formed collides with another region of 
the DNA due to the flexibility of DNA and a loop is formed. Once the loop is 
formed the second EcoKI molecule scans the DNA for the second target 
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sequence, and once both target sequences are identified translocation and 
subsequent cleavage of the DNA occurs. 
 
 
Fig. 3 Diagrammatic representation of EcoKI binding, translocation and cleavage of 
DNA. A monomer of EcoKI binds to a DNA site and then a second monomer binds to 
the first monomer forming a dimer. The dimer forms a loop by colliding with another 
region of DNA. Translocation occurs from both monomers and the process is stopped 
when the loop between the monomers becomes fully contracted. After translocation is 
stalled cleavage of the DNA occurs. Reprinted from Neaves et al., 2009. 
 
The Type I R-M systems are divided into five families based on sequence 
similarity, functional complementation and antibody cross-reactivity 
(Cajthamlova et al, 2007): Type IA, e.g EcoKI; Type IB, e.g. EcoAI; Type IC, e.g. 
EcoR124I; Type ID, e.g. StySBLI and Type IE, e.g. KpnBI. 
 
Two published crystal structures of HsdS from Methanococcus jannaschi and 
Mycoplasma genitalium (Calisto et al., 2005; Kim et al., 2005) have become 
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available. The monomeric structure of the S subunit from M. jannaschi shows 
four continuous structural motifs: an N-terminal first TRD (TRD1) (Target 
Recognition Domain), a long-helical CCR (Central Conserved Region), the 
second TRD (TRD2), and the C-terminal long-helical DCR (Distal Conserved 
Region). TRD1 and TRD2 have very similar fold and each has extensive 
interaction with one of two CR helices: TRD1 exclusively interacts with the CCR 
helix and TRD2 with the DCR helix. CRs form two ten-turn helices running in 
an antiparallel way and interacting with each other by hydrophobic contacts. 
The CRs have been suggested to provide a structural motif for protein–protein 














Fig. 4 Crystal structure of the Type-I S subunit from Methanococcus jannaschi. A 
monomer consists of four successive structural domains: the globular TRD1, a long 
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helical CCR domain, the globular TRD2, and a C-terminal DCR helix. (Image reprinted 
from Kim et al., 2005). 
 
The crystal structure of HsdS from Mycoplasma genitalium shows a very similar 
fold to the HsdS structure from Methanococcus jannaschi even though the 
sequence identity of the two subunits is below 20% (Calisto et al., 2005). 
 
There are no published structures of HsdM, however, there are two 
unpublished structures deposited in the PDB including the crystal structure of 
HsdM of EcoKI from Escherichia coli (pdb accession number: 2ar0) (Rajashankar 
et al., 2005). An attempt to model the HsdM and HsdS subunits in the MTase has 
been made by Obarska et al., 2006. A structural model of the Type IC 
M.EcoR124I DNA methyltransferase (MTase), comprising the HsdS subunit, 
two HsdM subunits, the cofactor AdoMet and the substrate DNA molecule is 
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Fig. 5 Model showing the predicted structure of the M.EcoR124I DNA 
methyltransferase and substrate. The HsdS subunit is shown in green. The two HsdM 
subunits are shown in yellow and orange and the substrate DNA in light blue. The 
adenines of the recognition sequence, which are to be methylated are shown ‘flipped-out’ 
coloured red, and the methyl donor is present above these bases (in blue). Reprinted form 
Obarska et al., 2006. 
 
 The latest contribution to the structure of Type I MTase comes from a 
combination of structural modelling along with information derived from 
cryoelectron microscopy. In this model (Fig. 6), the N-terminal domains of 
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Fig. 6 Model of EcoKI MTase in complex with substrate DNA and AdoMet. Yellow: 
HsdS; Grey: HsdM; Blue and cyan: DNA; Black: phosphate groups of DNA; Purple: 
AdoMet molecules; Orange: N-terminal domain of HsdM; Red: Catalytic domain of 
HsdM; Magenta: C-terminal domain of HsdM. Image reprinted from Kennaway et al., 
2009. 
 
In this model the N-terminal domains of each HsdM subunit come in contact 
forming a bridge that must open in order to allow DNA to enter and be 
recognised by HsdS. Taking both models (Obarska et al., 2006; Kennaway et al., 
2009) into consideration, it is probable that the structure of Type I MTases 
fluctuates between an open form (Fig. 5) and a closed form (Fig. 6). This opening 
and closing motion is facilitated by twisting and bending of the coiled-coil 
region of the HsdS subunit (Kennaway et al., 2009). 
 
The characterisation of the HsdR subunit of EcoR124I by dynamic light 
scattering, analytical ultracentrifugation and small angle neutron scattering has 
indicated that the subunit is monomeric, globular and fairly compact (Obarska 
et al., 2008). Indeed, the recent crystal structure of the HsdR subunit of EcoR124I 
(Lapkouski, et al., 2009) revealed four globular domains in a square-planar 
arrangement. The four domains are: an endonuclease domain, two RecA-like 
helicase domains (1 and 2) and a helical domain with no apparent structural 
relatives (Fig. 7).  
 
















Fig. 7 Crystal structure of the HsdR subunit of EcoR124I. Four domains can be seen: 
Endonuclease (residues 13-260), helicase 1 (261-461), helicase 2 (470-731) and helical 
domain (732-892). Image reprinted from Lapkouski et al., 2009. 
 
1.4.2 Type II restriction-modification systems 
 
The Type II R-M systems are the simplest of the R-M systems with separate 
restriction and modification enzymes and no special cofactor requirements for 
cleavage other than Mg2+. They methylate both strands of DNA at a specific base 
resulting in N6-methyladenine, 5-methylcytosine or N4-methylcytosine. In 
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contrast to Type I systems, Type II nucleases recognise and cleave DNA at fixed 
positions thus making them invaluable tools in molecular biology. Some Type II 
REases act as homodimers or tetramers thus binding two or more copies of their 
recognition site before DNA is cleaved (Halford, 2004). Most enzymes can 
recognise palindromic sequences of 4–8 bp in length, and cleave DNA within 
this sequence in both strands, producing 3’-hydroxyls and 5’-phosphate ends. 
Some Type II REases recognize discontinuous palindromes, interrupted by a 
segment of specified length but unspecified sequence. The DNA fragments 
produced have ‘blunt’ or ‘sticky’ ends with 3’- or 5’-overhangs of up to 5 
nucleotides. Most of the restriction enzymes used for recombinant DNA work  
belong to the subtype that recognises palindromic sequences, which is called 
Type IIP (P for –palindromic) (Roberts et al, 2003). 
 
 
1.4.3 Type III restriction-modification systems 
 
Type III restriction enzymes consist of two subunits only, Mod (responsible for 
DNA recognition and modification) and Res (responsible for DNA cleavage). 
Active nucleases have a Mod2Res2 stoichiometry, require ATP and Mg2+ for 
activity and are believed to be stimulated by AdoMet, although recent findings 
suggest that AdoMet may not be necessary for DNA cleavage (Buchner-Moncke 
et al., 2009). The recognition sequence of Type III enzymes is asymmetric, 
uninterrupted and 5–6 bp in length. They translocate the DNA in an ATP-
hydrolysis dependent manner and cut the DNA close to one recognition site. 
Typical examples are EcoP1I and EcoP15I (Bourniquel & Bickle, 2002). Studies 
utilizing fast-scan atomic force microscopy revealed that EcoP15I initially 
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employs diffusive looping to reduce the inter-site DNA distance, followed by 
translocation-coupled extruded looping (Crampton et al., 2007). 
 
1.4.4 Type IV restriction systems 
  
The Type IV R-M systems are methylation-dependent restriction systems. The 
first restriction enzyme that was shown to require a methylated substrate was 
DpnI from Streptococcus pneumoniae, which cleaves the sequence GATC only if 
the A is methylated (Lacks et al, 1986). Type IV R-M systems are REases with no 
associated methyltransferase and recognize and cleave DNA that has been 
modified (methylated, hydroxymethylated and glucosyl-hydroxymethylated). 
Thus foreign DNA is attacked because it does contain methylated bases in a 
particular sequence, rather than because it does not (Stewart et al, 2000). The best 
studied Type IV system is McrBC from E. coli K12. McrBC consists of two 
polypeptides: one (McrB) that is responsible for GTP binding/hydrolysis as well 
as DNA binding and another (McrC) that is responsible for DNA cleavage. The 
enzyme recognizes two methylated or hemimethylated sites at a distance of 
approximately 30 to more than 2000 base pairs and cleaves the DNA close to one 
of the two sites. This process is strictly coupled to GTP hydrolysis and involves 
the formation of high-molecular mass complexes (Pieper et al, 2002). A novel 
Type IV modification dependent restriction nuclease was recently found that 
targets glucosylated hydroxymethyl cytosine modified DNAs of the 
bacteriophage T4, T2 and T6 (Bair & Black, 2007). 
 
 
 - 17 -
1.5 Antirestriction Strategies 
 
R-M systems are not a perfect barrier to invasion by foreign DNA. 
Bacteriophage and conjugative plasmids have developed several strategies to 
avoid restriction. 
 
1.5.1 Viral-encoded DNA modifications 
 
Some phage genomes encode their own methyltransferases that methylate and 
thus protect the viral DNA within the bacterial host. Such methylase genes have 
been found in the Bacillus subtilis phage SPβ and φ3Τ . The SPβ  genome contains 
a gene that codes for a modifying DNA-methyltransferase which methylates the 
central C in the BsuR recognition sequence 5'GGCC (Trautner et al., 1980). 
Similarly, the DNA of the Bacillus subtilis temperate phage φ3T is not susceptible 
to cleavage by the restriction endonuclease HaeIII due to the production of the 
viral MTase φ3TI (Cregg et al., 1980). 
 
Another example of viral DNA modification is the acetimidation of the N6 
position of 15% of the adenine residues in the DNA of bacteriophage Mu 
rendering the virus immune to the EcoKI, EcoBI, EcoP1 and EcoAI restriction 
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1.5.2 Viral stimulation of host modification functions 
 
Some lambdoid phage are able to overcome the restriction problem either by 
stimulating the host MTases to modify phage DNA or by destroying the REase 
cofactors. The Ral protein of phage lambda can prevent restriction of 
unmodified phage DNA by the EcoKI and EcoBI enzymes by stimulating the 
host methyltransferases (Zabeau et al., 1980). Interestingly, it has been shown 
that Ral enhances modification in a host strain lacking the entire hsdR gene, and 
lambda phage carrying the hsdM and hsdS genes modify their own DNA 
inefficiently in the absence of Ral. A model has been proposed in which, as a 
consequence of the interaction of Ral with either the HsdM or the HsdS 
polypeptide, the conformation of the enzyme is changed and the efficiency of 
methylation of unmodified target sites is enhanced (Loenen & Murray, 1986). 
An analogous function has been found in the Lar protein. The gene encoding 
Lar lies within Rac, a cryptic prophage sequence present in the genome of most 
E. coli K-12 strains (King & Murray, 1995). The ability to destroy REase cofactors 
has been found in phage T3 which destroys intracellular S-adenosylmethionine 
(SAM) necessary for methylation, by the production of a SAM hydrolase 
(Kruger et al., 1975). 
  
1.5.3 Incorporation of unusual bases in viral DNA 
 
Many B. subtilis phage contain unusual bases in their DNA. Unusual bases in 
this case are defined as the bases which are not adenine, cytosine, guanine or 
thymine and which are synthesized at the level of nucleotide metabolism, not as 
 - 19 -
post-synthetic DNA modifications. The T-even phage of E. coli contain DNA in 
which cytosine is completely replaced by the unusual base 
hydroxymethylcytosine (HMC). HMC-containing DNA is completely resistant 
to HhaI and HpaII and almost completely resistant to BamIII, HindII and 
HindIII (Huang et al., 1982). However, E.coli has developed  mechanisms to deal 
with these unusual bases, by a) producing the Rlg protein (Rlg for restriction of 
non-glucosylated DNA) and b) producing a type IV restriction enzyme that is 
specific for non-glycosylated, HMC-containing DNA (Bair & Black, 2007). The T-
even phage have in turn evolved a gene called arn (antirestriction of 
endonucleases) which produces an inhibitor of the Rlg enzymes (Kim et al, 
1997). Other examples of phage containing unusual bases include phage SPO1, 
SP8, SP82G where thymine is completely replaced by 5-hydroxymethyluracil, 
and phage PBS1 and PBS2, where thymine is replaced by uracil (Warren, 1980). 
 
1.5.4 Counterselection of restriction sites in phage genomes 
 
By reducing or completely eliminating the recognition sites in their DNA, phage 
can avoid restriction. Pseudomonas phage ΦST1 appears to have no recognition 
sites for some of the restriction enzymes found in its host (Gachechiladze et al., 
1990). The same has been found for the streptomycete phage FP22 (Hahn et al., 
1990). Increasing the distance between EcoRII restriction sites (two copies of the 
target sequence are necessary for cleavage to take place) is the strategy adopted 
by the coliphage T7 and T3 (Kruger et al, 1988). 
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1.5.5 Coinjection of proteins occluding restriction sites 
 
The restriction target sites of phage DNA can be protected by producing virus-
encoded proteins which bind to the restriction sites thus creating an obstacle 
preventing the restriction enzymes from gaining access. Phage P1 is insensitive 
to restriction due to the production of the head proteins DarA and DarB (dar for 
defense against restriction). The darA and darB gene products are found in the 
phage head and protect any DNA packaged into a phage head, including 
transduced chromosomal markers, from restriction. The proteins must, 
therefore, be injected into recipient cells along with the DNA. These proteins are 
coinjected with the phage DNA in the bacteria and bind to the phage DNA 
recognition sites thus rendering them inaccessible to Type I restriction enzymes 
(Iida et al., 1987). 
 
1.5.6 Host-mediated restriction alleviation  
 
 
The host cell’s DNA is normally immune to restriction since the unmethylated 
strand produced by DNA replication is methylated before the next round of 
replication. However, when the host DNA is damaged by agents such as UV 
light, nalidixic acid and 2-aminopurine, a temporary loss of restriction 
proficiency occurs (restriction alleviation) (Thoms, & Wackernagel, 1984). This 
loss of restriction has been attributed to the ClpXP protease (Makovets et al., 
1999).  
 
In eukaryotes, proteins destined for proteolysis are ubiquitinated on a specific 
lysine residue which is recognised by the 26S proteasome (Voges et al., 1999). In 
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prokaryotes, proteins that are destined for degradation are tagged with an 11 
amino acid sequence (AANDENYALAA). This specifically directs the tagged 
proteins to the ClpXP or ClpAP proteases. This 11 amino acid peptide is coded 
by SsrA, a unique tmRNA which functions as both a messenger and a transfer 
RNA. The degradation of tagged proteins by ClpXP is markedly enhanced by an 
adaptor protein SspB which binds specifically to the 11 amino acid tag. SspB is 
believed to have a role in helping the ClpX recognise the tagged protein. The tag 
is attached to the C-terminus of nascent polypeptides on stalled ribosomes. 
When protein synthesis on the ribosome stalls (because it cannot bind the 
release factors necessary for termination) the SsrA tags the incomplete nascent 
protein. The alanine-charged SsrA binds to the stalled ribosome mimicking a 
tRNA and the nascent chain is transferred to the SsrA by transpeptidation. 
Then, the SsrA functions as a mRNA translating the reading frame coding for 
the 11 amino acid tag (Keiler et al., 1996) 
 
 
ClpXP is a two component system consisting of ClpP and ClpX (Fig. 8a and 8b). 
The activator is ClpX and the proteolytic core is ClpP. ClpX is composed of a 
hexamer which is the ATPase domain. ClpP contains two rings of seven 
subunits , the rings placed on top of each other. The binding of ClpX to ClpP is 
mediated by a hydrophobic loop referred to as the IGF loop (Kim et al., 2001). 
ClpP digests the protein translocated from ClpX into uniform peptide fragments 
of six to eight residues (Choi & Licht, 2005). 
 
 




Fig. 8  a. The structure of ClpP is viewed face-on with the hydrophobic pocket coloured 
in cyan, which has been suggested to interact with ClpX and ClpA. b. Cartoon depicting 
how the ClpX hexamer may dock with the ClpP 14-mer via the exposed IGF loop. 
Reprinted from Kim et al., 2001. 
 
 
ClpXP has been shown to degrade the R subunit from EcoKI so that the latter 
cannot cleave the host’s chromosomal DNA. The host’s chromosome is 
recognized as “self” rather than “foreign” even in the absence of modification. 
HsdR is recognised by ClpXP only after the EcoKI complex has embarked on its 
restriction pathway but before any damaged is inflicted on the unmodified 
chromosomal DNA. Furthermore, HsdR is lost only in cells in which HsdR 
could produce functional EcoKI (Makovets et al., 1999). It has also been 
demonstrated that ClpX and ClpP are necessary for the efficient transmission of 
the genes encoding EcoKI and EcoAI. When the hsd genes are transferred to a 
 
b
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recipient cell that lacks a protective modification system, its DNA becomes 
susceptible to degradation once the endonuclease is formed. It is believed that 
the ClpXP protease competes with MTase for interaction with HsdR delaying 
the production of the whole EcoKI complex (Makovets et al., 1998). Even though 
restriction alleviation via ClpXP has been demonstrated for Type IA and Type 
IB systems, restriction alleviation of Type IC and ID systems does not involve 
the ClpXP protease (Makovets et al., 2004). It is still not clear how unmodified 
sequences in the resident bacterial chromosome are distinguished from 
“foreign” DNA that has recently entered the bacterial cell. Perhaps host DNA 
differs from invading DNA in its location, its association with other proteins 
and its topology (Murray, 2002). 
 
1.5.7 Production of proteins that inhibit restriction enzymes 
 
The most thoroughly investigated example of active antirestriction is that 
exerted by the closely related phage T3 and T7. The phage gene responsible is 
gene 0.3 from its map position that codes for the Ocr protein (overcome classical 
restriction) (Studier, 1975). T3 and T7 are closely related, and their DNA 
molecules hybridize extensively; however, there are several functionally 
important nonhomologous regions. One of the differences between the two 
phage is the coding of an S-adenosylmethionine hydrolase (SAMase) by gene 0.3 
of T3, but not by T7. Even though the T7 gene product only shows the ocr 
phenotype it is nevertheless as resistant to restriction as T3 (Kruger & Schroeder, 
1981). Ocr is the first product to be expressed by phage T7 as it enters a 
bacterium. The phage first injects the early region of its genome which contains 
the ocr gene. Transcription of this region of the genome is a prerequisite for the 
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injection of the remaining DNA. The delayed injection of the phage DNA may 
be a mechanism by which the phage prevent exposure of the DNA recognition 
sites before the appearance of Ocr (Kruger & Schroeder, 1981). 
 
Ocr is a 26 kDa homodimer that protects DNA from restriction by competing 
with DNA for the DNA-binding site of the Type I R-M enzyme 
(Bandyopadhyay et al., 1985). The mechanism by which Ocr binds to these 
enzymes is not target sequence specific. Instead, Ocr mimics the shape and 
charge distribution of B-DNA. As shown by its crystal structure (Fig. 9), Ocr is 
highly acidic and its negatively charged groups are superimposable upon the 
phosphate backbone of DNA.  The length of the Ocr dimer corresponds to 24 bp 
or two to three turns of B-DNA. The bend angle between the fitted DNA 
duplexes is 33.6 degrees, similar to that induced by Type I R-M systems in their 
DNA targets (Walkinshaw et al., 2002). A 1:1 strong interaction between Ocr and 
M. EcoKI suggests that the primary mode of binding is one Ocr dimer per M. 
EcoKI (Atanasiu et al., 2002). It has been shown through mutational studies that 
the hydrophobic contact at the interface of two Ocr monomers is critical for the 
ability of Ocr to inhibit the modification activity of EcoKI and to a lesser extent 
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Fig. 9  Superposition of two 12 bp B-DNA molecules on the Ocr dimer (green strands: 
DNA; Blue: Ocr; Yellow: phosphorous atoms; Purple: oxygen atoms of the phosphate 
groups;  Red: oxygen atoms of the carboxyl groups; Black: carbon atoms of the carboxyl 
groups). Reprinted from Walkinshaw et al., 2002. 
 
Another virus-encoded inhibitor of restriction enzymes is produced by Bacillus 
phage φNR2rH and φ1rH. These two phage provide the first examples of an 
active viral block of a type II restriction enzyme. The protein has a molecular 
weight of 20 kDa and is an inhibitor of the restriction enzyme BamNx (Makino 
et al., 1980). 
 
Stp is a 26 residue polypeptide encoded by bacteriophage T4 (Depew & 
Cozzarelli, 1974). Stp activates the latent ACNase (anticodon nuclease) and 
alleviates the Type IC R-M systems DNA restriction activity. Stp affects the 
dissociation of the R2 complex of the R-M system, shifting the equilibrium 
towards R1 complex formation which is the restriction-deficient form of the 
REase (Lisle et al., 2000). 
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An example of inhibition of restriction of an exonuclease and not an 
endonuclease is the activity of the Gam protein produced by bacteriophage 
lambda. The RecBCD enzyme of E. coli has several known activities including  
ATP-dependent dsDNA and  exonuclease activity. RecBCD contributes to the 
degradation of foreign DNA entering the cell. The nuclease activities of RecBCD 
are involved directly, and its helicase activity is involved indirectly by creating 
ssDNA which is acted upon by other  nucleases (Kowalczykowski et al., 1994). 
The recently solved crystal structure of Gam suggests that the protein inhibits 
RecBCD by preventing it from binding DNA (Court et al, 2007).   
 
1.5.7.1 The Ard proteins 
 
To overcome the host restriction barrier many self-transmissible plasmids and 
mobile elements in bacterial chromosomes encode Ard proteins (alleviation of 
restriction of DNA). Ard proteins fall into three distinct groups, ArdA, ArdB 
and ArdC based on amino acid sequence homology. All groups have a small 
region similarity that includes 14 residues designated as the “antirestriction 
motif” (Belogurov & Delver, 1995). Mutational substitution of negatively 
charged amino acid residues present in the motif of ArdA from IncN plasmid 
pKM101, however, did not affect the antirestriction activity, but completely 
abolished the antimodification activity (Rastorguev & Zavilgelsky, 2004). ArdA 
proteins seem to be prevalent among Ard proteins with 75 ArdA sequences 
known today. Sequenced ardA genes are predicted to encode small polypeptides 
of 166-169 amino acids, which are highly acidic with net negative charges 
ranging from -22 to -29 (Wilkins, 2002). Antirestriction proteins belonging to the 
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ArdA family are strongly acidic, like Ocr. However, there is no significant 
sequence similarity between the ArdA protein and Ocr. 
 
ardA genes are expressed rapidly and transiently in the infected cell aiding in 
the establishment of the immigrant plasmid. Other genes such as psiB and ssb 
are also expressed early following plasmid conjugative transfer. The increased 
production of PsiB is thought to prevent induction of the bacterial SOS response, 
while the overproduction of SSB may confer the benefit of avoiding SSB 
starvation after plasmid entry (Bagdasarian et al., 1992; Jones et al., 1992). 
Interestingly, ardA, psiB and ssb genes have the same transcriptional orientation 
such that the transferred strand is the same as the transcribed strand (Chilley 
and Wilkins, 1995). This raises the possibility that these genes are transcribed 
from the entrant strand before the synthesis of the complementary DNA strand. 
This is achieved by a special type of promoter, ssi3, which acts only on single 
stranded DNA and provides the synthesis of a sufficient amount of ArdA 
protein during conjugation (Bates et al., 1999; Nasim et al., 2004). This would 
allow accumulation of the antirestriction protein before the formation of the 
double-stranded substrate which would be degraded by endonucleases 
(Althorpe et al., 1999). 
 
ArdAs are produced in the new host in time to prevent destruction of the 
incoming DNA by restriction endonucleases. Two factors contribute to this: first, 
ardA genes reside in plasmid leading regions (Chilley & Wilkins, 1995). Second, 
early in conjugation there is a burst of ardA transcription. The transcription is 
initiated within a minute of entry of the leading region (Althorpe et al., 1999). 
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The first plasmid antirestriction system to be discovered was on the 
enterobacterial plasmid pKM101, a member of the IncN group (Belogurov et al., 
1985). pKM101 encodes two non-homologous antirestriction proteins, ArdA and 
ArdB. ArdA from pKM101 inhibits R/M by the Type I R-M enzyme, EcoKI, but 
the ArdB is ineffective against the modification activity (Belogurov et al., 1993). 
Similarly, ArdA from plasmid R16 preferentially targets restriction activity of 
the Type I system EcoKI leaving significant levels of methyltransferase activity 
under conditions in which restriction is almost completely prevented (Thomas et 
al., 2003).  
 
The third type of anti-restriction protein (ArdC) is found in the IncW plasmid 
pSa, which has a high degree of similarity to the N-terminal region of RP4 TraC1 
primase. ArdC can bind to single-stranded DNA. Furthermore, ArdC protects 
the single-stranded but not double-stranded DNA against the activity of Type II 
endonuclease HhaI (Belogurov et al., 2000).  
 
 
1.5.7.2 The KlcA proteins :  ArdB homologues 
 
 
In the present work, the product of the klcA gene from the incompatibility 
plasmid pBP136 from Bordetella pertussis was characterised and its structure 
determined. Sequence alignment revealed that KlcA from pBP136 is 
significantly related (30% identity, 46% similarity) to the 16.5 kDa ArdB from the 
IncN plasmid pKM101 (Belogurov et al., 1993).   
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Bordetella pertussis is the causative agent of whooping cough, a disease 
predominantly affecting young children and is spread in aerosols created by 
infected individuals. The organism adheres to the cilia of the respiratory 
epithelia and secretes several toxins that kill epithelial cells, causing dysfunction 
of the central nervous system and inducing hypoglycaemia. The prolonged 
paroxysms of coughing can lead to apnoea and eventually death (Preston, 2005). 
Despite the development of several vaccines, immunity is short-lived resulting 
in reinfection. Thus eradication of B. pertussis still remains a challenge with 
300,000 deaths occurring each year worldwide (He & Mertsola, 2008). 
 
In 2002, a B. pertussis isolate that harboured an IncP-1β plasmid,was identified 
from a fatal case of pertussis which is believed to be the first case of B. pertussis 
with a naturally occurring plasmid (Kamachi et al., 2006). The 41 kb plasmid was 
named pBP136, contains 46 open reading frames (ORFs) and possesses a 
classical IncP-1β backbone. Plasmids of the incompatibility group P are found in 
a wide range of Gram-negative bacteria (Adamczyc & Jagura-Burdzy, 2003). 
Incompatibility is often a necessary consequence of the cellular mechanism to 
maintain a defined copy number of a particular plasmid. IncP-1β members carry 
multiple antibiotic resistance determinants and genes for the degradation of 
xenobiotic compounds (Burlage et al., 1990). An exception is the IncP-1β plasmid 
pA1 from Sphingomonas sp. A1 that does not contain any of the typical accessory 
genes of IncP-1β plasmids (Harada et al., 2006). Similarly, pBP136 was found to 
contain no accessory genes for antibiotic resistance, remnants of insertion 
sequences or transposons. The plasmid contains two regions involved in 
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plasmid conjugation and a third region involved in plasmid replication, central 
control, stable inheritance and partitioning. 
 
This third region is composed of incC (plasmid partitioning), kfrA and kor (both 
responsible for transcriptional regulation) and the kilC operon. Four kil loci have 
been identified so far in IncP plasmids: kilA, kilB, kilC and kilE. These genes have 
been designated as kil because it has been shown that their unregulated 
expression is lethal to E. coli cells, and genes that can override this lethality have 
been designated “ kor” (kill override) (Figurski et al., 1982).  kilA consists of three 
genes klaA, klaB and klaC. Genetic analysis of the locus has demonstrated that 
each of the three genes expresses a host-lethal phenotype when expressed from 
the unregulated kilA promoter (Goucharoff et al., 1991). The kilB locus consists of 
three genes: klbA, klbB, klbC. Deletion analysis established that the host-lethal 
phenotype requires klbB, and that klbA is required for conjugal transfer. The 
repressor korB seems to regulate expression of the kilB locus (Thomson et al., 
1993). The kilE locus (in RK2) contains two multicistronic operons: the kleA 
operon containing the kleA and kleB genes, and the kleC operon which contains 
four genes (kleC, kleD, kleE and kleF). Each operon is lethal to E. coli host cells in 
the absence of kor functions (korA and korC) (Kornacki et al., 1993). The kilC 
operon consists of three genes: korC, klcB and klcA. Genetic analysis has revealed 
that the host-lethal phenotype of the kilC operon of plasmid RK2 is klcA. 
Expression of klcA is controlled by korA and korC (Larsen & Figurski, 1994). 
However, thus far, no specific function had been attributed to klcA genes. 
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The aim of this project is to characterise with biophysical and structural 
methods the antirestriction proteins ArdA from Enterococcus faecalis and KlcA 
from Bordetella pertussis and understand their mechanism of action against Type 
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Chapter 2: Background theory of protein biophysical and 
structural methods 
 
2.1 Steady-state fluorescence  
 
 
Following electronic excitation by absorption of a photon, a molecule loses 
energy as heat by cascading through the closely spaced vibrational levels of all 
the excited energy levels. The molecule “hesitates” at the lowest vibrational 
level of the first singlet because a large amount of energy must be lost to go to 
the ground state. During this period three things may happen: 
- the molecule may fluoresce and drop to the ground state by emitting a 
photon 
- it may convert to a triplet state via intersystem crossing 
- may go to the ground state without emitting a photon via a non-radiative 
transition 
In the case of the triplet, the molecule may either phosphoresce and drop to the 
ground state emitting a photon or undergoes a non-radiative transition. The 
lifetimes for all these processes are illustrated in Fig. 10.  

















Fig. 10 One form of a Jablonski diagram (adapted from Van Holde et al., 2006) showing 
the lifetimes of absorption, fluorescence and phosphorescence at the equilibrium 
internuclear distance of the ground state. 
 
Fluorescent light is emitted from samples in an excited electronic state. 
Fluorescence instruments use light to excite the sample and then observe the 
light emitted. A monochromator before the sample chooses the wavelength of 
exciting light, and a monochromator after the sample scans the wavelengths of 
emitted light. The shape of the fluorescence spectrum as scanned by the 
emission monochromator will be independent of the wavelength of absorption 
because excited molecules decay to the ground vibrational level of the first 
singlet state before fluorescing. 
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Intensity measured as a function of wavelength comprises the fluorescence 
spectrum. A plot of emission against wavelength for any given excitation 
wavelength gives the emission spectrum. When the wavelength of the exciting 
light is changed and the emission from the sample is plotted against the 
wavelength of exciting light, the result is the excitation spectrum.  
 
The time-dependence of fluorescence intensity following excitation of the 
fluorophore is related to the excited state lifetime, τ. This parameter 
characterises the average time a molecule spends in the excited state before 
emitting a photon: 
 
            I(t) ~ e-t/τ 
 
 
The fluorescence of protein molecules arises from the presence of the aromatic 
amino acids Trp, Phe and Tyr. The UV absorption maxima of these amino acids 
in water are 280 nm for tryptophan, 258 nm for phenylalanine and 275 nm for 
tyrosine. The emission maxima are around 350 nm for tryptophan, 282 nm for 
phenylalanine and 304 nm for tyrosine (Lakowicz, 2006). The emission of 
tryptophan is highly sensitive to its local environment and thus is used as a 
reporter group for protein conformational changes. Generally the emission 
spectrum of Trp is shifted to shorter wavelengths and becomes more structured 
with decreased polarity of the surrounding environment. In order to excite Trp 
fluorescence a wavelength of 295 nm or more is chosen in order to minimise any 
effects from the Tyr absorbance and eliminate the absorption of phenylalanine. 
Shifts of the Trp emission spectrum are often used to detect protein structural 
changes, however, the fluorophore is affected only by its immediate 
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environment and no information can be obtained regarding global changes in 
protein structure. 
 
When the intrinsic fluorescence of the molecule is not enough, fluorescence can 
be obtained by labelling the molecule with fluorescence probes which will 
preferably have longer excitation and emission wavelengths than the aromatic 
amino acids. The protein-labeling reagents can be convalently or non-covalently 
attached to the protein. Covalent fluorophores include dansyl chloride (DNS-
CL), fluoresceins and rhodamines and non-covalent probes include 1-
anilinonapthalene-6-sulfonic acid (ANS) (Lakowicz, 2006).  
 
In a homogeneous solution the ground state fluorophores are all randomly 
oriented. When exposed to polarised light (i.e. light which has been filtered to 
vibrate only in one plane either vertical or horizontal), those fluorophores that 
have their absorption transition moments oriented along the electric vector of 
the incident light are excited. The extent of polarisation of the emission is 
described in terms of the anisotropy (r).  
 
In a fluorescence anisotropy experiment the sample is excited with vertically 
polarised light. In this way, the electric vector of the excitation light is oriented 
parallel to the vertical axis. The intensity of the emission is measured through a 
polariser. When the emission polariser is oriented parallel to the direction of 
excitation light the observed intensity is called I║ and when oriented 
perpendicular is called I┴ (Lakowicz, 2006).  A diagram showing the 
experimental setup for anisotropy measurements is shown in Fig 11.  





Fig. 11 Experimental method for measuring the anisotropy of fluorescent emission. 
Polarised light is sent along the x-axis with the electric vector along the z-axis. The 
molecule of interest is place at point 0 in the Cartesian coordinate system and has a 
transition dipole for absorption at an angle θ and an emitting dipole at an angle γ. The 
polarised light emitted is observed along the y-axis and a polariser is used to separate the 
intensity of the electric vectors which are parallel or perpendicular to the electric vector 
of the excited light. In a T-format method the parallel and perpendicular components are 
observed simultaneously through separate channels. Image adapted from Van Holde et 
al., 2006. 
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Where the G factor is the ratio of the sensitivities of the detection system of 
vertically and horizontally polarised light. Measuring the G-factor is important 
since when the ratio is different than one, the sensitivity of one detection is 
different from the other and thus the intensity observed is not the true intensity. 
The G-factor is measured using horizontally polarised excitation. 
 
Factors that affect rotational diffusion such as molecular weight, shape and 
viscosity will also affect anisotropy. Anisotropy measurements can be useful for 
measuring any process which increases or decreases the extent of rotational 
diffusion of the fluorophore.  The extent to which a fluorophore rotates during 
the excited state determines its anisotropy. Thus, the anisotropy measured 
through steady-state fluorescence can be used to follow the molecular weight 
changes that result from binding. When a protein binds to a ligand the 
rotational correlation time decreases and the anisotropy increases. The 
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Where η is the viscosity of the solution, V the molecular volume, R the gas 
constant and T the temperature in Kelvin. The relationship between the 






where r0 is the anisotropy that would be measured in the absence of rotational 
diffusion and τ the excited-state lifetime (Lakowicz, 2006). 
 
 
2.2 Differential Scanning Calorimetry (DSC) 
 
DSC is one of the primary methods for the study of thermal protein 
denaturation. It is the measurement of the change of the difference in the heat 
flow rate to the sample and to a reference sample while they are subjected to a 
controlled temperature program (Fig.12). DSC allows reaction heats and heats of 
transition to be quickly measured on small sample masses. 
 
In a basic DSC experiment, energy is introduced simultaneously into a sample 
cell and a reference cell containing only the solvent, raising the temperatures of 
both identically over time. The difference in the input energy required to match 
the temperature of the sample to that of the reference at each step of the scan is 
the amount of excess heat either absorbed (endothermic reaction) or released 
(exothermic reaction) by the molecule in the sample. 
 
















Fig. 12 Diagram of a typical DSC used for thermal studies of biomolecules. Reproduced 
from Cooper et al., 2000. The sample (S) and reference (R) cells are held under inert gas 
pressure to inhibit bubble formation while heating. The main heaters raise the 
temperature of the cells at a constant rate while monitoring the difference in temperature 
ΔT1 of the S and R cells and the surrounding adiabatic jacket ΔT2. Feedback heaters 
compensate for any temperature differences. 
 
 
If we consider the sample to be a protein, more energy is required to bring the 
sample to the same temperature as the reference because of the excess heat 
absorbed by the protein. The excess heat (dq) absorbed for the incremental 
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change in temperature (dT) will be a measure of the heat capacity (Cp) of the 
protein: 
 
Cp = dq /dT 
 
 
The heat capacity (Cp) changes from that of the native form (CN) to that of the 
denatured form (CD). After concentration normalisation and baseline correction, 
DSC data can be fit to a two-state model to yield the enthalpy of denaturation 
and the melting temperature. The temperature at which half the protein is 
denatured is the melting temperature (Tm) of the protein. The integrated area 
under the curve is the calorimetric enthalpy (ΔHcal) of the denaturation which 
represents the total heat energy uptake by the sample undergoing the transition. 
Calorimetric enthalpy depends on the total amount of protein in the calorimetric 
cell. 
     
ΔHcal = ∫ ΔCp dT 
  
 
The van’t Hoff enthalpy (ΔHVH) is a measure of the cooperativity of transition; 
the greater the cooperativity, the sharper the transition. ΔHVH depends on the 
shape of the endotherm and is independent of the amount of protein present. 
 
                        4R T2m Cp(max) 
                                ΔHVH =    ----------------------------- 
                             ΔHcal 
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 Normally ΔHcal should be equal to ΔHVH , however, in cases where the unfolding 
is not two-state or the protein concentration is under-estimated, ΔHcal > ΔHVH. 
On the other hand, if ΔHcal < ΔHVH,  then either the protein concentration is over-
estimated,  or aggregation causes distortion of the peak, or not all the protein is 




















Fig. 13 DSC plot of protein denaturation. The heat capacity Cp changes from that of the 
native form CN(T) to that of denatured CD(T). The integrated area under the curve from 
T1 to T2 is the enthalpy of denaturation. Tm denotes the midpoint temperature. The 
associated enthalpies for the folded state ΔHN(T) and unfolded state ΔHD(T) are equal 
and of opposite signs. Image adapted from van Holde et al., 2006. 
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When the structure of a protein is “melted” in this way there are no changes to 
the covalent nature of the molecule. It is only non-covalent interactions that are 
perturbed and in many cases, if the protein is cooled down again these 
interactions will reform spontaneously, yielding the active native conformation. 
To check the reversibility of denaturation, the heated sample is first cooled and 
then it is heated again with the same scanning rate. If the original curve is 
completely reproduced, the denaturation is reversible. If no heat absorption is 
observed at reheating, denaturation is considered to be irreversible. 
 
DSC can also be used to study the thermochemistry of interacting molecules 
such as protein-protein or protein-ligand interactions (Weber & Salemme, 2003). 
Some problems for using DSC for such studies are that the fractions of bound 
and free proteins may be temperature dependent and each component can 
undergo thermal denaturation during the experiment. For these reasons, the 
more typical method for studying the thermochemistry of interacting molecules 
is isothermal titration calorimetry (ITC). 
 
 
2.3 Isothermal Titration Calorimetry (ITC) 
 
Isothermal titration calorimetry measures the amount of heat absorbed or 
released by a reaction that results from mixing together two or more 
components. 
 
ITC involves the incremental addition over time of a ligand into a solution with 
the molecule of interest (e.g. protein). At each titration point, formation of the 
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complex results in the release or absorption of heat (q) which is the heat of 
complex formation. Initially, the amount of free protein is sufficient to bind 
ligand according to the concentrations of free ligand and protein in solution. 
Later, however, the amount of free protein becomes limited, until at the end of 
the titration there is no protein available to form a complex and thus no excess 
heat is absorbed or released upon addition of the ligand. 
 
 The ITC instrument is very similar to the DSC apparatus (see Fig. 12) with the 
exception that the sample and reference cells are kept at constant temperature 
(isothermal). A syringe injects small quantities of ligand into the sample cell and 
a stirrer mixes the solution constantly.  
 
Fig. 14 shows an example of an ITC diagram. The top graph shows the heat 
change over time. After integration of the area under each peak and substitution 
of the dilution heat effects and normalisation per mole injected ligand, a 
titration curve is obtained (bottom graph). The data from the titration curve can 
be fit with the help of specialised software such as Microcal Origin to a non-
linear least squares Marquardt algorithm as described elsewhere 
(Ladbury &  Chowdhry, 1996) to yield three thermodynamic parameters: the 



























Fig. 14 ITC plot of protein binding to a ligand. The heat change over time is shown in 
graph B. After integration of the area under each peak from the top graph, the individual 
heats are plotted against the molar ratio (C). After non-linear regression analysis, the 
thermodynamic parameters n, Kα and ΔΗ  can be determined. Reprinted from Haian, 
2004. 
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One limitation of ITC is that it cannot yield meaningful quantitative results 
when the binding between two molecules is very strong and the Ka is very 
large- the practical upper limit is estimated to be Ka = 109 M-1 (van Holde et al., 
2006). The resulting titration will show a sharp transition from complete binding 
of added ligand to no binding. 
 
 
2.4 Circular Dichroism (CD) 
 
Dichroism is the phenomenon in which light absorption differs for different 
directions of polarisation. Linear dichroism involves linearly polarised light 
where the electric vector is confined to a plane. The direction of the electric 
vector is constant and its magnitude is modulated. Linear dichroism is a 
function of wavelength λ and is defined as the difference between absorption of 
parallel and perpendicular polarised light. 
 
LD(λ) = A║(λ) - A┴ (λ) 
 
In circularly polarised light, the magnitude is constant and the direction is 
modulated. The plane polarised radiation is split into in two circularly polarised 
components. If after passage through the sample, the left and right circularised 
polarised components are not absorbed or are absorbed to the same extent, then 
radiation polarised in the original plane will be generated again. However, if 
one of the two components is absorbed to a different extent, the polarisation of 
the resultant radiation would form an ellipse. The CD instrument will then 
display the dichroism at a given wavelength of radiation as either the difference 
in absorbance of the two components: 
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ΔΑ = ΑL - ΑR 
 
or as the ellipticity in degrees (θ, mdeg) which is related to the differential 
absorption ΔA as follows: 
 
ΔA = θ/33000 
 
A CD signal will only be observed when a chromophore is chiral (optically 
active). A chromophore can be chiral due to: i) the nature of its structure, ii) 
being covalently linked to a chiral centre (e.g. a haem group) or iii) being placed 
in an asymmetric environment (Kelly & Price, 1997). 
 
The CD of a native protein depends on the fractions of its component secondary 
structures. The study of protein secondary structure by their far-UV CD spectra 
is based on the suggestion that these spectra are determined mainly by the local 
conformation of the protein backbone, which can be roughly described by 
secondary structure. In other words, far-UV CD spectra of proteins are 
considered as a superposition of spectra of different classes of secondary 
structure such as α-helix and β-sheet. The presence of secondary structure in a 
protein will result in a spectrum with positive and negative signals, whereas the 
absence of regular chiral structure will result in zero CD intensity. 
 
The far-UV absorption region (<250 nm) is dominated by electronic transitions 
of the peptide backbone of the protein, but transitions from side chains also 
contribute in this region. The peptide chromophore which gives rise to the 
transitions observed in the far-UV region has non bonding electrons on the 
oxygen and also on the nitrogen atoms, π-electrons which are delocalised to 
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some extent over the carbon, oxygen, and nitrogen atoms and sigma bonding 
electrons. The lowest energy transition of the peptide chromophore is an n to π* 
transition and the next transition is π to π*. Even though a number of amino acid 
side chains also have transitions in the peptide region (and these transitions are 
often stronger than the peptide π to π* transitions) since the peptide 
chromophores are in excess, the side chain transitions are generally nearly 
impossible to detect. 
 
Typical of the α helix is a negative CD band at about 222 nm and a negative and 
positive couplet at about 208 and 190 nm. The magnitude of the negative 222 nm 
band is a good measure of α−helix content in a protein. β-sheets exhibit a broad 
negative band near 218 nm and a large positive band near 195 nm. Disordered 
chains have a weak broad positive CD band near 217 nm and a large negative 
band near 200 nm. 
 
 
 The near-UV CD signal (250-310 nm) arises from the environments of aromatic 
amino acids side-chains as well as disulfide bonds or non-protein cofactors. In 
the near-UV the aromatic amino acid side-chains (phenylalanine, tyrosine and 
tryptophan) absorb in the range of 250-300 nm. As an approximation, the 
aromatic side chains and disulfides absorb at the following frequencies: 
 
-250-270 nm: phenylalanine signal 
-270-290 nm: tyrosine signal 
-280-300 nm: tryptophan signal 
-260 nm: disulfide bond signal 
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There are several applications of CD to proteins including: determination of 
secondary structure, analysis of thermodynamics and kinetics of protein folding 
and characterisation of protein-ligand interactions (Greenfield, 1999). 
 
2.5 Matrix Assisted Laser Desorption Ionisation- Time Of Flight/ Mass 
Spectrometry (MALDI-TOF/MS) 
 
Matrix-assisted laser desorption/ionisation (MALDI) time-of-flight (TOF) mass 
spectrometry (MS) produces gas-phase protonated ions by excitation of the 
sample molecules using the energy of a laser pulse absorbed by an ultraviolet 
light absorbing matrix. 
 
Protein samples after trypsin digestion, are mixed with an appropriate matrix 
solvent and spotted onto a stainless steel plate. The solvent is dried and the 
plate is introduced into the vacuum system of the MALDI-TOF analyser. A laser 
pulse irradiates the sample which causes ionisation of both the matrix and the 
sample. Without the matrix, the analytes could only be desorbed at higher 
energies, but this would result in their fragmentation. Because the matrix is of 
much lower MW than the ionised samples, the matrix does not interfere with 
the assay of the protein. Ions are then focused into the mass spectrometer. 
Larger ions require more time to reach the detector than smaller ions.  
 
Matrix substances are small organic molecules (mainly acids) that have an 
absorption maximum at the laser wavelength and can co-crystallise with the 
analyte. The most commonly used method for co-crystallisation is the “dried-
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droplet” method where the sample is premixed with the matrix and the mixture 
is allowed to evaporate slowly at room temperature (Fuchs & Podda, 2004). 
 
In order for desorption to occur, the matrix sample co-crystals are irradiated 
with a nanosecond laser beam (from a UV laser with a wavelength of 266 or 337 
nm). The energy introduced by the laser irradiation causes a structural 
decomposition of the crystal (in other words, the laser energy is converted to 
vibrational oscillation of the crystal molecules) and generates a particle cloud. 
This cloud contains ions that follow a Boltzmann distribution of their initial 
velocities. Due to the high matrix concentration, the analyte ions are prevented 
from interacting with each other. Following acceleration, the extracted ions drift 
through a field-free path and finally reach a detector. The mass-to-charge ratios, 
(m/z) are calculated by measuring their time-of-flight (TOF) which is longer for 
larger molecules. 
 
The MALDI-TOF MS utilises the following principle to determine the mass of 
ions generated in the MALDI process. This is based on the time (t) taken for an 
ion of mass (m) and known kinetic energy (eV = ½ mv2) to travel a distance (l) in 
a field-free region.  This time t is proportional to the square root of the mass of 
the ion: t = l√m/2eV (Hoffmann & Stroobant, 2007) 
 
There are two types of TOF analyser, the linear mode and the reflectron mode.  



























Fig. 15 A reflectron TOF analyser (image adapted from Manz et al., 2004) 
 
 
In a reflector TOF mode, as the ions travel through the field-free tube, they are 
forced to change direction due to an electrical opposing field which is placed at 
the end of the tube. Ions that have the same mass but higher velocities get 
deeper into this field and thus need more time to change direction, but catch up 
with slower ions at a certain point. By putting the detector at that specific 
focusing point, very sharp signals can be obtained providing high resolution 
and mass accuracy (Manz et al., 2004). 
 
 
MALDI-TOF MS has become the preferred method for high-throughput 
identification of proteins using peptide mass fingerprinting (PMF). The proteins 
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are first digested with an endopeptidase such as trypsin. Trypsin cleaves the 
protein after lysines and arginines generating peptides 8-10 amino acids long. 
Another endopeptidase commonly in use is Lys-C. Lys-C is used when 
generation of larger peptides is desired. The resultant fragmented mixture is 
very specific for a given protein. The peptide mixtures are analysed with 
MALDI-TOF MS. After peak detection and calibration with internal standards 
the peak lists are transferred to a peptide mass fingerprint program such as 
Mascot. The resulting peptide mass fingerprints are compared to theoretical 
fingerprints from a protein database for identification.  
 
2.6 Nuclear Magnetic Resonance (NMR) Spectroscopy 
 
Nuclear magnetic resonance involves sophisticated manipulation of nuclear 
spins. Nuclear spin is one of the four physical properties of nuclei, the others 
being mass, charge and magnetism. Even though mass and charge play 
fundamental roles in the chemical and physical behaviour of substances, nuclear 
magnetism and nuclear spin have almost no effect. However, the latter two 
nuclear properties can be an important tool for elucidating the structures of 
molecules without disturbing them. The magnetism of a nucleus means that the 
nucleus can interact with magnetic fields like a tiny bar magnet. Spin can be 
imagined as the spinning of particles around their axes. However, this 
oversimplification does not adequately describe the true nature of spin since the 
concept of the spin is a difficult and highly abstract one, which can only be fully 
described using quantum mechanical equations.  
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Most NMR work on biological molecules uses nuclei with the spin number of ½ 
because the spectra is greatly simplified when there are only two possible 
quantum states. When an external magnetic field is applied to the sample, the 
spins start to precess.  A compass needle rotates so as to bring the magnetic 
moment parallel to the field minimising the magnetic energy. However, the 
response of the spin to the magnetic field is to precess around the magnetic field 
vector like around a cone, keeping a constant angle (which depends on the 
initial spin polarisation) between the spin magnetic moment and the field. This 




Fig. 16 Spin precession in the presence of             






2.6.1 Chemical Shift 
 
The electrons that surround the nuclei in atoms set up tiny magnetic fields of 
their own. These small magnetic fields act in opposition to the external applied 
field so that the actual field felt by the nuclei is weaker than the applied field. 
Since each nucleus in a molecule is in a unique electronic environment, each 
nucleus is shielded to a different extent from the applied field. Thus nuclei of 
the same element which are in different chemical environments within a 
molecule will have different Larmor frequencies. This effect is called chemical 
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shift. In NMR spectra field strength increases from right to left; left being the 
“downfield” or “deshielded” part of the spectrum and right being the “upfield” 
or “shielded” part. Nuclei that require a stronger field strength for resonance 
will absorb on the upfield side implying that these nuclei are heavily shielded 
from the external magnetic field.  
 
The chemical shift measured in Hz is field dependent. When the magnetic field 
increases, the chemical shift increases in a linear proportional way. Since the 
nuclear Larmor frequency and the chemical shift are both proportional to the 
applied magnetic field, the ratio of these two quantities is fixed. The field-





where ω0 is the Larmor frequency of the nucleus and ω0ref is the Larmor 
frequency of the same isotope in a reference compound such as tetramethyl 
silane for organic molecules. Chemical shifts δ are given in parts per million 
(ppm) where the dimensionless symbol ppm has the meaning as 10-6. The use of 
ppm instead of Hz allows for direct comparison of spectra when different 
magnet strengths are used. 
 
The electron density that a nucleus experiences depends on the atomic number 
of the atom as well as the electronegativity of neighbouring atoms. However, 
chemical shift is not affected solely by the electronic cloud surrounding the 
nucleus. Chemical shift can also be perturbed by additional magnetic fields that 
arise from the presence of delocalised electrons of aromatic rings or carboxylic 
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acid groups. This phenomenon is known as the “ring current effect”. As an 
example, aromatic protons because of their close proximity to the centre of the 
ring experience an increase of ~ 2 ppm due to ring current effects. Other 
parameters that can influence the chemical shift include paramagnetic ions and 
hydrogen bonding. Paramagnetic ions such as Fe2+, Mn3+ inside a protein 
molecule may perturb the Larmor frequency of nuclei nearby. Finally, the 
Larmor frequency of a proton involved in a hydrogen bond is raised slightly. 
 
 
2.6.2 Indirect spin-spin interaction 
 
 
Indirect spin-spin interactions are often referred to as through-bond 
interactions, scalar coupling or J-coupling.  This type of coupling represents the 
interaction of the nuclear spins with each other through the involvement of 
electrons and is independent of molecular orientation. The nuclear spin 
polarisation of one atom affects the polarisation of the surrounding electrons. 
The electron polarisation subsequently produces a change in the magnetic field 
that is sensed by the coupled spin. The result of such an interaction is an 
observable splitting of the resonance in the NMR spectrum.  
 
The splitting is independent of the magnetic field, and depends only on the 
nature of the bonding between the two nuclei. The splitting coupling constant J 
gives the splitting in Hz. Since it is independent of the applied magnetic field, 
this will be the splitting measured on any NMR spectrometer. The size of J-
coupling depends on several factors, including the gyromagnetic ratio and the 
number of bonds connecting the coupled spins. In the case of multiple bond 
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couplings, the value of J-coupling is also affected by the conformation of the 
intervening bonds. This means that the value of J depends on the relative 
orientation of the magnetic dipoles of the nuclei (the torsion angle) involved in 
scalar coupling according to the Karplus relationship: 
 
xJyz = A cos2 θ + Β cos θ + C 
 
 
In the case of protons, θ is the angle between the protons for geminal (two-bond) 
coupling (x=2) or the dihedral angle between protons for vicinal (three-bond) 
coupling (x=3). The subscripts y and z define the nuclei that are interacting, and 
A, B and C are empirical constants. The J-coupling has a sign. A positive J 
indicates that the spin-spin coupling makes a positive contribution to the energy 
when the spin polarisations are parallel, and a negative contribution when the 
spin polarisations are opposite. Typical J-coupling values of proteins are shown 



















Fig. 17  Example of J-coupling constants in peptides and proteins. 
ii-1 
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2.6.3 Nuclear Overhauser Effect (NOE) 
 
 
When a weak radiofrequency field is applied at the Larmor frequency of one 
spin for a sufficiently long time, it has a strong effect on the longitudinal 
magnetisation of the non-irradiated spins enhancing the magnetisation of those 
spins. This is known as the Nuclear Overhauser Effect or NOE. The NOE is a 
dipole-dipole interaction that depends strongly on the distance between the two 
types of nuclei falling off as the sixth power of internuclear separation (as r-6). It 
is based on cross-relaxation rather than scalar coupling. If the intensity of a 
resonance I is I0, then saturate some neighbouring nucleus  and find that 
intensity I0 has changed to I, the nuclear overhauser enhancement will be: 
 
ni(s) = (I-I0)/I0 
 
The NOE effect is used in protein structure determination with the acquisition 
of 2D and 3D NOESY experiments. The basic NOESY pulse sequence is 900- t1- 
900- tm - 900- t2. The NOESY experiments still involve cross-relaxation, but there is 
no saturation of spins. Instead the NOE arises when the magnetisation of a spin 
precessing at one frequency during a period t1, is transferred via the cross-
relaxation mechanism to another spin during the mixing period known as the 
mixing time (tm). The final 900 pulse along the x-axis flips the magnetisation 
from the z-axis to the y-axis where it becomes observable transverse 
magnetisation. Now the nuclei have a different frequency t2 and produce a 
crosspeak revealing the chemical shifts of the two sites.  
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The second dimension in 2D NOESY (and in every 2D NMR experiment) is 
achieved by varying the delay t1 and collecting a series of spectra at various 
values of this delay. Thus, a second Fourier transform of intensity vs. 
incremented delay generates a second dimension (frequency axis). The 
technique can be extended to include another series of delays, thus creating a 
third dimension and so on.  Strong NOE peaks are observed for nuclei which 
are less then 2.5 Ǻ apart and intermediate ones for 2.5 -3.5 Ǻ apart. Extending the 
mixture time will reveal crosspeaks from nuclei even 5 Ǻ apart. Normally, for 
proteins of 10-15 kDa a mixing time of 100 msec is used. 
 
 
2.6.4 Spin perturbation 
 
 
Before the pulse, the distribution of magnetic dipoles in the x-y plane is random, 
i.e. there is no relationship between the transverse (x-y) magnetisation of one 
spin to another. Thus the transverse magnetisation is termed to be incoherent. 
Since the sum of a large collection of vectors aligned in random directions is 
zero, there is no bulk transverse magnetisation at thermal equilibrium. 
 
When a radiofrequency pulse B1 of the appropriate frequency is applied, the 
bulk magnetic moment of the sample is tipped from the z-axis to the x-y plane. 
The extent of precession about B1 depends on both the strength of the B1 field 
and the length of time the pulse was applied. Note that the total magnetic field 
in the rotating frame is now the sum of both the static field (Bo) and the 
oscillating field (B1). A pulse of length τ applied at a field of strength ω will 
rotate the magnetisation through a “flip” angle of β = ωτ. After the application of 
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the pulse with a flip angle β, a component of the magnetisation cos β will remain 
along the z-axis and a component in the x-y plane equal to sin β will have been 
created by the pulse. For example, if a B1 pulse is applied along the y-axis the 
individual components of the magnetisation after the pulse are: 
 
Mz =Mocos (β)      Mx =Mosin (β)      My = 0       
 
When the flip angle is π/2, the bulk magnetisation is found only along the x-axis. 
This is referred to as the 90o pulse. After the B1 pulse is turned off, the transverse 
magnetisation precesses in the x-y plane around the Bo field, just as it did before 
the pulse. The key difference is that the transverse magnetisation is now 
coherent and gives rise to a non-zero magnetic moment in the x-y plane. Thus 
the net result of a 90o pulse is to turn the equilibrium bulk magnetisation from 
the z-axis and place it in the x-y plane. The effect of a y-pulse on the individual 
magnetic dipoles is shown in Fig. 18. 
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Fig. 18 Effect of a B1 y-pulse on the nuclear spins. The upper part of the figure shows a 
collection of individual magnetic dipoles while the lower part shows the bulk 
magnetisation. The leftmost part of the panel illustrates the state of the system at 
thermal equilibrium prior to the pulse. The subsequent sections show the state of the 
system near the beginning, at the middle and at the end of a 90o pulse. Image adapted 
from Rule & Hitchens, 2006. 
 
When the pulse ends, the nuclei relax and return to their equilibrium positions, 
and the signal decays. This decaying signal contains the sum of the frequencies 
from all the target nuclei and it is referred as the Free Induction Decay (FID). 
 
The transverse magnetisation induces a current in the receiver coil of the probe.  
This induced current is sampled at discrete times (dwell time) and digitised. The 
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frequency domain spectrum is obtained from the time domain data by Fourier 















Fig. 19  The conversion of the free induction decay (FID) signal to an NMR spectrum. 
 
2.6.5 Spin Relaxation 
 
After perturbation of the nuclear spins by RF pulses, the magnetisation returns 
to equilibrium via two relaxation pathways (Fig. 20): spin-lattice relaxation and 
spin-spin relaxation. The first relaxation process arises from a re-alignment of 
the bulk magnetic moment along the static field transferring energy from the 
excited state to the surroundings (lattice). The second relaxation process causes 
reduction of the coherent signal in the x-y plane. The time constants for spin-
lattice and spin-spin relaxation are T1 and T2 respectively. 
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Fig. 20  Relaxation of nuclear spins. Panel A illustrates spin-lattice relaxation in the 
absence of spin-spin relaxation and the effect on bulk magnetic moment and z-
magnetisation over time (Ai and Aii respectively). Panel B shows spin-spin relaxation 
in the absence of spin-lattice relaxation. Image adapted from Rule & Hitchens, 2006. 
 
The experiments used to measure the relaxation parameters (T1, T2 and 
Heteronuclear NOE) are all 2D HSQC-like experiments with pulse sequences 
that utilize coherence selection to generate quadrature detection and sensitivity 
enhancement to increase signal to noise. In addition, they are designed to avoid 
saturation of the water magnetization in order to reduce the saturation of the 
amide protons that would arise from exchange with the water protons.  
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HetNOE: The heteronuclear NOE is a measure of the change in the steady-state 
populations of the heteronuclear (15N) spin when the attached proton (1H) spin 
is saturated. The pulse sequence of a steady-state heteronuclear NOE 
experiment utilizes a pulse train to saturate proton equilibrium magnetization 
prior to the heteronuclear magnetization being excited. Two spectra are 
collected, one with proton saturation and one without (reference spectrum). The 
value of the HetNOE is obtained by calculating the ratio of the peak intensities 
of the spectra taken from the experiment utilizing proton saturation vs the 
reference experiment. The HetNOE experiment provides information about the 
motion of individual N-H bond vectors. Those that undergo motion faster than 
the overall tumbling of the molecule, show a decreased NOE intensity relative 
to the average observed for the majority of the residues.  
 
T1/T2:  The T1 and T2 times are sensitive to motions on different timescales. T1 is 
sensitive to the dynamics on the timescale of ps-μs, whereas T2 is sensitive to the 
motions on both ps-μs and μs-ms timescales. For the 15N spins that have a T1/T2 
ratio below the average value by a difference larger than the standard deviation, 
local conformational averaging is assumed to be responsible for the shortening 
of the T2. When the T1/T2 ration is above the average by a difference larger than 
the standard deviation, the prolongation of T1 is probably caused by motion 
comparable to the overall correlation time (τm), i.e. ns timescale. The T1 and T2 
values are also used to define the rotational diffusion properties of the molecule 
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2.6.6 Residual Dipolar Couplings (RDCs) 
 
 
A nuclear spin experiences many different sources of local magnetic fields 
which change as the molecule rotates in solution. Neighbouring nuclear spins 
also generate magnetic fields of their own. This type of interaction is the 
magnetic dipole-dipole interaction or dipolar coupling. In an isotropic liquid, 
the dipole couplings cancel out, but in an anisotropic medium there is 
incomplete averaging of these magnetic interactions.  These residual anisotropic 
magnetic interactions are called residual dipolar couplings (RDCs) and can be 
useful in many applications such as the refinement of a 3D structure, 
characterisation of protein dynamics (Tolman, 2001), and in proteins with 
multiple domains RDCs can give more information regarding the orientation of 
these domains (Fischer et al., 1999). The principle of residual dipolar couplings is 








Fig. 21 The coordinate system for the 
analysis of residual dipolar couplings 
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A 15N-1H is depicted in this figure in a weakly oriented molecule. For simplicity, 
the molecule is depicted as an ellipsoid. By dissolving the molecule in an 
anisotropic liquid phase, it becomes possible to estimate the angle θij which 
determines the way the 15N-1H vector “points” with respect to the rest of the 
molecule. The angle Θ is the angle between the molecular long axis and the field 
and the angle Θij is the angle between the internuclear vector and the field. This 
angular information complements the internuclear distance information 
revealed by NOESY experiments, to give a more accurate picture of the 
structure of the molecule. 
  
 
The average angular dependence of the RDC between a pair of ½ spin nuclei is 
described by the following equation: 
Dij = bij <½ (3cos2 Θij -1)> 
 
Where bij is the dipole-dipole coupling constant: 
         
           μ0          γi  γj ħ 
bij = -    
           4π           r3ij 
 
 
Here, Dij  is the residual dipolar coupling in Hz between nuclei i and j, γi and γj 
are nuclear magnetogyric ratios, rij is the internuclear distance (assumed fixed), 
and Θij angle of the inter-nuclear vector with respect to the external magnetic 
field. ħ  is Dirac’s constant, a physical constant used to describe sizes of quanta.  
The brackets signify the time average of the quantity. 
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The term Dij is called the residual dipolar interaction. In a fully anisotropic 
liquid, Dij vanishes. In a weakly anisotropic liquid, Dij is small but finite. 
Measurement of the Dij allows the estimation of angle Θij which describes the 
orientation of the internuclear vector with respect to the molecular long axis. 
 
The idea is to induce a weak alignment, because increasing the alignment 
sharply degrades the resolution of the spectra. If the molecules are oriented too 
strongly, all of the dipolar couplings become finite, the spin system becomes 
strongly coupled, and the spectrum becomes intractable. Consequently, the 
coupling is attenuated by orienting only a small fraction of the molecules of 
interest, usually one part in 104.  
 
Depending on the molecule, a small degree of ordering will give rise to 
observed dipolar couplings ranging from 1 to 50 Hz. Normally, elongated 
proteins tend to align more strongly than globular ones. 
 
Information from an RDC measurement is of a “global” nature since it provides 
the orientation of the inter-nuclear vector with respect to a common axis, the 
applied magnetic field. Also because this effect depends on 1/r3 instead of 1/r6 as 
for the NOE effect, from RDC measurements we can obtain information from 
longer interatomic distances  
 
The spectrometer’s magnetic field has only a very small orientating effect on the 
protein molecule because normally proteins are diamagnetic. However, it has 
been possible to measure this tiny alignment (Tjandra & Bax, 1997). Exceptions 
exist when the protein has a paramagnetic centre, such as a heme group, so that 
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the anisotropy of the paramagnetic centre is large enough to align the whole 
molecule to a noticeable extent (Tolman et al., 1997). 
 
In order to induce alignment, several alignment media exist such as 
phospholipid bicelles, cooperative anisotropic membranes, charged 
polyacrylamide gels or Helfrich phases (Prestegard et al., 2004). However, the 
most popular method for generating an anisotropic environment utilise 
filamentous bacteriophage (Hansen et al., 1998). 
 
One example of filamentous bacteriophage used for RDC measurements is Pf1. 
Pf1 derived from Pseudomonas aeruginosa, is a rod-shaped filamentous 
bacteriophage, 2000 nm long with a 6.6 nm in diameter, harbouring single-
stranded circular DNA. The DNA is packaged with coat protein at a 1:1 
nucleotide: coat protein ratio. The coat proteins form a repeating network of 
carbonyl groups that are believed to be the source of the phage’s large 
anisotropic magnetic susceptibility (Torbet & Maret, 1979). Pf1 is negatively 
charged at pH 7.4.  Pf1 has several advantages as an alignment medium 
compared to other alignment media. Some characteristics of Pf1 are as follows: 
- It aligns spontaneously in the presence of a magnetic field (with the rod 
lying parallel to the magnetic field). 
- Even though the addition of phage makes the protein solution much 
more viscous, this viscosity has surprisingly no effect on the rotational 
correlation time of the protein. 
- It is stable at pH 6-8 
- The aligned sample can be measured even after storage at 4 0C (although 
prolonged storage times will increase the alignment) No 1H or 31P 
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resonances are observed from the large phage particles, thus the phage 
does not add more peaks in the protein NMR spectrum. 
- It is possible to separate the phage from the dissolved protein by 
ultracentrifugation which pellets the phage while leaving the protein in 
the supernatant. 
 
Upon addition of the alignment medium to the sample, the degree of alignment 
is measured by observing the splitting of the D2O signal. The splitting of D2O 
signal arises from the large deuterium quadrupole moment that is not 
isotropically averaged for water bound to the aligned phage particles. By 
adding more phage to the protein sample, the alignment increases. A splitting of 
no more than ~15 Hz is normally used.  Higher degrees of alignment cause line 
broadening from unresolved proton-proton dipolar coupling. 
 
 
After addition of the alignment medium, two independent 15N-1H IPAP-HSQC 
spectra are acquired. These spectra are acquired in an interleaved manner 
without 1H decoupling in the 15N dimension. In one data set, the scalar and 
dipolar coupling lead to in-phase splitting of the resonances in the nitrogen 
dimension, while in the other data set, this splitting is anti-phase. The addition 
of these spectra gives a spectrum that contains one of the doublets while the 
subtraction of the two spectra gives a spectrum containing the other doublet. 
This approach is referred to as IPAP (in-phase, anti-phase) (Ottiger et al., 1998). 
 
On aligned sample the splitting is the sum of the scalar and dipolar coupling 
(J+D). The splitting observed in the aligned sample is either either larger than 
 - 68 -
the J-coupling, or slightly smaller depending on the orientation of the 15N-1H 
vector with respect to the molecule. If the vector is parallel to the long axis of the 
molecule, the doublet splitting is slightly smaller.The RDC values are measured 
as difference in splitting between aligned and isotropic phase. 
 
2.6.7 NMR Experiments for protein structure determination 
 
Because for the present work, no pulse design was attempted, a brief overview 
of the experiments used for resonance assignments is described below.  A full 
comprehensive experimental setup guidance and pulse sequences used for the 
following experiments can be accessed online at:  
(http://nmr-linux.chem.ed.ac.uk/highfield/highfield.html) 
 
2.6.7.1 2D Experiments for backbone and side-chain assignment:  
 
1H-15N HSQC and 1H-13C HSQC 
 
In order to identify each amino acid in the assignment process, a spectroscopic 
“handle” is chosen to which all the backbone and side-chain resonances are 
associated. This is used to catalogue all the chemical shifts of a given amino 
acid. This kind of “handle” is the backbone amide proton and nitrogen as each 
amino acid contains only one amide group in the backbone. Thus, the NH group 
serves as a reference point to which all other backbone and side-chain atoms can 
be linked. The spectrum that gives information for the dispersion of the NH 
groups of amino acids in the molecule is the 1H-15N HSQC.  The NH groups 
shown in an HSQC experiment are the backbone amide groups, Trp side-chain 
Nε-Hε groups, Asn/Gln side-chain Nδ-Hδ2/Nε-Hε2, Arg Nε-Hε peaks (usually 
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appearing as folded peaks). The Arg Nη-Hη and Lys Nζ-Hζ are not normally 
visible due to water exchange unless the experiment is recorded at very low pH.  



















This experiment correlates the amide 1H and 15N signals with both the 
intraresidue (i) Cα and Cβ signals and with the Cα  and Cβ of the preceding 
residue (i-1). The experiment exploits the fact that each amide nitrogen is 
coupled to its own Cα  (1JCN ~12 Hz) more strongly than to the Cα  preceeding it 
(2JCN ~7 Hz). As a result, the strip for each N-H contains intense peaks for its own 
Cα and Cβ resonances and weaker peaks for the Cα and Cβ resonances of the 
previous residue. The way that magnetisation is transferred between Cα and 
Cβ causes the cross peaks of these carbons to have opposite signs. Aligning the 
weak peaks in one strip with the strong peaks from another establishes that the 
corresponding N-H pairs are adjacent in the sequence. 
 




Fig. 22 Transfer of 











This experiment correlates the 1H and 15N amide resonances of one residue with 
both Cα  and Cβ resonances of its preceding residue. A more sensitive 
experiment (less time to acquire data) than its “partner” CBCANH. The 
interresidue correlations are established by transferring coherence via the 
intervening 13CO spin. Two peaks are generated in this spectrum instead of four 
in the CBCANH. The CBCA(CO)NH shows carbon peaks only from the i-1 
residue whereas the CBCANH shows both i-1 (these should overlap with the 




Fig. 23 Transfer of 








This experiment correlates amide protons with carbonyl carbons. The 
magnetisation is transferred from the HN(i) proton via the N(i) atom to the directly 
attached CO(i-1) carbon atom and return the same way to the HN(i) nucleus which 
is directly detected.  The most sensitive experiment of all the backbone 
assignment experiments, HNCO was among the first triple-resonance 
experiments to be developed and its high sensitivity makes it one of the most 





Fig. 24 Transfer of 










This is a complementary experiment to HNCO. In the HN(CA)CO experiment 
the magnetisation is transferred from the HN(i) proton via the N(i) atom and the 
Cα(i) to the CO(i) and CO(i-1) carbon atom and back the same way. The Cα(i) and 
Cα(i-1) act only as a relay nuclei, their frequency is not detected. Only the 
frequencies of HN, N and CO are detected. The experiment provides 
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intraresidue and some weaker interresidue correlations, but is much less 





Fig. 25 Transfer of 










HBHANH and HBHA(CO)NH 
 
 
The HBHANH and HBHA(CO)NH experiments are collectively used to assign 
each Hα(i), Hβ/β’(i), Hα(i-1), Hβ/β’(i-1) resonance quartet (or pentet or sextet depending 
on the multiplicity and degeneracy of the Hβ protons) to its amide resonance 
group. The magnetisation of HBHANH and HBHA(CO)NH  is similar to the 
CBCANH and CBCA(CO)NH accordingly (see Fig. 22 and 23), however, this 
time the peaks in the spectrum belong to the protons rather than the carbons. 
Hα and Hβ resonances complement the Cα and Cβ resonances in establishing 
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The   HC(C)H-TOCSY experiment correlates all aliphatic 1H and 13C spins within 
residues and is used to assign aliphatic 1H and 13C resonances and connect the 
side-chain chemical shifts with the backbone assignments. The reference point 
for the sidechain assignments is not the 1H-15N HSQC as it is for the backbone 
assignment, but the 1H-13C HSQC spectrum. All proton shifts of the (i) residue 
from the HC(C)H-TOCSY are correlated with CH-HC of the 1H-13C HSQC. The 
HC(C)H-TOCSY experiment spreads a 2D-TOCSY spectrum into a 3rd 
dimension to reduce signal overlapping. The magnetisation transfer starts from 
the 1H to its directly attached 13C nucleus via the 1JCH coupling (~140 Hz), then 
from the 13C to neighbouring 13C nuclei via the 1JCC coupling (~35 Hz), and 







Fig. 26 Transfer of  magnetisation in                                                          
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H(CCO)NH and C(CO)NH  
 
 
Two other experiments that help with the assignment of sidechain atoms are the 
H(CCO)NH and C(CO)NH . They are useful experiments for the identification 
of Cγ, Cδ and Hγ and Hδ  when the information from the HC(C)H-TOCSY is 
ambiguous. The experiments have similar magnetisation transfer pathways with 
the H(CCO)NH correlating sidechain proton chemical shifts from i-1 residue 
with the i residue amide groups and the C(CO)NH correlating the carbon 
chemical shifts.  The transfer of magnetisation starts from the side-chain 
hydrogen nuclei to their attached 13C nuclei and subsequently to their adjacent 
carbon nuclei through isotropic mixing. From here, magnetisation is transferred 
to the carbonyl carbon, on to the amide nitrogen and finally to the amide 





Fig. 27 Transfer of magnetisation in 
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2.6.7.4  2D Experiments for the assignment of aromatic residues:  
 
 
Three 2D experiments were used for the assignment of aromatic side-chains. A 
1H-13C HSQC optimised for aromatic residues, and aromatic (HB)CB(CGCD)HD 
/ (HB)CB(CGCDCE)HE experiments. The (HB)CB(CGCD)HD correlates Cβ with 
Hδ of aromatic residues, and the (HB)CB(CGCDCE)HE correlates Cβ   with  Ηε of 
aromatics. These experiments were utilised for the complete assignment of 
histidine, phenylalanine, tryptophan and tyrosine residues. 
 
 
2.6.7.5  3D Experiments for the acquisition of NOE restraints: 
 
 
15N-NOESY-HSQC and 13C-NOESY-HSQC  
 
 
3D NOESY-HSQC is formed by combining an HSQC spectrum with a NOESY 
spectrum after removing the acquisition period of the NOESY and the 
preparation period of the HSQC. The mechanism involves a 1H-1H NOE step 
followed by heteronuclear transfer via 1JNH (or 1JCH).  At the beginning of the 
experiment, the magnetisation is labelled with the frequency of a proton (HX).  
After the evolution of HX chemical shifts, the magnetisation is transferred to 
vicinal amide protons by dipolar coupling during the NOESY mixing period τm. 
the magnetisation is then passed via scalar coupling to the bound amide 
nitrogen. The final step involves the transfer of magnetisation again through 
scalar coupling from the amide nitrogen to the amide proton. Thus the final 
signal is recorded with three frequencies: HX, 15N and HN. The HN is detected in 
the direct dimension while the amide nitrogens and the chemical shifts of the 
protons close in space are detected indirectly. Each strip in the spectrum 
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contains NOEs from one N-H (or C-H) group to all other hydrogen atoms close 
by.  
 
The relatively poor chemical shift dispersion of protons can often lead to 
multiple assignment possibilities for a given NOE. Thus, in order to help the 
structure calculation programs reach a fairly correct conformation even from the 
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Chapter  3:  Methods 
 
3.1 Expression and purification of ArdA/ KlcA  
 
An almost identical protocol was used to purify ArdA or KlcA. E. coli 
BL21(DE3) was transformed with pDMArdA (pTrc99A containg the orf18 gene) 
or pDMKlcA (pET24-a containing the klcA gene) and plated onto LB agar 
supplemented with 100 μg/ml carbenicillin or 25 μg/ml kanamycin. A single 
colony was picked and grown in LB medium plus 100 μg/ml carbenicillin (or 
kanamycin) to an optical density at 600 nm (OD600) of 0.5 at 37 0C. 
Heterologous gene expression was induced by the addition of IPTG to 1 mM 
and the growth continued for a further 4 hours at 37 0C for ArdA and at 30 0C 
for KlcA before harvesting. The amount of recombinant protein was assessed by 
SDS-PAGE (4-12% gradient gel) analysis. Typically 40 g of cells from 10 L of 
culture broth were obtained. Cells were harvested by centrifugation (6000 g, 4 0C, 
15 min) and the cell pellet was stored at -20 0C until required. 
 
Approximately 20 g of cell pellet was defrosted on ice for 30 min and 
resuspended in 200 ml of buffer A (20 mM Tris–HCl, pH 8.0, and 7 mM 2-
mercaptoethanol). Protease inhibitors benzamidine and PMSF 
(phenylmethylsulfonyl fluoride) were added to a final concentration of 10 μM. 
The cells were disrupted by sonication on ice using a Soniprep 150 sonicator 
(Sanyo, Tokyo, Japan) fitted with a 9-mm-diameter probe (5×1 min bursts with 
15 s intervals between each burst). The extract was centrifuged at 20,000g for 1 h 
at 4 °C, and the supernatant was filtered through a filter unit (0.45 μM; Sartorius 
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AG, Goettingen, Germany). The clarified extract was then loaded onto a DEAE 
anion exchange column (30 cm×1.6 cm diameter), equilibrated with buffer A, at 
a flow rate of 60 ml/h. The column was washed with approximately three 
column volumes of buffer A to remove unbound material. Bound proteins were 
then eluted using a 500-ml gradient of 0–1 M NaCl in buffer A at a flow rate of 
20 ml/h. Fractions that gave a UV absorbance were subsequently analysed by 
SDS-PAGE. Fractions containing ArdA or KlcA were pooled and concentrated 
using a spin concentrator with a 10-kDa cutoff membrane (VivaScience AG, 
Hanover, Germany) to a final volume of 5 ml. The sample was then loaded on a 
Superdex-200 column (GE Healthcare, Uppsala, Sweden), equilibrated with 
buffer A plus 0.2MNaCl, and the protein was eluted at a flow rate of 30 ml/h. 
The fractions were subsequently analysed by SDS-PAGE, and those containing 
ArdA or KlcA were pooled and concentrated as before. The extinction 
coefficient of ArdA was calculated using the ExPASy ProtParam tool to be 
30,370 cm−1 M−1, assuming ArdA is a monomer. For the KlcA the extinction 
coefficient was calculated to be 24,410 cm−1 M−1 assuming KlcA to be a monomer.  
Purified ArdA or KlcA was stored at −20 °C in buffer A containing 50% (v/v) 
glycerol. 
 
3.2 Size-exclusion HPLC 
 
The molecular mass of ArdA at different protein concentrations was determined 
by size-exclusion HPLC. The experiment was conducted using a Superose 12 
(10/300) column (GE Healthcare) at a flow rate of 0.5 ml/min. The buffer used 
was 20 mM Tris–HCl, 20 mM 4-morpholine-ethane sulfonic acid (Na salt), 200 
mM NaCl, 10 mM MgCl2, 7 mM 2-mercaptoethanol and 0.1 mM 
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ethylenediaminetetra-acetic acid adjusted to pH 6.5. Protein elution from the 
column was monitored by UV absorption at 280 nm and fluorescence emission 
at 350 nm with excitation at 295 nm. The column was first calibrated with 
protein standards (bovine serum albumin, alcohol dehydrogenase, carbonic 
anhydrase and cytochrome c), which were run individually. The ArdA was then 
analysed at a range of different concentrations from 50 nM to 100 μM. 
 
3.3 Circular Dichroism 
 
CD measurements were carried out on a Jasco model J-180 spectropolarimeter 
(Jasco Corporation, Tokyo, Japan) in 10 mM Tris–HCl, pH 8.0, 50 mM NaF and 7 
mM 2- mercaptoethanol buffer. Far-UV CD spectra (190–260 nm) used a protein 
concentration of 30 μM and a 0.2-mm pathlength cell. Near-UV CD 
measurements (260–320 nm) used a protein concentration of 130 μM with a 0.5-
cm path-length cell. A bandwidth of 1 nm was used with a scan speed of 10 
nm/min. All CD measurements were made at 25 °C, and each spectrum was the 
average of five individual scans. The spectra were corrected for buffer 
contribution. 
 
3.4 Fluorescence quenching for the determination of tryptophan accessibility 
 
Fluorescence quenching measurements were performed on an Edinburgh 
Instruments FS900 spectrofluorometer (Edinburgh, UK). The concentration of 
ArdA was 3 μM in buffer A, 25 °C. Samples were excited at 295 nm, and the 
emission spectra were recorded between 300 and 420 nm with 5-nm bandwidth. 
Tryptophan fluorescence was 
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quenched by successive additions of acrylamide solution (5 M). Iodide 
quenching was also performed with successive additions of 5 M KI 
supplemented with 2 mM Na2S2O3 to prevent the formation of I-3 (Lakowicz, 
2006). The fluorescence of the buffer was subtracted from the emission spectra. 
The spectra were also corrected for dilution and inner filter effects (acrylamide 
has a molar extinction coefficient of 0.23 M−1 at 295 nm). The data were fitted 
with the Stern–Volmer equation (Eftink & Ghiron, 1981); F0/F = (1+Ksv [Q]) 
where F0 and F are the fluorescence intensities in the absence and presence of 
quencher respectively, [Q] is the quencher concentration and ksv the collisional 
quenching constant. The fitting was performed using Origin 7.5 analysis 
software (MicroCal, Northampton, MA). 
 
3.5 Determination of the unfolding free energy ΔG using fluorescence 
spectroscopy 
 
Equilibrium unfolding as a function of GdmCl was monitored by fluorescence 
spectroscopy. A stock solution of 8M GdmCl was made up, and the precise 
concentration was determined from the refractive index of GdmCl (Creighton, 
1990). Native protein (3.5 μM) in buffer A was incubated with various 
concentrations of GdmCl at 25 °C and allowed to equilibrate overnight at room 
temperature. The fluorescence intensity was then measured for each sample 
using excitation at 295 nm and emission at 330 nm with 5-nm bandwidths. 
Experimental data were fitted to a two-state unfolding model (Pace et al., 1989) 
assuming a linear relationship between free energy of unfolding and 
concentration of GdmCl as follows: 
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   {sF+mFD+(sU+mUD)exp[-(ΔGw-mD)/RT]} 
S= ----------------------------------------------------------------------     
          {1+exp[-(ΔGw-mD)/RT]} 
 
Where ΔGw:  free energy of unfolding in water ; D:  molar concentration of 
denaturant ; S:  observed spectroscopic signal ; sF:  spectroscopic signal of the 
folded state ; m: slope of transition; sU: spectroscopic signal of the unfolded 
state; mF: slope of the folded state; mU: slope of the unfolded state; R: gas 





DSC measurements were done using a VP-DSC calorimeter (MicroCal) with a 
cell volume of 0.52 ml. The experiments were performed in 20 mM Tris–HCl, 
pH 8.0, 6 mM MgCl2 and 7 mM 2-mercaptoethanol buffer with a protein 
concentration of 50 μM. DSC data were corrected for instrument baselines and 
normalised for scan rate and protein concentration. Scans were from 15 to 100 
°C at a rate of 60°/h. Samples were degassed under vacuum for 2 min with 
gentle stirring before being loaded into the calorimetric cell. Experiments were 
performed under a constant external pressure of 25 psi to avoid bubble 
formation. Once the first scan was completed, the sample was cooled and 
rescanned under the same experimental conditions to test for the reversibility of 
the denaturation reaction. Fitting of the partial heat capacity (Cp) curves using a 
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3.7 ITC 
 
ITC was performed using a VP-ITC calorimeter (Micro-Cal). The stocks of ArdA 
and M.EcoKI were transferred into 20 mM Tris–HCl, pH 8.0, 6 mM MgCl2 and 7 
mM 2-mercaptoethanol buffer using a PD-10 column (GE Healthcare). SAM was 
added to a final concentration of 100 μM. Protein and buffer were degassed 
prior to use. A stock solution of ArdA (51.8 μM) was titrated into 5.0 μM 
M.EcoKI in the VP-ITC cell (active volume=1.4 ml). The heat of dilution was 
obtained by injection of ArdA into buffer alone or buffer into buffer. These 
values were subtracted from the ITC titration data. Calorimetric data were 
converted to differential binding curves by integration of the resultant peaks 
and fitted to a standard single-site binding model using MicroCal LLC Origin 
software. 
 
3.8 In vivo Restriction/Modification assays  
 
A spot test was first performed to test for alleviation of restriction by ArdA or 
KlcA. A 200-μl aliquot of an overnight culture of restriction-proficient E. coli 
strains (NM1049, restriction system Type IA; NK354, Type IB; NK402, Type IC; 
NM1009, Type ID) and restriction-deficient E. coli (NM1261 strain) harbouring 
either pDMArdA or pTrc99A were mixed with 3 ml of molten BBL top agar (<40 
°C) and poured over BBL bottom plates containing carbenicillin. A 5-μl aliquot 
of various dilutions (10−1–10−9) of unmodified virulent phage lambda, λv.0, was 
then spotted in a defined array onto the plates. After incubation at 37 °C 
overnight, the number of plaques within each spot was assessed. Based on the 
results of these spot tests, efficiency of plating (EOP) experiments were then 
performed. A 200-μl aliquot of an overnight culture from each test strain was 
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mixed with 50–100 μl of phage at an appropriate dilution to give a total of 100–
200 plaques per plate. The mixture was incubated at 37 °C for 15 min to allow 
phage absorption and then mixed with molten BBL top agar (3 ml) and 
immediately poured onto a BBL bottom plate. Each experiment was performed 
in triplicate. The plates were incubated at 37 °C overnight.  
 
EOP was derived by determining the titre of phage on the restriction-proficient 
strains relative to the nonrestricting strain. Antirestriction was defined as the 
EOP obtained with strains containing the plasmid pDMArdA divided by the 
EOP obtained from strains containing the plasmid pTrc99A. For the 
antimodification assays, plaques grown on each E. coli strain in the presence 
(i.e., strains harbouring pDMArdA) or absence (i.e., strains harbouring pTrc99A) 
of ArdA were picked and resuspended in 1 ml of phage buffer containing 50 μl 
of chloroform. The phage suspension was incubated for at least 2 h at room 
temperature to allow any remaining bacteria to be killed. After spinning the 
suspension at 6000 g for 1 min, spot tests and EOP measurements were 
performed as described for the restriction assay experiments using strains that 
had not been transformed with pDMArdA or pTrc99A. The degree of 
antimodification was assessed by determining the EOP of each phage stock on 
the restriction-proficient strain relative to the nonrestricting strain. 
Antimodification was defined as 1/(EOP).  
 
The same procedure was followed for the in vivo restriction/modification assay 
involving pDMKlcA. In this case, however, since the vector was pET24-a, the r-
m- and r+m+ strains needed to be made lysogenic. The strains were made 
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lysogenic (courtesy of Dr. Gareth Roberts, Edinburgh University) using the 
λDE3 lysogenization kit (Novagen) with some modifications. Where necessary, 
the selection phage provided in the kit was replaced with NM848 phage. 
Lysogenisation was then verified using a T7 tester phage (Novagen). 
 
3.9 In vitro antirestriction activity of ArdA/ KlcA 
 
 
The in vitro assay for antirestriction activity monitored the cleavage of 
unmethylated pBRsk1 using purified EcoKI in the absence or presence of ArdA 
or KlcA. The same protocol was used for both ArdA and KlcA. Typical reaction 
digests were performed in a 50-μl volume at 37 °C and contained 100 mM Tris–
acetate, pH 7.5, 100 mM magnesium acetate, 7 mM 2-mercaptoethanol, 50 μg/ml 
bovine serum albumin, 2 mM ATP, 0.1 mM SAM, 3 nM pBRsk1 and 30 nM 
EcoKI. Where required, ArdA or KlcA (3, 30 and 300 nM of monomer) was 
briefly preincubated with EcoKI in the reaction mix prior to initiating the 
reaction with ATP. Reactions were performed for 10 min and then quenched by 
incubation at 68 °C for 10 min. The effect of ArdA or KlcA on the linearisation of 
pBRsk1 with EcoRI was also tested. These reactions were performed using 5 U 
of EcoRI at 37 °C for 25 min in the following buffer: 50 mM NaCl, 100mMTris–
HCl, 10 mM MgCl2 and 0.025% Triton X-100, pH 7.5. The reaction was stopped 
by incubation at 68 °C for 10 min. Samples were mixed with gel loading buffer 
and loaded onto 0.8% agarose gel and subjected to electrophoresis in TAE buffer 
(40 mM Tris acetate and 2 mM ethylenediaminetetraacetic acid) at 100 V/h. 
DNA was visualised using ethidium bromide (0.1 μg/ml) under UV 
illumination. 
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3.10 In vitro assay of DNA displacement from M.EcoKI by ArdA 
 
 
Competition for binding either ArdA or a DNA duplex to M.EcoKI was 
determined using fluorescence anisotropy. A 21-bp DNA duplex containing the 
EcoKI target site sequence (AAC(N6)GTGC), and end-labelled with 
hexachlorofluorescein was used at a concentration of 2 nM in 20 mM Tris–HCl, 
pH 8.0, 6 mM MgCl2 and 7 mM 2-mercaptoethanol buffer plus 100 μM SAM. 
ArdA, if present, was at a monomer concentration of 50 nM. M.EcoKI was 
titrated to DNA in the presence or absence of ArdA up to a final concentration 
of 1 μM. The fluorescence anisotropy change caused by the addition of M.EcoKI 
was measured at 25 0C on an Edinburgh Instruments FS900 spectrofluorometer 
(Edinburgh, UK).  The excitation and emission pathlengths were 10 and 2 mm 
respectively. The samples were excited at 530 nm and emission was detected at 
560 nm. 
 
3.11 NMR spectroscopy and structure calculations 
 
KlcA was uniformly labelled with 15N/13C by growing the recombinant strain in 
M9-minimal medium containing 15NH4SO4 and 13C-D-glucose as the sole 
nitrogen and carbon sources, respectively; (per litre: 25.6 gr Na2HPO4, 6.0 gr 
KH2PO4, 1.0 gr NaCl, 2.0 gr 15NH4SO4, 4 ml MgSO4 (1M), 1 ml CaCl2 (1M), 40 ml 
20 % 13C-D-glucose). The labelled protein was purified as described above. 
Samples for NMR measurements contained 0.7 mM KlcA, 90% H2O/10% D2O 
and 0.05% NaN3 in 20 mM deuterated sodium acetate buffer (pH 6.0). All NMR 
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experiments were carried out at 298 K unless stated otherwise on a Bruker 
AVANCE 800 MHz with a 5-mm triple resonance cryoprobe. NMR experiments 
for 1H, 15N, and 13C backbone and sidechain resonance assignments included: 2D 
1H-1H TOCSY, 1H-1H NOESY, 1H-15N HSQC, 1H-13C HSQC, 3D HNCO, 
HN(CA)CO, CBCANH, CBCA(CO)NH, HBHA(CO)NH, HBHANH, (H)CCH-
TOCSY, H(CCO)NH, C(CO)NH, and aromatic 2D (HB)CB(CGCD)HD/ 
(HB)CB(CGCDCE)HE using parameters as described previously (Uhrinova et 
al., 1998) 3D 15N- and 13C-edited NOESY-HSQC spectra were acquired to obtain 
the distance constraints (Muhandiram et al., 1993). Aromatic 1Hδ and 1Hε 
frequencies were obtained from the combined use of the (HB)CB(CGCD)HD/ 
(HB)CB(CGCDCE)HE spectra (Yamazaki et al., 1993) where the aromatic 1H 
frequencies are correlated with the assigned 13Cβ frequencies of the aromatic 
residue.  
 
NMR data were processed using the Azara suite of programs provided by 
Wayne Boucher and the Department of Biochemistry, University of Cambridge, 
UK and analysed by the CcpNmr Analysis program (Vranken et al., 2005). NOE 
assignments of KlcA were generated using the CANDID module (Herrmann et 
al., 2002) of CYANA 2.1 software (Guntert, 2004). Dihedral constraints were 
generated using TALOS (Cornilescu et al., 1999). The standard protocol was 
used with seven cycles of combined automated NOE assignment and structure 
calculation of 100 conformers in each cycle. The NOE assignments obtained by 
CANDID were checked manually and from the 100 structures calculated, 20 
structures with lowest target function were selected for further analysis. The 
structures were further refined using residual dipolar couplings (RDCs) using 
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the Crystallography and NMR system (CNS) (Brunger et al., 1998). 
PROCHECK-NMR (Laskowski et al., 1996) and WHATIF (Vriend, 1990) were 
used to analyse the quality of the structures. MOLMOL (Koradi et al., 1996) and 
PYMOL (http://www.pymol.org) were used for visualisation. 
 
A  200 μM 15N-labelled KlcA sample in 20 mM deuterated sodium acetate, 0.05% 
NaN3, pH 6.0 in 90% H2O/10 % D2O aligned with 6.25 mg/ml of Pf1 filamentous 
phage (Pf1 protease and RNase free, Profos) was used to measure RDCs. 
Magnetic alignment was monitored by 1D 2H NMR spectra as a function of 
phage concentration. A 7 Hz residual quadropolar splitting of the deuterium 
signal was achieved with 6.25 mg/ml phage. 1H-15N splittings were measured 
under isotropic and partially aligned conditions using 2D IPAP 1H-15N HSQC 
experiments (Ottiger et al., 1998). Analysis and back-calculation of the residual 
dipolar couplings was performed with the program REDCAT (Valafar & 
Prestegard, 2004). 
 
Relaxation experiments were performed on a 600 MHz Bruker spectrometer at 
25 °C with 200 μM 15N labelled KlcA. For the longitudinal (T1) and transverse 
(T2) relaxation data for the backbone 15N nuclei of KlcA, water was kept along 
the z axis during the entire pulse sequence  (Grzesiek & Bax, 1993) and extra 
delays were used in the T1 experiment to eliminate the differential heating 
arising from the variations of the relaxation delay (Yip &, Zuiderweg, 2005). 
Eight interleaved spectra were recorded for each type of relaxation with 
different duration of the relaxation delay, T1 (51 (twice), 401, 601, 801, 901, 1001, 
1201 ms) and T2 (16 (twice), 48, 64, 80, 96, 112, 144 ms).  
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T1 and T2 cross-peak intensities were measured from peak heights and fit to an 
exponential decay function I (t) = I(o)e (-R* t) where I(o) is the cross-peak 
intensity at time zero, I(t) is the cross-peak intensity at time t (t is the relaxation 
delay) and R (1/T) is the relaxation rate. . The fit was performed by non-linear 
least-squares method using the Analysis software package (Vranken et al., 2005). 
For the 2D 1H-15N heteronuclear NOE experiment (Grzesiek & Bax, 1993) a 3 s 
pre-saturation period and a 2 s relaxation delay was used; the control 
experiment had an equivalent 5 s delay. In these experiments, water was 
returned to the z-axis prior to each scan to avoid saturation transfer. Spectra 
from the heteronuclear NOE experiment were extended by linear prediction 
and zero filling prior to apodization with a 5 % shifted mixed 
Gaussian/exponential function. NOE peak heights were taken from the 
Gaussian fits of the frequency-domain data. The NOE was calculated as NOE= 
Ion/Ioff where Ion and Ioff are the peak heights with and without 1H presaturation, 
respectively.  
 
T1, T2 and NOE data were fitted using the “Quadric_diffusion” program, 
developed in the laboratory of Arthur G. Palmer (Columbia University), in 
order to obtain the rotational diffusion tensor. Model-free analysis of the 
relaxation data was performed using the program Tensor2 (Dosset et al., 2000). 
For this analysis a subset of relaxation data was selected using the following 
criteria. (a) Residues possessing considerable internal motion with 
heteronuclear NOE values smaller than 0.65 were discarded. (b) residues 
involved in conformational exchange identified using the following criterion: 
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[(<T2> - T2,n)/<T2> - (<T1> - T1,n)/<T1>] > 1.5 x SD, where T2,n is the T2 value of 
residue n and <T2> is the average T2 and SD is the standard deviation of the 
above formula, were also discarded (Tjandra et al., 1995).  
 
3.12 KlcA fold recognition and comparison 
 
The B. pertussis KlcA sequence was subjected to a BLAST search (Altschul et al., 
1990; Altschul et al., 1997) against the Protein Data Bank (PDB) (Berman et al., 
2002) and to fold recognition servers 3D-PSSM (Kelley et al., 1996); PHYRE 
(Bennett-Lovsey et al., 2008) and the BioInfo server (Ginalski et al., 2003) to check 
if there was any clear or remote homology to an existing structure or fold. 
Additionally, the solved KlcA structural fold was compared against fold 
libraries, SCOP (Murzin et al., 1995) and CATH (Orengo et al., 1997; Greene et 
al., 2007) with the following methods: (i) DALI version 3.0 (Holm & Sander 
1993; Dietmann et al., 2001); (ii) CATHEDRAL (Redfern et al., 2007); and (iii) 
SSM (Krissinel &Henrick, 2004).  
 
3.13 KlcA conservation and surface analysis 
 
Related sequences to the B. pertussis KlcA sequence (UniProt Accession no: 
Q08L07) were obtained using a BLAST (blastp) search (Altschul et al., 1990; 
Altschul et al., 1997) against the UniProt sequence database (Bairoch et al., 2005), 
via the NPS@ server (Combet et al., 2000). A total of 182 sequences with an E-
value of less than 10-6 were obtained and this list was made non-redundant 
initially by removing 62 identical sequences. The remaining 120 KlcA-like 
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sequences were retrieved and a multiple sequence alignment was generated 
using the program PROMALS3D (Pei et al., 2008a; Pei et al., 2008b). This set of 
sequences was rendered further non-redundant by removing all 90% pairwise 
identical sequences in the alignment using the Expasy server 
(http://www.expasy.ch/tools/redundancy/). A total of 44 non-redundant 
divergent sequences were thus obtained. Upon analysis, one sequence that 
lacked the C-terminal helix 5 was discarded and three other sequences, which 
possessed N-terminal extensions, were trimmed. The remaining 43-aligned 
sequences were used as input for the Consurf server (http://consurf.tau.ac.il/) 
(Glaser et al., 2003; Landau et al., 2005), to map sequence conservation on the 
surface of the protein. The results were viewed under PyMol version 1.0 
(http://www.pymol.org).   
 
The electrostatic surface potential representation was calculated using GRASP 
(Nicholls et al., 1991). The lipophilic surface rendition was generated using 
MOLCAD under SYBYL version 6.9 (Tripos Associates, St. Louis, MO, USA).  
Solvent-accessible calculations for each residue were performed using 
'NACCESS' computer program (Department of Biochemistry and Molecular Biology, 
University College London). 
 
 
3.14 Purification of DNA fragments from PCR reaction 
 
The purification of PCR products used for cloning purposes was performed 
using the QIAquick PCR Purification Kit Protocol (Qiagen). Five volumes of 
Buffer PB (Qiagen supplied) were added to one volume of the PCR sample. The 
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sample was applied to a QIAquick column and centrifuged for 30–60 s at 13,000 
rpm. The flow-through was discarded and 0.75 ml of the washing Buffer PE 
(Qiagen supplied) was applied to the QIAquick column and centrifuged for 30–
60 s. The flow-through was discarded and the column was centrifuged for an 
additional 1 min to completely remove residual ethanol. The column was placed 
in a clean microcentrifuge tube, 30 μl of buffer EB (10 mM Tris·Cl, pH 8.5) was 
applied at the center of the column membrane, the column was left to stand for 
1 min and the final purified sample was collected after centrifugation of the 
column for 1 min.  
 
 
3.15 DNA extraction from agarose gels 
 
The extraction and purification of DNA from agarose gels was performed using 
the QIAquick Gel Extraction Kit Protocol (Qiagen). The gel slice containing the 
DNA of interest was excised with a scalpel from the agarose gel. The slice was 
weighed and 3 volumes of buffer QG (Qiagen supplied) were added to 1 
volume of gel (100 mg ~100 μl). The slice was incubated for 10 min (or until the 
agarose had completely dissolved depending on the size of the gel slice) at 50°C 
with occasional vortexing every 2-3 min. After the agarose had dissolved 
completely, 1 gel volume of isopropanol was added, mixed, applied the sample 
to a QIAquick column to bind the DNA and centrifuged for 1 min. at 13,000 
rpm. The flow-through was discarded after the run had finished, 0.5 ml of 
Buffer QG was added to the column and centrifuge for 1 min. in order to 
remove all traces of agarose. For the washing step, 0.75 ml of Buffer PE (Qiagen 
supplied) was applied to the column and centrifuged for 1 min. The flow-
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through was discarded and the column was centrifuged for an additional 1 min. 
The column was placed in a microcentrifuge tube,  30 μl of buffer EB (10 mM 
Tris·Cl, pH 8.5) was applied at the center of the column membrane, the column 
was left to stand for 1 min and the final purified sample was collected after 







For the isolation of proteins in denaturing conditions, Sodium Dodecyl Sulphate 
Polyacrylamide Gel Electrophoresis (SDS-PAGE) was used. Protein samples 
were mixed with 6x SDS-loading buffer and loaded on pre-cast 4-12% NuPAGE 
Novex gels (Invitrogen). An X-cell Sure Lock (Invitrogen) apparatus was filled 
with 1x NuPAGE buffer (Invitrogen provided) and the gels were run at a 
constant 150 V for 45 min.  
 
 
3.17 BN-PAGE  
 
 
For the isolation of proteins in their native state and protein complexes, Blue-
Native Polyacrylamide Gel Electrophoresis (BN-PAGE) was used. Protein 
samples were mixed with NativePage sample buffer (Invitrogen provided) and 
loaded on pre-cast 4-16% NativePAGE Novex Bis-Tris gels (Invitrogen). The 
upper buffer chamber was filled with 200 ml 1x NativePage Cathode buffer 
(Invitrogen) and the lower buffer chamber with 550 ml 1x NativePage Anode 
buffer (Invitrogen). 8 μl NativeMark (Invitrogen) marker was used as a size 
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ladder. The electrophoretic apparatus was an X-cell Sure Lock (Invitrogen). A 
running time of 120 minutes was used with a constant 150 V. 
 
 
3.18 DNA electrophoresis 
 
 
Agarose gels for electrophoretic analysis of DNA were prepared with 1x TAE 
buffer and 0.8 or 1.2% agarose depending on the size of DNA that was to be 
analysed. The mixture was heated until all the agarose was dissolved, left to 
cool and ethidium bromide was added (0.5 μg/ml). The mixture was poured in 
an electrophoretic apparatus, a comb was inserted to create the wells and the gel 
was left to solidify. After the gel was solid, the comb was removed and the 
samples containing DNA mixed with loading buffer were loaded in the wells 
after the immersion of the gel in 1 x TAE buffer. The gel was run at 120 Volts for 
1-2 hrs, and the DNA was visualised using a UV transilluminator. 
 
3.19 Cloning Procedure 
 
 
Orf18 of Tn916 was amplified by the polymerase chain reaction (PCR) from 
plasmid pAM120 using the following pair of primers: forward, 5′- AGT 
CGTCCATGGACGATATGCAAGTCTATATTG- 3′; reverse, 5′- GACACT 
AAGCTTTTAATAGACGATTTCAAAAATCCC-3′. To facilitate cloning, the 
forward and reverse primers included NcoI and HindIII recognition sites, 
respectively. PCR was performed using 1.5 U of Taq DNA polymerase, 10 mM 
Tris-HCl (pH 9.0 at room temperature), 50 mM KCl, 1.5 mM MgCl2, 200 μM 
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each deoxynucleoside triphosphate, 40 pmol of each primer and ~50 ng of 
plasmid DNA. The PCR consisted of the following steps: denaturation for 1 min 
followed by 30 cycles of denaturation (95ºC for 30 sec), primer annealing (45 0C 
for 30 sec) and extension (72 0C for 4 min). An amplified product of the 
anticipated size was obtained, digested with NcoI and HindIII and then ligated 
into the corresponding sites on pTrc99A using the Quick T4 DNA Ligation kit 
(New England Biolabs) to generate the expression construct pDMArdA. Plasmid 
DNA was prepared and nucleotide sequencing of the insert DNA was 
performed to ensure no mistakes had been introduced during amplification.  
 
The same cloning procedure was followed for all the constructs described in this 
work. The truncated orf18 was ligated into pET15-b. The primers used were: 
forward, 5’- CGG TGT CCA TAT GGT ATC GGA ATT AC -3’; reverse, 5’- CAG 
CTA GGA TCC CTA TTA ATA GAC GAT TTC-3’. klcA was synthesised by 
GeneArt (Germany) using the deposited DNA sequence (Gene ID: 4364084) as a 
starting point for codon optimisation and synthesis. The synthetic gene was 
inserted into vector pET24-a. The N-terminus- and C-terminus -myc-tagged klcA 
were ligated into pET24-a. For the N-terminus-myc-tagged klcA the primers 
were: forward, 5’- ATC AGT CCA TAT GGA ACA AAA ACT TAT TAG TGA 
AGA AGA TCT TAT GAA CAC CGA AGA AC-3’; reverse, 5’-CCG TAC TAA 
GCT TTC ATC AAT CAA TCG CAC GAT A -3’. For the C-terminus-myc-tagged 
KlcA : forward, 5’- GAT CAG TCC ATA TGA ACA CCG AAG AAC AG-3’; 
reverse, 5’- GTA CTA AGC TTT CAA AGA TCT TCT TCA CTA ATA AGT TTT 
TGT TCA TCA ATC GCA CGA TAA -3’. 
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3.20 Plasmid transformation 
 
Prior to transformation, bacterial cells were made competent by using the Ca2+-
treatment (Sambrook, 2002). Overnight cultures (10 ml) of bacteria incubated at 
37°C were recovered by centrifugation at 3500 rpm for 10 min. The medium was 
decanted and the cell pellets were resuspended by gentle mixing in 20 ml ice 
cold 80 mM MgCl2 - 20 mM CaCl2 solution. The cells were centrifuged once 
more, the supernatant was discarded and the pellets were resuspended in 2 ml 
ice-cold 0.1M CaCl2. For the transformation, 100 μl of competent cells were 
mixed with 1 μl of plasmid DNA and left on ice for 30 min. The cells were 
subsequently heat-shocked for 35 sec at 42 °C and immediately put on ice for 2 
min. 900 μl of warm LB broth or SOC medium (2% w/v bacto-tryptone, 0.5% 
w/v bacto-yeast extract, 10mM NaCl, 2.5mM, KCl, 10mM MgCl2 , 20mM 
glucose,  pH 7.0) was added to the cells and left to incubate at 37 °C for 1 hr. in 
order for expression of antibiotic resistance genes to take place. Cells were 
plated on selective media and incubated overnight at 37 °C to obtain 
transformants. 
 
3.21 Plasmid DNA isolation 
 
 
All plasmid isolations were performed with the help of the Qiaprep kit from 
Qiagen. This protocol (for small volume plasmid extraction) is designed for 
purification of up to 20 μg of high-copy plasmid DNA from 1–5 ml overnight 
cultures of E. coli in LB medium. The procedure is based on alkaline lysis of 
bacterial cells followed by adsorption of DNA onto silica in the presence of high 
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salt. Pelleted bacterial cells were resuspended in 250 μl Buffer P1 (50 mM Tri-
HCl, pH 8.0, 10 mM EDTA, 100μg/ml RNaseA) and transfered to a 
microcentrifuge tube. 250 μl Buffer P2 (200 mM NaOH, 1% SDS) were added 
and mixed thoroughly by inverting the tube 4–6 times.  350 μl Buffer N3 (4.2 M 
Gu-HCl, 0.9 M potassium acetate, pH 4.8) were subsequently added and mixed 
immediately and thoroughly by inverting the tube 4–6 times. The solution was 
centrifuged for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge. 
The supernatants from the previous step were applied to the QIAprep spin 
column, centrifuged for 30–60 s and discarded the flow-through.  The QIAprep 
spin column was washed by adding 0.5 ml Buffer PB (5 M Gu-HCl, 30 % 
ethanol) and centrifuging for 30–60 s. The flow-through was discarded and the 
QIAprep spin column was washed by adding 0.75 ml Buffer PE (10 mM Tris-
HCl, pH 7.5, 80 % ethanol) and centrifuging for 30–60 s. The flow-through  was 
discarded, and the column was centrifuged for an additional 1 min to remove 
residual wash buffer. To elute DNA, the QIAprep column was placed in a clean 
1.5 ml microcentrifuge tube and 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) were 
added to the center of each QIAprep spin column which was let to stand for 1 
min. and finally and the column was sucentrifuged for 1 min and the flow-
through was collected. 
 
 
3.22 Western Blot 
 
A precast 4-15 % SDS-PAGE gel (Invitrogen) was run and following 
electrophoresis the bottom ‘lip’ and ‘top comb’ of the gel was cut off. The gel 
was soaked twice for 15 min in 100 ml of chilled Towbin buffer (per litre: 3.03 gr 
Tris base, 14.4 gr glycine, 100 ml methanol) to remove residual SDS. The 
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nitrocellulose membrane was soaked for 30 min in 50 ml of chilled Towbin 
buffer. Two pieces of extra thick blotting paper and both fabric sponges were 
soaked for 5 min in 50 ml Towbin buffer. The gel sandwich was assembled 
under a good depth of Towbin buffer. The sandwich holder was placed clear 
side down. One of the fabric sponges was rolled up under the buffer level and 
squeezed to remove any residual air bubbles, the sponge was then laid on the 
clear side of the holder. Next one piece of blotting paper was placed on top of 
the sponge, followed by the membrane and the gel. Finally, the last piece of 
blotting paper followed by the last sponge was placed on top. The holder was 
then closed and placed into the mini-protean blotting cell (Invitrogen). Transfer 
was achieved by electrophoresis at a constant voltage of 150V for 1 hour and 30 
min.  The transfer was confirmed by observing the transfer of prestained 
markers. Following transfer, the membrane was blocked for 1 hour in 1xPBS + 
5% skimmed milk powder (Sigma). The membrane was subsequently washed 
three times in 1xPBS + 0.05% Tween 20 for 5 min each time. The membrane was 
then washed for a further 20 min in just 1xPBS. The antibody (monoclonal anti-
polyhistidine-peroxidase conjugate clone His-1) (Sigma) was prepared 
according to the manufacturer’s description, and used 50 μl of the antibody per 
50 ml of 1xPBS + 5% skimmed milk powder and left to react overnight. The next 
day, the membrane was washed for 1 hour with 3 changes using 1xPBS + 0.05% 
Tween 20 before rinsing for 20 min with 1xPBS. The membrane was stained 
using 1 tablet of 3,3’- diaminobenzidine (DAB) (Sigma) and one tablet of urea 
(Sigma) dissolved in 5 ml dH2O. Bands appeared within two min. The reaction 
was stopped by pouring away the development solution and rinsing the 
membrane with dH2O.  
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3.23 In-gel protein digestion with trypsin 
 
Bands of interest from an SDS-PAGE gel were cut tightly with a scalpel. The gel 
slices were incubated in 300 μl 200 mM NH4HCO3 in 50 % acetonitrile (ACN) at 
room T for 30 min. This step was repeated twice to remove residual SDS. The 
slices were incubated in 300 μl 20 mM DTT, 200 mM NH4HCO3, 50% ACN at 
room T for 1 h to reduce the protein. The slices were then washed in 300 μl 200 
mM NH4HCO3 in 50 % ACN three times. The cysteines were alkylated in fresh 
100 μl 50 mM iodoacetamide (IAA), 200 mM NH4HCO3, 50% ACN at room T in 
the dark for 20 min. The slices were washed with 500 μl 20 mM NH4HCO3, 50% 
ACN and spinned at 13,000 rpm for 2 min. The slices were then covered with 
ACN for 5 min. The slices after this step turned white. The ACN was decanted 
and allowed the slices to dry. A stock solution of trypsin was prepared by 
adding 50 μl 50 mM NH4HCO3 to a new vial of trypsin (Promega). The gel slices 
were swelled in 29 μl 50 mM NH4HCO3 containing 1 μl of trypsin solution 
prepared previously. During the swelling step, the slices were kept at 4 °C to 
avoid autodigestion of trypsin. The tops of the tubes containing the gel slices 
were sealed with Nescofilm and incubated at 32°C overnight. A trypsin blank 
was also prepared and incubated to be used later as a control. The next day, the 
samples were sonicated for 10 min to facilitate liberation of the peptides still 
trapped in the gel. The digests were stored at -80°C. 
 
3.24 MALDI-TOF-MS  
 
A matrix containing a-cyano-4-hydroxycinnamic acid (CHCA) was prepared as 
follows: weighed 10 mg of CHCA (Sigma), added 400 μl of water, 100 μl of 3% 
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TFA and 500 μl and mixed. The solution was centrifuged at 5,000 rpm for 1 min. 
The supernatant was used for spotting along with the sample on the MALDI 
plate. 0.5 μl of sample was first applied on the wells of the metallic plate and 0.5 
μl of matrix were subsequently added. The plate was allowed to dry at room 
temperature and then loaded on an AppliedBiosystems Voyager DE-STR 
instrument operating in reflectron mode. The system utilizes a pulsed nitrogen 
laser, emitting at 337 nm. For each mass spectrum, 200 single laser shots were 
averaged. The extraction voltage was 20 kV and the low mass gate was set to 
500 Da to prevent the saturation of the detector by ions resulting from the 
matrix. The spectra acquired were calibrated with a trypsin standard (842.5099 
Da), baseline corrected and noise filtered and the peak lists were transferred to  
the Mascot server (Perkins et al., 1999) for peptide mass fingerprinting analysis. 
 
3.25 Co-Immunoprecipitation assay 
 
Competent BL21(DE3) cells were transformed with the pET24-a construct 
harbouring the N-terminus tagged klcA and a 500 lt culture in LB + kanamycin 
(25 μg/ ml) was grown at 370C until OD600 reached 0.5 - 0.7. The gene was 
expressed with 1 mM IPTG for 3 hours at 30 0C. A 3 gr cell pellet was 
subsequently dissolved in 1 ml of BupH TBS buffer (Pierce provided). The cells 
were sonicated for 5 min and centrifuged for 30 min at 13,000 rpm. 300 μl of the 
supernatant were mixed with 10 μl of mouse IgG agarose (Sigma) for the 
preclearing step and left at 4 0C for 1 hr. The precleared lysate was subsequently 
loaded on a Handee Spin Column (Pierce). The same procedure was followed 
for the controls: uninduced N-terminus tagged klcA, pET24-a vector without 
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insert, and an E.coli extract containing c-myc-tagged glutathionine S-
transferease (GST) as a positive control. For the GST control, 50 μl of the lysate 
were mixed with 150 μl BupH TBS buffer. After all the lysates had been applied 
to the Handee Spin Columns, 10 μl of anti-c-myc agarose slurry was added to 
each column. The columns were incubated overnight at 4 0C with gentle end-
over-end mixing. Next day the columns were pulse centrifuged for 10 sec. and 
washed with 0.5 ml of TBS containing 0.05% Tween-20 and centrifuged again. 
The washing step was repeated for a total of 5 times. For the elution step, 10 μl 
of Elution Buffer pH 2.8 (Pierce provided) was loaded on the columns and pulse 
centrifuged for 10 sec. the elution step was repeated for a total of three times. 
The eluent was neutralised immediately by adding 1 μl of 1M Tris, pH 9.5 per 
20 μl of Elution Buffer. For reducing gel analysis, 5 μl of 2-mercaptoethanol 
were added to 40 μl of 5x Lane Marker Non-Reducing Sample Buffer (Pierce). 
7.5 μl of the above described reducing sample buffer were added to 30 μl elution 
sample. The mixture was heated at 95 0C for 5 min. and loaded on a SDS-PAGE 
for analysis. 
 
3.26 His-tagged protein purification 
 
 
The His-tagged truncated Orf18 was purified with the use of a HisTrap FF crude 
column (GE Healthcare). The truncated Orf18 was prepared and induced as the 
wild type Orf18 (see above). The cells were harvested by centrifugation at 3700 
rpm for 15 min at 4 0C. The supernatant was discarded and 5-10 ml of binding 
buffer were added for each gram of cell paste. The solution was mixed 
thoroughly and sonicated on ice for 5 min with it was no more viscous. The 
 - 101 -
stopper of the column was removed and the column was connected to the 
syringe with the provided adapter “drop-to-drop” to avoid introducing air into 
the column. The snap-off end was removed and the column was washed with 5 
ml of dH2O. Using a syringe, the column was equilibrated with 10 mls of 
binding buffer. The sample was loaded on the column as crude lysate.  The 
flow-through fraction was collected for testing later on.  The column was 
washed with 10 ml binding buffer and collected the wash fraction. For the 
elution step, 5 mls 1x phosphate buffer containing 40 mM imidazole were 
loaded on the column. The eluent was collected in 1 ml fractions. The elution 
proceeded with the next imidazole concentration (60 mM) and the same 
procedure was repeated for the rest of the imidazole concentrations (100, 300 
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Chapter 4: ArdA Results and Discussion 
 
 
4.1 Cloning, overexpression and purification of orf18 
 
The gene orf18 from Tn916 was inserted into the cloning vector pTrc99A. The 
pTrc99A expression vector is a derivative of the pKK233-2 expression vector 
with a strong promoter (trc) upstream of the multiple cloning site (MCS) and a 
strong transcription termination signal (rrnB) downstream. The presence of the 
laq Iq gene on the vector allows pTrc99A to be used in E. coli hosts lacking the 
lactose repressor gene (Amann et al., 1988).  
 
In order to test whether insertion of the orf18 into the expression vector was 
successful, a PCR reaction was performed containing the orf18 primers and the 
plasmid DNA as template. Thus, only plasmids containing the orf18 insert 
would yield a PCR product. The expected band size of the orf18 insert was 
expected to be 468 bp. A 0.8% agarose gel with the PCR reaction is shown below 
















Fig. 28 Confirmation of recombinant plasmid
Lane 1: a λDNA/HindIII marker. Lane 2: the 
PCR product of pTrc99A plasmid having 
acquired the orf18 insert. 
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Colonies from transformed bacteria were inoculated into LB-carbenicillin 
medium, and induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) in a 
fermenter once the cell density reached O.D600nm of 0.5. IPTG induces activity of 
beta-galactosidase, an enzyme that promotes lactose utilization, by binding and 
inhibiting the lac repressor. In cloning experiments, the lacZ gene is replaced 
with the gene of interest and IPTG is then used to induce gene expression 
(Brown, 2001). The expression strain BL21 DE3 was used for overexpression 
purposes as it is deficient in the lon  and the ompT  proteases that can degrade 
proteins during purification (Terpe, 2006).  
 
The overexpressed ArdA eluted from the diethylaminoethyl (DEAE) ion 
exchange column towards the end of the gradient as a broad peak in ∼0.7 M 
NaCl with a purity of almost 95% (Fig.  29).  
 
 
 - 104 -
Fig. 29 SDS-PAGE analysis of fractions obtained from anion exchange (DEAE) 
chromatography during purification of recombinant Orf18 ArdA. Lane 1, clarified cell-
free extract of induced E. coli BL21(DE3) pDMArdA cells as applied to the column; lane 
2, flow-through fraction (i.e., unbound material). The next lanes (left to right) represent 
fractions of eluted protein corresponding to the major peaks obtained from an increasing 
salt gradient (0–1 M NaCl). Highlighted fractions containing ArdA were pooled and 
then further purified on a Superdex-200 column. Molecular mass markers are shown in 
lane M. 
 
The acidic nature of the ArdA protein, with a predicted pI of 3.91, may account 
for the observed tight binding to the column matrix. Fractions containing ArdA 
were subsequently pooled, concentrated and then further purified by gel 
filtration chromatography using a Superdex-200 column to remove minor 
protein contaminants. Thus, the surprisingly good resolution obtained from the 
DEAE column facilitated the purification of ArdA to homogeneity in only two 
steps. Typically, an overall yield of ∼8 mg of purified ArdA per gram (wet 
weight) of cell paste was obtained.  
 
The identity of the purified protein was confirmed by N-terminal sequencing 
(courtesy of Dr. Andy Cronshaw, Edinburgh University). Ten unambiguously 
assigned residues (MDDMQVYIAN) were determined, which matched the 
anticipated sequence from the sequence database. Furthermore, the accurate 
mass of the purified protein was obtained by electrospray mass spectrometry. 
The mass spectrum was obtained on a 12T FT-ICR spectrometer (courtesy of Dr. 
Logan Mackay, Edinburgh University).  The experimentally determined mass 
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(19,153 Da) was 28 Da higher than that predicted (19,125 Da) from the primary 
amino acid sequence. This difference was presumably due to the presence of a 
formyl group on the N-terminal methionine of the protein that had not 
undergone complete post-translational removal. In bacteria, translation initiates 
with formyl-methionine; however, the N-terminal formyl group is usually later 
removed by the enzyme deformylase (Berg et al., 2001). A minor species (12%) 
corresponding to the exact predicted mass of the protein was also detected, 
indicating that some deformylation had occurred.  
 
4.2 Secondary structure analysis of ArdA  
 
The far-UV circular dichroism (CD) spectrum of ArdA (Fig. 30) indicated that its 
secondary structure consisted primarily of α-helices, as determined by the two 
characteristic minima at 208 nm (part of the π-to-π* transition) and 222 nm (the 
n-to-π* transition) in the peptide bond.  
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Fig. 30 Far-UV CD spectrum of 30 μM ArdA. 
 
 
The DICHROWEB server (Whitmore et al., 2004) was used to determine the 
percentage of secondary structure in the protein employing the K2D (Andrade 
et al., 1993) neural network algorithm with built-in protein reference data.  The 
K2D analysis gave a prediction of 35% α-helix, 15% β-sheet and 49% random 
coil.  
 
CD spectra in the near-UV region (250–350 nm) reflect the asymmetry of the 
environment of aromatic amino acid residues. A profound negative band with 
minima at 278 and 285 nm (Fig. 31) was an indication of aromatic side chains 
(tyrosine and tryptophan) located in a folded tertiary structure.  
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Fig. 31 Near-UV CD spectrum of 130 μM ArdA 
 
 
Analysis of the secondary structure of ArdA using the PSIPRED prediction 
server (McGuffin et al., 2000) was largely in agreement with the CD experiments 
in terms of the β-sheet component (50% α-helix, 15% β-sheet), with helices 
predicted to occur at amino acids 3–14, 30–37, 63–75, 78–90, 94–100, 113–122, 
126–127, 131–137 and 139– 148. Strands were predicted at amino acids 18–25, 46–
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4.3 Size-exclusion HPLC 
 
Size-exclusion HPLC was used to determine the quaternary structure of ArdA 
over a range of monomer concentrations. Size-exclusion chromatography (or gel 
filtration) separates molecules according to their size. The stationary phase 
consists of porous beads with a well-defined range of pore size. Proteins that are 
small enough can fit inside all the pores in the beads and are said to be included. 
These small proteins have access to the mobile phase inside the beads as well as 
the mobile phase between beads and elute last in a gel filtration separation. 
Proteins that are too large to fit inside any of the pores are said to be excluded. 
They have access only to the mobile phase between the beads and, therefore, 
elute first. 
 
A gel filtration column was first equilibrated with protein standards and the 
resulting calibration curve is shown in Fig. 32. The ArdA was tested at the 
following concentrations: 50 nM, 200 nM, 500 nM, 1 μM, 10 μM, 50 μM, and 100 
μM. The elution time of each sample was multiplied with the flow rate (0.5 
ml/min) to obtain the elution volume. This elution volume was used as the “y” 
parameter in the equation of the calibration curve. The expected molecular mass 
of the ArdA as a monomer (19,125 Da) was divided from the antilog of y to 
obtain the molecular weight of each sample. 















Fig. 32. Calibration curve of protein standards. A Superose-12 gel filtration column was 
calibrated with protein standards. The equation derived from plotting the elution volume 
vs. log molecular weight of standards was used to calculate the molecular weight of 
ArdA. 
 
ArdA appeared to exist as a dimer at lower concentrations (50 and 200 nM) but 
formed larger species, perhaps tetramers and hexamers, at higher 
concentrations (Fig. 33). The fact that ArdA existed as a dimer at low 
concentrations agrees with findings for another ArdA from plasmid ColIb-P9 
(Nekrasov et al., 2007). The data were fitted with a one-binding site equation 
(Klotz, 1997) and the dissociation constant Kd was found to be 1.4 μM, 
suggesting a relatively weak interaction for this aggregation.  
Superose 12 Calibration Curve
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The width of each elution peak was measured as a single peak can mask 
overlapping peaks. Theoretically, a peak of the same width should be obtained 
at all concentrations for a homogeneous protein. In this experiment, a maximum 
peak width at 1 μM was observed, suggesting that a mixture of species was 
present in this concentration region. 
 
Fig. 33 Size-exclusion chromatography analysis of ArdA to investigate the solution 
molecular mass at different protein concentrations. Black squares: molecular mass 
values of ArdA at different concentrations; red squares: peak width values obtained at 
different concentrations of ArdA. ArdA forms a dimer at the lower concentration range 
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peak width was obtained at 1 μM, suggesting that the protein exists as more than one 
species at this concentration. 
 
 
4.4 Fluorescence Quenching Experiments for the Determination of 
Tryptophan topology 
 
Although fluorescence measurements do not provide detailed structural 
information, the technique has become quite popular because of its acute 
sensitivity to changes in the structural and dynamic properties of biomolecules 
and biomolecular complexes. In a globular protein, the degree to which an 
amino acid side chain is exposed to the solvent depends on how much it is 
shielded by the surrounding protein segments. Information regarding the 
exposure of a residue in a protein can be obtained by crystallographic studies, 
however, in this way only a static view of the positioning can be obtained. Since 
proteins in solution are mobile and can change conformation, a simple and 
effective way to experimentally determine the degree of exposure of 
tryptophanyl residues in solution is by fluorescence quenching. Acrylamide, 
oxygen and iodide can act as quenchers. These agents decrease the fluorescence 
intensity of the trp residues via physical contact with the excited indole ring 
(Eftink & Ghiron, 1976). 
 
Orf18 ArdA contains two tryptophan residues (W23 and W70). The emission 
maximum of the ArdA appears to be at 340 nm (Fig. 34). The protein spectrum 
is slightly blue-shifted from that of aqueous tryptophan (350 nm), suggesting 
that at least one of the tryptophan residues was partially buried.  
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Fig. 34 Emission maximum of ArdA. Protein sample was excited at 295 nm and the 
emission spectrum was recorded between 300 and 420 nm. ArdA shows an emission 
maximum at 340 nm. 
 
A way to experimentally determine the degree of exposure of tryptophanyl 
residues in solution is fluorescence quenching by acrylamide, oxygen or iodide 
via physical contact with the excited indole ring (Eftink &. Ghiron, 1976). 
Addition of successive aliquots of acrylamide to ArdA caused a gradual 
reduction in the fluorescence signal intensity. Acrylamide quenching yielded an 
almost linear response with an effective quenching constant of 3.9 M−1 (Fig. 35). 
The absence of significant curvature implied that the two tryptophan 
residues differed only slightly in their solvent accessibility (Eftink &. Ghiron, 
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1981). Quenching was also performed with KI. Although iodide is an effective 
quencher, it cannot penetrate into the protein structure to quench buried 
tryptophan residues. The quenching constant for KI quenching was found to be 
1.63 M−1. As anticipated, the value of the quenching constant was smaller for 
iodide quenching than for acrylamide quenching. Interestingly, although ArdA 
has an overall negative charge at neutral pH (pI=3.91), the results from the 
iodide quenching experiments appeared to show that the microenvironment 
surrounding the two tryptophan residues was not highly negatively charged. If 
it were negatively charged, then this would repel the iodide and no quenching 
would take place. Indeed, for this reason, the intrinsic fluorescence of the Ocr 
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Fig. 35 Fluorescence quenching of ArdA. 3μΜ of ArdA were quenched with increasing 
concentrations of acrylamide (black squares) and iodide (red circles). The data were fitted 
into a modified Stern-Volmer plot equation. 
 
4.5 Determination of the free energy ΔG of unfolding 
 
Of special interest in understanding the three dimensional structure of proteins 
in solution is the detection and identification of stable intermediates between the 
native and unfolded states by studying the equilibrium denaturation of the 
protein in the presence of a strong denaturant. Measuring the conformational 
stability requires determining the equilibrium constant and the free energy ΔG 
for the reaction: 
 
Folded (F)  Unfolded (U) 
      
Several chemical agents such as urea and guanidinium chloride are known to 
induce the unfolding of native proteins when present at high concentrations. 
Titration of a protein solution with increasing concentration of the denaturant 
shifts the equilibrium between the native and denatured states of the protein to 
gradually favour the denatured form. The amount of denaturant needed and the 
steepness of the titration curve can provide quantitative information on the 
stability of the protein sample. 
 
Increasing amounts of GdmCl were added to ArdA and fluorescence 
measurements were performed. The addition of the denaturant causes the 
protein to unfold. The unfolding causes changes in the quenching of the 
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tryptophan. The fluorescence intensity was measured as a ratio of the 
fluorescence intensity at 320nm vs. 370 nm. Upon dilution of the solution, 
fluorescence recovery was observed following the same transition as the 
unfolding process, indicating that the refolding of ArdA was fully reversible. 
The data revealed a two-state transition (Fig. 36) with no intermediate step and 
were fitted to a two-state model equation (Pace et al., 1989). The midpoint of 
unfolding occurred at 3 M GdmCl, and the free energy of unfolding, ΔG, was 
found to be 31.5 kJ/mol. This is less than that found for the Ocr protein, with a 

















Fig. 36 Unfolding curve of ArdA with increasing concentration of GdmCl. The 
fluorescence intensity was measured as a ratio of the fluorescence intensity at 
320nm vs. 370 nm. The process of unfolding appeared to be totally reversible (refolding). 
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4.6 Differential scanning calorimetry (DSC) 
 
DSC was used to study the thermal stability of 50 μM ArdA. The data show a 
significant heat uptake consistent with a cooperative  endothermic unfolding 
transition with midpoint temperature Tm= 46.9 °C ±1.9 °C (Fig. 37) Analysis of 
the DSC endotherm yielded two independent estimates of the unfolding 
enthalpy of the protein under these conditions. The estimate for the calorimetric 
enthalpy (ΔHcal=23± 13 kcal/mol) was significantly lower than that for the van't 
Hoff enthalpy (ΔHVH =110 ± 77 kcal/mol), indicating the presence of more than 
one species within the solution. These findings were in good agreement with the 
results from size-exclusion chromatography. A rescan showed that the 
unfolding of the protein was fully reversible. 
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Fig. 37 DSC of 50 μM ArdA. ArdA has a Tm = 46.9 ±1.9ºC. Fitting of the partial heat 
capacity (Cp) curves was carried out using a two-state unfolding model.  
 
 
4.7 ArdA–M.EcoKI interaction by ITC 
 
Isothermal titration calorimetry (ITC) was used to study the binding of ArdA to 
M.EcoKI. A typical titration of M.EcoKI with ArdA is shown in Fig. 38. The 
interaction of M.EcoKI with ArdA is exothermic, with a clear end point 
corresponding to the concentration of ArdA at which M.EcoKI becomes 
saturated. After integration of each injection peak and subtraction of the heats of 
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dilution, the values of the heat of interaction normalised for the ArdA monomer 
concentration were plotted versus the molar ratio of ArdA to M.EcoKI. The data 
were fitted to a theoretical titration curve (single-site model) to determine the 
enthalpy (ΔH) and stoichiometry (n) of interaction. Using this procedure, the 
ΔH value was calculated to be −17.0 ± 0.2 kcal/mol. The binding between ArdA 
and M.EcoKI was clearly strong (Kd <1 nM), with a sharp transition that 
unfortunately precluded reliable  determination of the binding affinity using 
ITC as observed for binding between Ocr and M.EcoKI (Atanasiu et al., 2002). 
 
 It is worth noting that the raw ITC data showed a small endothermic event after 
the end point, which was not evident in the dilution control (i.e., injection of 
ArdA into buffer). This possibly indicates a shift in equilibrium in the 
aggregation state of ArdA induced by M.EcoKI binding. The apparent 
stoichiometry of interaction, n, was found to be 1.3±0.01 ArdA monomers per 
M.EcoKI. It is not clear at this stage whether this non-integer value reflects the 
true stoichiometry of the ArdA–M.EcoKI complex or is simply a consequence of 
uncertainties in the quaternary structure of ArdA. However, given the results 
from the size-exclusion chromatography, it is more likely that several complex 
equilibria exist with the M.EcoKI binding to ArdA with different quaternary 
structures and further experiments are required to define the interaction 
stoichiometry. It was not possible to carry out the ITC experiment using EcoKI 
instead of M.EcoKI due to the relatively large amount of protein required for 
each titration.  
 






















Fig. 38 Calorimetric titration of ArdA into M.EcoKI. The ITC titration curve is shown 
in the upper panel. The lower panel shows the calorimetric binding isotherm for the 
ArdA–M.EcoKI interaction. The x axis shows the molar ratio of ArdA (monomer 
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4.8 Restriction/Modification assays 
 
4.8.1 In vivo restriction/modification assay 
 
In the restriction assay, E. coli strains containing different Type I R/M systems 
were infected with unmodified virulent λ phage (λv.0). A restriction and 
modification deficient (r−m−) strain was used as a control (NM1261). Infection 
using λv.0 of each of the four restriction and modification proficient strains 
(r+m+) of E. coli gave a much reduced titre of phage compared with that 
obtained using NM1261. No difference in the number of plaque-forming units 
was observed using the NM1261 strain harbouring either pDMArdA or vector 
alone (pTrc99A). If ArdA was capable of complete antirestriction, then the r+m+ 
strains harbouring pDMArdA would give the same number of plaque-forming 
units as the r−m− strain NM1261. The restriction assay results (Table 1a) showed 
that orf18 ArdA provided between 2 and 4 orders of magnitude of protection to 
phage infection using λv.0. The greatest level of antirestriction activity was 
against the Type IA system.  
 
The ArdA was also tested for possible interference with the modification 
activity of Type I R/M systems. In the modification assay, phage were recovered 
from plaques obtained using r+m+ strains harbouring either pDMArdA or 
pTrc99A. The recovered phage stocks were subsequently used to infect strains 
lacking the plasmid, either the appropriate r+m+ strain or the NM1261 control 
strain. If ArdA was capable of inhibiting modification, phage DNA would not 
have become modified and would therefore remain vulnerable to restriction. 
Thus, the number of plaque-forming units should be greatly reduced in the 
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corresponding r+m+ strain compared with the r−m− control strain. However, if 
ArdA did not inhibit modification, the recovered phage DNA would be 
modified and rendered immune to restriction. In this case, phage would survive 
and the numbers of plaque-forming units on the corresponding r+m+ strain and 
the r−m− control strain would be the same. The results from the 
antimodification assays (Table 1b) revealed that ArdA was capable of inhibiting 
the modification activities of all four Type I R/M systems to varying degrees. 






Table IA.  Orf18 ArdA antirestriction against Type IA–ID R/M systems as determined 

























1261 r-m- 7.50E+09 1.15E+10       
NM 
1049 EcoKI-IA 9.26E+05 2.86E+10 1.24E-04 2.49E+00 2.02E+04 
NM 
354 EcoAI-IB 6.63E+07 1.56E+10 8.84E-03 1.36E+00 1.54E+02 
NK 
402 EcoR1241-IC 4.26E+06 1.17E+10 5.68E-04 1.02E+00 1.79E+03 
NM 
1009 StySBLI-ID 2.53E+06 8.10E+09 3.37E-04 7.06E-01 2.09E+03 
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4.8.2 In vitro antirestriction activity of ArdA 
 
The in vivo restriction assays showed that ArdA displayed the greatest level of 
antirestriction against the EcoKI Type IA R/M system. The inhibition of EcoKI 
was also analysed in vitro. The assay involved monitoring the linearisation of 
unmethylated plasmid DNA (pBRsk1) using EcoKI in the presence or absence of 
ArdA. The results are shown in Fig. 39. Incubation of pBRsk1 with a 10-fold 
excess of EcoKI resulted in complete digestion of the DNA within 10 min (lanes 
1 and 2). The experiment was then repeated with three concentrations of ArdA 
(calculated as monomer) in the reaction mix (i.e., the molar ratio of ArdA–EcoKI 
was 1:10, 1:1 or 10:1; lanes 3–5). No significant change in the level of digestion 
could be observed using substoichiometric and stoichiometric amounts of 
 
 
Host strain Antimodification Activity 
{(pfu/ml of r-m-)/(pfu/ml of r+m+)} 
 
NM 1261 1 
 
NM 1049 1.28E+01 
 
NM 354 1.71E+01 
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ArdA. However, almost complete inhibition of the reaction was clearly seen 
using a 10-fold excess of ArdA over nuclease. Perhaps the ArdA may have 
required preincubation with nuclease in order to observe full antirestriction 
activity. The preincubation was performed for 10 min at 37 °C in the reaction 
mix lacking DNA and ATP. After completion of the preincubation period, the 
reaction was initiated by addition of DNA plus ATP and allowed to proceed for 
10 min. As can be seen in Fig. 39, the highest concentration of ArdA (10-fold 
excess over EcoKI) caused complete inhibition of digestion (lane 8). No nuclease 
inhibition was evident at the two lower concentrations of ArdA (lanes 6 and 7). 
  
To test whether ArdA was able to block the nuclease activity of DNA-bound 
EcoKI, the reaction mixture was made up and incubated for 1 min at 37 °C 
before addition of the antirestriction protein. No detectable inhibition was 
observed even at the highest concentration of ArdA (lanes 9–11) using these 
conditions. Finally, the preincubation of EcoKI with ArdA in the reaction 
mixture was repeated for 10 min, this time in the presence of pBRsk1. The 
reaction was then initiated by the addition of ATP. The results of this 
experiment were essentially the same as those observed when the preincubation 
of ArdA and EcoKI was performed in the absence of DNA. For the experiments 
at a 1:1 ratio with 30 nM ArdA monomer, gel filtration indicated that the ArdA 
protein would be a dimer at a concentration of 15 nM, half that of the EcoKI 
nuclease. In this situation, one would have expected 50% inhibition of the 
nuclease if the ArdA–EcoKI association was as strong as that observed for the 
Ocr protein. Since substantial inhibition was not observed, this implies that 
ArdA does not interact as strongly as Ocr with EcoKI.  
 






Fig. 39 In vitro inhibition of EcoKI nuclease by ArdA. pBRsk1, with a single EcoKI 
recognition site, was used as substrate. Lane 1, uncut pBRsk1; lane 2, EcoKI linearised 
pBRsk1; lanes 3, 4 and 5, reactions performed in the presence of 0.1-, 1- and 10-fold 
amounts of ArdA over EcoKI, respectively; lanes 6–8, as for lanes 3–5, except that EcoKI 
was preincubated with ArdA before initiating the reaction by addition of pBRsk1 and 
ATP; lanes 9, 10 and 11, plasmid digestion performed for 1 min prior to addition of 0.1-, 
1- and 10-fold amounts of ArdA, respectively; lanes 12–14, as for lanes 3–5, except that 
EcoKI was preincubated with ArdA in the presence of pBRsk1 before initiating the 
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4.9 In vitro assay of DNA displacement from M.EcoKI by ArdA 
 
Fluorescence anisotropy of the labelled DNA duplex starts at a low value in the 
absence of bound M.EcoKI. As M.EcoKI is added, the amount of DNA–M.EcoKI 
complex increases and since this has a high value of anisotropy, the observed 
value of the anisotropy for the whole sample increases. If the M.EcoKI is unable 
to bind to the DNA due to, for instance, the presence of ArdA, then the 
anisotropy of the whole sample will not increase until all of the ArdA has been 
bound. Addition of further M.EcoKI then allows the DNA– M.EcoKI complex to 
be formed, and the anisotropy of the whole sample increases.  
 
Fig. 40 shows that ArdA was an effective competitive inhibitor of DNA binding 
by the M.EcoKI. Little DNA binding, as indicated by the low anisotropy 
reading, was observed in the presence of 50 nM ArdA until the M.EcoKI 
concentration reached ∼10 nM, whereas in the absence of ArdA, DNA binding 
was observed at ∼10-fold lower M.EcoKI concentration. This indicated that 
ArdA bound more strongly to the M.EcoKI and suggested that once this 
complex was formed, DNA binding could no longer take place. Should ArdA 
operate in the same manner as the Ocr protein, this effect would be due to a 
direct binding of ArdA within the DNA binding groove on M.EcoKI. The effect 
of ArdA was less pronounced than that of Ocr as the onset of DNA binding in 
the presence of ArdA was not as sharp as observed in the presence of Ocr 
(Atanasiu et al., 2001). This also indicates that ArdA has a weaker affinity for 
M.EcoKI than Ocr. Addition of further M.EcoKI caused a further increase in the 
anisotropy signal indicative of multiple M.EcoKI binding to the DNA above ∼50 
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nM M.EcoKI. This has not been observed so strongly in previous work and 











Fig. 40 Competition between DNA and ArdA for binding to M.EcoKI as determined 
using the fluorescence anisotropy signal from 2 nM 21-bp fluorescent DNA duplex. 
Binding of DNA to the M.EcoKI in the absence of ArdA (open circles) or in the presence 
of 50 nM ArdA (monomer concentration, solid circles) is indicated by an increase in 
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anisotropy. ArdA prevents DNA binding until sufficient M.EcoKI has been added to 




4.10 Preliminary NMR experiments with Orf18 ArdA 
 
 
In order to assess whether ArdA would be a suitable candidate for NMR 
structure determination, a series of preliminary experiments was conducted. 
First, a 1D 1H spectrum of the protein was collected. A 1D proton spectrum is 
the simplest of the NMR experiments but it can give a rough idea of the 
condition of the sample. In the 1D 1H NMR spectra, the dispersion of the NMR 
signals in the regions of the methyl protons (-0.5 to 1.5 ppm), α-protons (3.5-6 
ppm), and amide protons (6-10 ppm) provides the main indicator of folded 
globular proteins along with the appearance of a very shielded methyl peak at -
0.5 ppm. For the ArdA proton spectrum (Fig. 41), there is narrow chemical shift 
dispersion throughout the spectrum and particularly in the amide proton 
region. The presence of the large broad signal at the methyl region of the proton 
















Fig. 41 1D 1H spectrum with presaturation of 100 μM ArdA in 20 mM phosphate 
buffer, pH 6.0 at 25 0C 
 
A 2D 1H-1H NOESY spectrum (Fig. 42) was also acquired. The experiment 
transfers magnetisation through space and shows crosspeaks to all protons that 
are close in space regardless of whether they are in the same spin system or not.  
The poor dispersion of the peaks in the aliphatic side chain-aliphatic side chain 
region implies some type of aggregation taking place. Furthermore, the lack of 









Fig. 42 1H-1H NOESY spectrum of  230 μM ArdA in 20 mM phosphate buffer, pH 6.0 
at 25 0C. 
 
From the 1D proton spectrum and the 2D homonuclear NOESY spectrum, 
however, it cannot be shown unambiguously whether a sample can be a suitable 
candidate for NMR studies. A uniformly 15N labelled ArdA sample was 
prepared and a 2D HSQC spectrum was acquired (Fig. 43) 
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Fig. 43 1H-15N HSQC spectrum of 140 μM ArdA in 20 mM phosphate buffer, pH 6.0 at 
25 0C 
 
The spectrum showed very poor dispersion of peaks with most of the signals 
occupying the centre of the spectrum, a sign of possible aggregation/partial 
unfolding/oligomerisation of the protein. 
 
In order to improve the quality of the spectra, different conditions were tested 
such as:  
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- Buffer: Phosphate buffer is the most commonly used buffer for protein NMR 
studies, however, phosphate buffer can sometimes make proteins more prone to 
aggregation than other buffers. Because aggregation was suspected for ArdA, 
deuterated sodium acetate buffer was also tested, but no improvement was 
observed in the spectra. 
 
- Temperature: increasing the temperature normally produces sharper peaks in 
spectra since the higher temperature increases the correlation time of the 
molecule. A short correlation time implies prolonged relaxation of the spins. 
The widths of the lines in an NMR spectrum are proportional to 1/T2, T2 being 
the transverse relaxation time. In other words, fast-moving molecules have long 
T2 values which in turn will produce sharp peaks in the spectrum. Increasing 
the temperature to 37 0C did not produce significant improvement of the 
spectrum. 
 
- pH : Protein NMR spectra should normally be collected at a pH below neutral. 
The reason for this is that the amide protons of exposed amide groups are in 
exchange with the solvent, and this exchange is pH dependent. If amide protons 
are allowed to exchange with the solvent, the amide proton peaks will disappear 
from the spectrum. The pH dependence of the amide proton exchange rate is 






Where kH, kOH and k0 are the rate constants for acid-catalysed, base-catalysed 
and direct exchange with water, respectively. Amide proton exchange rates 
kex = kH [H+] + kOH [OH-] +k0 
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reach a minimum at pH ~ 3 for model compounds. Different pH values were 
tested with the minimum pH being 5.0. No significant improvement in the 
amide region was observed. Below 5.0 the spectra were worsened probably 
because the pH was approaching the isoelectric point of the molecule (pI = 3.91).  
 
- Ionic strength: Small amounts of NaCl in the protein sample may help to 
decrease possible aggregation.  Increasing amounts of NaCl were titrated to the 
protein sample up to 200 mM NaCl concentration (high ionic strengths > 0.2 M 
NaCl is normally avoided because of the generation of ion currents during 
radiofrequency pulses. These currents decrease the efficacy of the pulses, 
especially towards the centre of the sample, and lead to sample heating). The 
addition of even small amounts of NaCl decreased the resolution of the spectra 
clearly aggregating the protein.  
 
Because the addition of salt worsened the aggregation problem, the type of 
aggregation was presumed to be hydrophobic in nature. The addition of a non-
denaturing detergent is expected to disrupt these hydrophobic intermolecular 
interactions, alleviating the aggregation problem. The detergent that was chosen 
was CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate) 
which is a zwitterionic surfactant commonly used to solubilise membrane 
proteins as it does not change their secondary and tertiary structure (Kline et al., 
1989). The detergent has been successfully used for the structure determination 
of calcineurin B (Anglister et al., 1993). CHAPS is not commercially available in 
deuterated form, however, because the protein was isotope-enriched, the signals 
from the detergent would not interfere with the HSQC experiment. 
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The effect of CHAPS, however, has been found to be protein dependent as well 
as concentration dependent. The detergent at 5mM concentration has been 
shown to have an excellent stabilising effect on beta-lactoglobulin, but the same 
concentration of surfactant caused unfolding of a different protein, ovalbumin 






Fig. 44 1H-15N HSQC spectra of 140 μM ArdA in 20 mM phosphate buffer, pH 6.0 at 
25 0C with the addition of 2 mM CHAPS (a) and 10 mM CHAPS (b). 
 
 
The addition of CHAPS had no effect at μM concentrations and at higher (mM) 
concentrations clearly unfolded the protein as can be seen from the 
disappearance of most of the peaks and the enlargement of the central “blob” on 
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At low surfactant concentrations, protein-surfactant binding involves specific 
and non-cooperative electrostatic interactions. However, at high surfactant 
concentrations, massive, cooperative hydrophobic binding occurs which results 
in protein unfolding and denaturation by disrupting the α-helical network and 




4.11 Truncated Orf18 ArdA 
 
Since the Orf18 ArdA did not prove suitable for NMR studies, an attempt was 
made to create a truncated version with much lower MW in the hope that this 
species would not oligomerise or aggregate. Deletion studies that had been 
performed in the past of an ArdA protein encoded by the IncI plasmid ColIb-P9, 
revealed that the N-terminal half of the protein does not seem to be essential for 
its antirestriction activity (Delver et al., 1991; Read et al., 1992). It was also shown 
that the C- terminal portion of that ArdA containing 77 residues (coordinates 90 
to 166) was able to function against EcoKI restriction as a native ArdA 
(Nekrasov et al., 2007). Thus, a truncated version of Orf18 ArdA was designed 
where the largest part of the N-terminus was removed (the first 71 amino acids 
were deleted). The truncated version started with the 72nd amino acid, a 
methionine. The truncated Orf18 was cloned between the NdeI and BamHI 
recognition sites in the pET-15b vector which carries an N-terminal His-tag 
sequence followed by a thrombin cleavage site. The cloning procedure was 
performed as described in the general cloning methods. The following is the 
whole Orf18 ArdA sequence and the truncated version is highlighted in blue. 













In order to confirm that the cloning procedure was successful, a digestion of the 
construct with NdeI and BamHI was performed. The result is shown in Fig. 45. 
The linear pET15-b was expected to appear as a band close to 6 kb (5708bp). The 







An attempt was made to purify the truncated his-tagged Orf18 ArdA. With the 
HisTrap FF crude columns histidine-tagged proteins can be purified directly 
from unclarified cell lysates and are recovered from the column under mild 
elution conditions. The columns are precharged with Ni2+.  The matrix of the 
Fig. 45 Agarose gel showing the result of digestion of 
the pET15-b construct containing the truncated orf18.
Lane 1: 1Kb DNA marke ; Lane 2: 100 bp DNA ladder; 
Lane 3: pET15-b containing the insert uncut; Lane 4: 
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column consists of 90 μm particles of highly cross-linked agarose to which Ni2+ 
are bound by a stable chelating group. The imidazole side chain of histidine has 
an affinity for binding metal ions such as nickel (cobalt is another metal that can 
be used as an alternative for nickel). The more histidines present, the stronger 
the binding will be, thus six his residues were used to tag the protein instead of 
one. 
 
His-tagged proteins were eluted from the nickel rich column with buffers 
containing imidazole. Imidazole at low concentrations was used in the binding  
and wash buffers to minimise binding of unwanted host cell proteins. At higher 
concentrations, imidazole may decrease the binding of the his-tagged protein 
and thus the optimal concentration is different for different his-tagged proteins. 
The optimal imidazole concentrations was determined by stepwise elution of 
the protein with buffers containing increasing concentrations of imidazole. 
 
After running an SDS-PAGE of the eluted his-tagged protein at different 
imidazole concentrations, no distinct band for the truncated Orf18 was 
observed. There were however, several very faint bands visible in the gel 
suggesting non-specific binding of proteins to the column. Some bands of non-
specific binding were observed even at the highest recommended (500 mM) 
imidazole concentration. 
 
The truncated Orf18 was also tested for in vivo antirestriction activity, and no 
antirestriction activity was observed suggesting that the truncation affected the 
structure of the protein significantly.  
 - 137 -
Since no band was observed on the SDS-PAGE gel, in order to test whether the 
protein was successfully tagged and eluted, a Western blot was prepared (Fig 
46). Clearly a band can be seen on lane 6 corresponding to the truncated Orf18 
ArdA at the expected molecular weight (12859 Da). A positive control (His-
tagged P450 Rhf Heme protein) was also used to test efficiency of western blot. 
The expected MW of the control protein (P450 Rhf Heme) is 48 kDa. The protein 
seems to be somewhat degraded since two bands appear at around 50 kDa. Also 




















Fig. 46 Western Blot to test any signs of expression of the truncated Orf18 ArdA. 
Lane1: protein marker; 2: blank; 3:BL21 (DE3) + pET-15b (0 hrs); 4: BL21 (DE3) + 
pET-15b (3 hrs); 5: BL21 (DE3) + pET-15b + Truncated Orf18 (0 hrs);  6: BL21 (DE3) 
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+ pET-15b + Truncated Orf18 (3 hrs) at 30C ; 7: blank 8: (Positive Control) P450 Rhf 
Heme protein (His-tagged) 
 
The appearance of a band corresponding to the truncated his-tagged Orf18 
ArdA indicates that some protein was indeed expressed in the cell, although in 
very low concentrations which was not enough to purify the protein. The low 
expression of the protein implies that most of the protein in the cell must have 
been produced unfolded and thus degraded by proteases. The removal of 
almost half of the protein seems to have proven detrimental and perhaps one of 
the causes for causing folding instability may have been that the truncation 




4.12 X-ray crystal structure of Orf18 ArdA 
 
While this thesis was being prepared, the crystal structure of Orf18 ArdA was 
solved (McMahon et al., 2009). The ArdA was solved at a resolution of 2.8 Å 
(PDB Accession number: 2w82) and appears similar to Ocr (Walkinshaw et al., 
2002). The crystal structure of ArdA shows an extremely elongated dimer with a 
highly negatively charged surface (Fig. 47b). Its structure is reminiscent of ~42 
bp of B-form DNA making it the largest DNA mimic yet characterised.  
 
ArdA is composed of three domains (Fig. 47a) arranged in such a linear manner 
that only eight residues are buried form the solvent. The N-terminal domain 
resembles the B domain in biotin carboxylase from yeast   (Shen et al., 2004). The 
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central domain of ArdA shows weak similarity to the anti-termination ANTAR  
domain found in RNA binding proteins (Morth et al., 2004), while the C-
terminal domain shows similar fold with the arginine repressor protein (Garnett 
et al., 2008). Even though each of the three domains has similar folding to three 
known proteins, the overall structure of ArdA has no counterpart in any known 
structure. The second and third domain of ArdA have similar folding to 
nucleotide binding proteins, however, the extensive negatively-charged surface 
of ArdA makes the protein highly unlikely to interact with DNA. 
 
The dimer interface contains the antirestriction motif identified by Belogurov 
and  Delver (1995). Since it belongs to the interface it may be more important for 
the assembly of the dimer structure rather than having a direct implication in 
antirestriction activity. However, this is just an assumption and more 









































Fig. 47 a) Cartoon representation of ArdA monomer. The three domains are coloured 
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and basic residues are coloured light blue  c)Cartoon representation of the dimeric 
structure of ArdA. (Images reprinted from McMahon et al., 2009). 
 
By comparing the crystal structure of ArdA with the biophysical analysis of the 
protein discussed earlier, a few points can be made. The elongated nature of the 
protein along with its tendency to dimerise can explain the bad quality of the 
NMR spectra from the preliminary NMR experiments. Furthermore, the 
secondary structure elements derived from the crystal structure agree with the 
secondary structure predictions from PSIPRED as well as with the far-UV CD 
spectrum that the protein is largely composed of α-helices. However, the  
percentages somewhat differ with the crystal structure showing a higher 
percentage of  β−sheet ( 46% α-helix and 23 % β−sheet). 
 
The tryptophan quenching experiments showed that two tryptophan residues 
differed only slightly in their solvent accessibility. When examining the 3D 
structure (Fig. 48) it is evident that the W23 and W70 are both highly exposed 
with the indole ring of W23 being somewhat more exposed than that of W70. To 
further confirm the degree of solvent accessibility of the two residues an 
analysis was performed with the program GETAREA (Fraczkiewicz & Braun, 
1998). The program gave a ratio of side-chain surface area to "random coil" 
value per residue. The "random coil" value of a residue X is the average solvent-
accessible surface area of X in the tripeptide Gly-X-Gly in an ensemble of 30 
random conformations. The ratio for W23 was 36.4 and for W70 27.5, suggesting 
that W23 is slightly more exposed than W70. 
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Moreover, the fluorescence quenching experiments showed that the 
microenvironment surrounding the two tryptophan residues was not highly 
negatively charged since if that was the case, the negative charge would repel 
the iodide and no quenching would take place. Indeed, the area surrounding the 
two tryptophans is not highly negatively charged with the exception of the close 
proximity of D50 and E52 with W23 and E71 with W70. 
 
 
Fig. 48 Monomer of Orf18 ArdA showing the position of the two tryptophan residues 
(W23 and W70). Negatively charged residues (Asp, Glu) are coloured red, the 
tryptophan residues are coloured orange. Image generated using PyMol. 
 
 
Gel filtration analysis showed that the protein existed as a dimer up to 200 nM, 
but formed larger species (tetramers and hexamers) at higher concentrations. 
The crystal structure, however, shows the protein to exist as a dimer even 
though the concentration of the protein used to produce the crystal was ~1 mM. 
This discrepancy could be explained by the elongated shape of the molecule. 
A tumbling, elongated molecule occupies more volume than a spherical protein 
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of the same mass. Thus, an elongated molecule will not be able to enter the 
beads of the matrix in the column and will elute ahead of the spherical protein 
even though the two proteins are of the same molecular mass (Note also, that 
the gel filtration column was calibrated with globular protein standards: (BSA, 
carbonic anhydrase, alcohol dehydrogenase, β-amylase, cytochrome c). 
 
4.13 Conclusion for ArdA experiments 
 
The results of this work show the gene product of orf18 is an ArdA 
antirestriction protein and prove that such a function can exist on conjugative 
transposons in addition to the known antirestriction functions present in phage 
and conjugative plasmids. The antirestriction activity of Orf18 ArdA 
presumably aids successful conjugative transposition of Tn916 and thus assists 
the spread of antibiotic resistance, in this case tetracycline resistance, within the 
bacterial population. As was the case for Ocr, it was found that Orf18 ArdA 
inhibits different Type I R/M systems from different families with different 
DNA target recognition sequences.  
 
The in vivo experiments demonstrate that Orf18 ArdA displays potent 
antirestriction activity against all 4 classes of Type I R/M systems with the 
highest activity against the Type IA family. Furthermore, antimodification 
activity was observed against all four R/M systems with the greatest 
antimodification activity shown against the Type ID family. Antimodification 
was not as potent as found for the Ocr protein (Nekrasov et al., 2007) perhaps 
due to the weaker interaction of ArdA with the MTase core. Of further note is 
the difference in the relative effectiveness of antirestriction versus 
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antimodification. ArdA is more potent as an antirestriction protein than an 
antimodification protein versus the IA, IB and IC families. The effect of ArdA on 
the two activities might be expected to be equal if it only acts on the MTase core 
of a Type I R/M enzyme. Perhaps ArdA has binding sites on the HsdR 
restriction subunits in addition to a binding site on the core MTase and that 
these sites have different binding affinities. It was observed that Ocr also had 
multiple binding sites on EcoKI (Atanasiu et al., 2001).  
 
In vitro assays using EcoKI confirm that ArdA can inhibit Type I nuclease 
activity. However, this was only observed using an excess of ArdA (monomer 
concentration) over EcoKI. Stoichiometric and sub-stoichiometric levels of ArdA 
displayed no detectable inhibitory effects. As is the case for Ocr 
(Bandyopadhyay et al., 1985) ArdA appears to be ineffective in blocking 
nuclease activity once EcoKI has bound to the DNA. 
 
In this study it is shown that ArdA blocks DNA binding by the M.EcoKI and 
this should be sufficient to prevent both methylation and DNA cleavage 
activities by Type I R/M systems but, as noted above, there may be additional 
binding sites for ArdA on the complete R/M enzyme.The biophysical 
characterisation of ArdA suggests the protein exists as a dimer in solution at low 
concentration, as found for ArdA from a conjugative plasmid (Nekrasov et al., 
2007), but has a tendency to form larger molecular weight species at 
concentrations above ~1 μM.   
 
 - 145 -
The calorimetric data demonstrates tight association between ArdA and the 
M.EcoKI. However, because the transition was very sharp, it was not possible to 
accurately determine the association constant Ka. Nevertheless, Ka for ArdA-
M.EcoKI interaction is certainly >109 M-1, a rather stronger interaction than 
found for the plasmid-encoded ArdA (Nekrasov et al., 2007) but weaker than the 
Ocr-M.EcoKI interaction (Atanasiu et al., 2001). The nature of the active form of 
ArdA is unclear from the apparent stoichiometry of binding (n = 1.3 ArdA 
monomers per M.EcoKI) perhaps due to the variable quaternary structure of 
ArdA as suggested by the gel filtration and the discrepancy between ΔHcal and 
ΔHVH determined by DSC. 
 
The results on this ArdA from a classic conjugative transposon can be compared 
with those obtained previously with ArdA proteins from conjugative plasmids 
(Belogurov et al., 2000; Belogurov & Delver, 1995; Wilkins, 2002; Belogurov et al., 
1985; Belogurov et al., 1993; Thomas et al., 2003).  Although these plasmid-borne 
ardA genes have only been tested against the Type IA, IB and IC families, 
antirestriction and antimodification were clearly observed. Interestingly, the 
ArdA from plasmid ColIb-P9 had equally strong antirestriction and 
antimodification activities against EcoKI in vivo whereas in this study it was 
found that this is not the case for ArdA from Tn916 which displays a weaker 
antimodification activity. As the two ArdA proteins display limited sequence 
identity (24% identity, 58% similarity), they may have slightly different 
interfaces with and different affinities for the restriction and modification parts 
of the complete R/M enzyme. Whether these differences have a role to play in 
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the different mechanisms of HGT used by different mobile genetic elements 
remains to be seen. 
 
Preliminary experiments with a 15N-labelled ArdA sample showed that the 
protein is unsuitable for structure determination by NMR. However, the protein 
crystallized and the ArdA structure (McMahon et al., 2009) revealed a structural 
and electrostatic mimic of DNA in the same way as the Ocr protein. Comparing 
the biophysical analysis of ArdA with the information obtained from the 3D 
structure, the circular dichroism data agree well with the secondary structure 
elements of the crystal structure and the two tryptophans differ slightly in the 
solvent accessibility as it was predicted form the steady-state fluorescence 
experiments. The discrepancy between the initial estimation of oligomerisation 
of the ArdA with the gel filtration method and the apparent dimer from the 
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Chapter 5: KlcA Results and Discussion 
 
 5.1 1H, 15N  and 13C chemical shift assignments and structure calculations 
   
klcA was prepared by gene synthesis using the deposited DNA sequences as a 
starting point for codon optimisation and synthesis (GeneArt). The synthetic 
gene (Appendix Fig. I) was inserted into vector pET24-a carrying a kanamycin 
resistance determinant. E. coli BL21(DE3) cells were transformed with the 
recombinant plasmid (pDMKlcA) and klcA was overexpressed. KlcA from B. 
pertussis contains 142 amino acid residues (theoretical Mr: 15660) and is rather 
acidic (calculated pI: 4.76). The acidity of the protein helped the purification 
process and the KlcA was purified with exactly the same procedure as ArdA as 
described in Methods. An SDS-PAGE showing the purified KlcA is shown in 





Fig. 49 SDS-PAGE of purified KlcA. Lane 1: protein 
marker; Lane 2: purified KlcA after anion exchange 
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In order to assess whether KlcA would be suitable for NMR-based structure 
determination some preliminary NMR experiments were performed including a 
1D presaturated 1H spectrum and a 2D 1H-1H NOESY (Fig. 50) which showed 
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Fig. 50 a) 1D 1H spectrum with presaturation of 75 μM KlcA in 20 mM sodium acetate 
buffer, pH 6.0, at 25 0C. The large contaminating peaks at 3.5-3.8 ppm belong to 
residual glycerol after dialysis b) 1H-1H NOESY of 220 μM KlcA in sodium acetate 
buffer, pH 6.0 at 25 0C. 
 
A 15N labelled KlcA was subsequently prepared and the recorded 1H-15N HSQC 
spectrum  showed a folded protein with well dispersed signals and very little 
overlap, indicating the feasibility of structure determination of KlcA by NMR 
spectroscopy. A double labelled 15N-13C KlcA was used for the assignment 
process. Backbone and side-chain resonances of KlcA were assigned based on 
2D and 3D triple-resonance experiments as described in the Methods (Chapter 
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Fig. 51 2D 1H-15N HSQC spectrum of KlcA at 800 MHz with residue assignments 
included.  
 
3D 13C and 15N edited NOESY spectra were carefully peak picked and the NOE 
cross-peak assignments were obtained from the automated iterative assignment 
program CANDID which works in conjunction with 3D structure calculations 
in the program CYANA 2.1.  The lowest energy ensemble of 20 structures of 
KlcA were calculated using NOE restraints, TALOS dihedral restraints and 1H-
15N RDCs as detailed in the Methods section. Chemical shift has been shown to 
have a direct correlation with phi and psi torsion angles and thus with 
secondary structure (Wishart et al., 1991) The TALOS software tries to predict 
the most likely backbone angles for a given residue and searches a database that 
contains 13Cα, 13Cβ, 13C', 1Hα and 15N chemical shifts for 20 proteins for which a 
high resolution X-ray structure is available (Cornilescu et al., 1999). 
 
For the RDCs the filamentous phage Pf1 was used as the alignment medium. 
Since KlcA is a rather acidic protein, Pf1 appeared to be a good choice as an 
alignment medium for this protein because the negatively charged phage would 
not normally bind to the acidic KlcA due to electrostatic repulsion. Addition of 
6.85 μg/ml of phage appeared to be the optimum phage concentration for this 
sample which gave a D2O splitting of 7 Hz. Larger amounts of phage did not 
increase the splitting. Two 2D IPAP spectra were collected (with and without 
phage) and the RDCs were measured in Analysis with the help of the 
RDCcalculator macro, courtesy of Dr. Graeme Ball. The RDC values measured 
were used as input for REDCAT which calculated the alignment tensor from the 
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3D structure obtained without RDC refinement and gave the predicted (back-
calculated) RDC values. There was significant discrepancy in the back-
calculated and the actual experimental values. After addition of the measured 
couplings in the CNS program and recalculation and refinement of the 
structure, the new refined structure was again used in REDCAT and this time 
the measured vs. calculated couplings agreed well (Fig. 52) 
 
 
Fig. 52 Fitting of the 1DNH residual dipolar couplings in the refined KlcA structure. 
Back-calculation of the couplings was performed with the program REDCAT. 
 
The final ensemble of 20 structures after RDC refinement is shown in Fig. 53 
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Fig. 53 Stereoview of the 20 lowest energy structures of KlcA. The steroview was 
obtained with the program MolMol. 
 
 The calculations converged well, yielding RMSDs of 0.63 and 0.65 Å for 
backbone and all heavy atoms in structured regions (residues 5-142). The 
structures were validated using PROCHECK and WHAT IF. 98.5% of residues 
in the Ramachandran plot appeared in the most favourable and additionally 
allowed regions. WHATIF analysis yielded an RMS z-score of -1.432 suggesting 
a good quality structure. A list of the NMR restraints and structural statistics is 
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5.2 The three-dimensional structure of KlcA 
The KlcA protein structure is made up of five alpha-helices (labeled 1-to-5), a 
single 310-helix and five beta-strands (labeled A-to-E) and belongs to the mixed 
alpha-beta class of proteins (Fig. 54). The five beta-strands form two separate 
beta-sheets, the first composed of beta-strands A (usually occurring as an 
isolated beta-bridge from the ensemble consensus), B and C and the other made 
up of beta-strands D and E. Querying fold libraries and the PBD with the NMR-
determined KlcA structure shows that its fold is novel. This is consistent with 
the lack of sequence identity/significance scores for its sequence against the PDB 

















Fig. 54 A cartoon representation of KlcA using Pymol 
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Highlighting the location of all negatively charged side-chain residues on the 
cartoon schematic representation of KlcA reveals two distinct clusters - an 
“Aspartate cluster” made up of five linearly arranged residues – i.e. D61 (in the 
loop between beta-strands B and C), and D110, D112, D115, D119 (in the loop 
between alpha-helix 3 and 4 and on alpha-helix 4); and a “Glutamate cluster” 
that contains amino acid residues E47 (in the loop between alpha-helix 2 and 
beta-strand B), E75 and E77 (on beta-strand D), E86 (on beta-strand E) and E133 
(on alpha-helix 5) (Fig. 55) 
 
 
Fig. 55 Ribbon representation of KlcA highlighting the two negatively charged regions 
of the protein, the aspartate and glutamate “clusters”. Image generated using Pymol 
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An electrostatic surface rendition (Fig. 56a) generated by GRASP shows that the 
surface of KlcA is predominantly negatively charged, consistent with its 
theoretical pI (4.76). The residues involved in the Aspartate and Glutamate 
clusters are largely surface exposed. In addition to the five residues present in 
the ‘Glutamate cluster’ are residues E15, D69 and D90, which are also located 
nearby in 3-D space. Intriguingly, a striking linear arrangement of positive 
charge involving Arginine side-chains is also evident, predominantly on the 
opposite side of the KlcA protein surface (with respect to its negatively charged 
clusters). This “Arginine cluster” contains seven residues: R29, R33, R43 and 
R44 on alpha-helix 2, R48 (in the loop between alpha-helix 2 and beta-strand B; 
R84 on beta-strand E; and R120 on alpha-helix 4.  
 
Even though three distinct regions of charge are apparent from the electrostatic 
surface representation, only a handful of charged residues are conserved (Fig. 
56b). These include R18, E35, D61, D90, R125, E133 and D142 Additionally, the 
lipophilic surface rendition generated by MOLCAD (Fig. 56c) reveals two 
regions of spatially contiguous hydrophobic side-chains, i.e. on the “front-side” 
(Fig. 56c, left-hand panel) containing F83, L87, I118, Y121, A128, A135, A136, 
Y138 and I141 and a more prominent hydrophobic region on the “back-side” of 
the protein (Fig. 56c, right-hand panel) consisting of L19, F21, L22, Y25, P28, 
L30, M31, M32, A36, Y39, Y53, W54, Y56, L70, L74, I108 and A113. Among these, 
F21, L22, W54, F83, L87, A128 and I141 are largely conserved and along with 
other solvent-exposed conserved charged and polar amino acids in their 
vicinity, could be important for function.   
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Fig. 56 a) Electrostatic representations of the KlcA protein. Two views rotated by 180° 
along the y-axis of a GRASP (Nicholls et al., 1991) electrostatic surface representation 
of the KlcA protein. The molecule appears to expose many charged residues, labelled. 
Negative charge is coloured red and positive charge coloured blue, ranging from -10 kT 
to +10 kT (k = Boltzmann’s constant; T = temperature in Kelvin). b) Sequence 
conservation mapped onto protein structure and surface. Conservation surface 
representation based upon the PROMALS3D multiple sequence alignment of KlcA-like 
sequences where largely and completely conserved residues (labelled in the lower panel, 
where surface exposed) are shown in lavender/plum/violet colour mapped onto the 
cartoon secondary structure representation and surface. Images created using PyMol. c) 
Lipophilic representation of the KlcA protein. Two views rotated by 180° along the y-
axis of a MOLCAD (Heiden et al., 1993) lipophilic surface rendition of the protein, 
where regions of high lipophilicity (hydrophobicity) are coloured brown and labelled and 
regions of high hydrophilicity are coloured blue. 
 
Interestingly, in the 1H-15N spectrum of KlcA, two weaker peaks at chemical 
shifts 72 and 69 ppm are observed. A F1 1H-coupled 1H-15N HSQC (Fig. 57) 
showed that these signals belong to NH2 moieties. They appear in the spectrum 
as two outer lines of a triplet with the separation of ca 185 Hz. The 15N chemical 
shifts are consistent with values reported for the guanidinium moiety of 
arginine from BioMagResBank (Ulrich et al., 2008). These NH2 groups would 
normally undergo chemical exchange with water and thus rendered invisible. 
The fact that they are visible in the spectrum suggests that these are involved in 
hydrogen bonds. Indeed, by examining the three dimensional structure of the 
protein, the Νη2 of R73 (loop, one residue before strand D) and Οε2 of E86 (strand 
E) are separated by 2.97 Å, while this distance is 4.47 Å for R48 (loop) and E75 
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(strand D) (Fig. 58). The former pair meets the criterion (3.5 Å) for H-bonded 
salt bridge interaction (Kumar & Nussinov, 1999). Although such interactions 
involving side chains are less common than those of the backbone, they could 
play a role in maintaining the structural integrity of the protein. The relaxation 
data indicate that D, E strands are the most flexible on the fast time scale, so an 
H-bonded salt bridge can stabilise these relatively short beta strands. The 
second interaction can potentially maintain the relative orientation between the 
helix 2 and strands D and E, which connect to the rest of the protein via loops. 
 
 
Fig. 57 A F1 1H-coupled 1H-15N HSQC of KlcA (unfolded) showing the NεHε and NηHη 
of arginine residues. Image generated with Topspin NMR. 
























Fig. 58 Salt Bridges of  R48 : E75 and R73 : E86. Image generated with Pymol 
 
 
5.3 Backbone dynamics from 15N relaxation data 
 
15N NMR relaxation data are widely used to probe both molecular rotational 
diffusion and local backbone dynamics of a protein. We have measured 15N 
longitudinal (T1) and transverse (T2) relaxation times and steady state 1H-15N 
NOEs as detailed in the Methods section (Chapter 3). Plots of T1, T2 and 
heteronuclear NOEs against residue number are shown in Fig 59. Because of 
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partial peak overlap, only 113 of the 137 non-proline residues of the protein 
were used for the calculation of the relaxation parameters. The residues with 
higher amplitude of internal motions have simultaneously higher values of T1 
and T2. By contrast, amide groups with the simultaneously lowest values of T1 
and T2 values belong to the residues with the most restricted local mobility. The 
heteronuclear NOE values < 0.68   were used to identify residues of the protein 
that are dynamic on the ps-ns timescale. As the majority of heteronuclear NOEs 
are greater than 0.68, the backbone exhibits limited motions on this timescale 
(Kay et al., 1989). The only exceptions were residues 3 to 6 that exhibited 
negative NOE values indicating a flexible N-terminus. This correlates well with 














































Fig. 59  Experimental T1, T2 and  {1H, 15N} NOE as a function of residue number 
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The presence of internal motion and chemical exchange can lead to distortions 
of the T1/T2 ratio, therefore the collection of residues used to determine the 
diffusion properties of the entire molecule excluded mobile residues or those 
exhibiting slow exchange broadening. A subset of 97 residues selected as 
described in the Methods was used in the determination of the diffusion tensor. 
In this subset the average values of T1, T2 and heteronuclar NOEs were 737 and 
86 msec respectively. The relative moment of inertia values calculated  with the 
program “pdbinertia” from the Arhtur Palmer Group, Columbia University and 
found to be:  Iz: 1.00  Iy: 0.9858  Ix: 0.8629. Iy and Ix are very close to 1.00, implying 
that the protein does not deviate significantly from a sphere, having slightly 
oblate shape.  
 
The program “quadric_diffusion” from the Arthur Palmer Group was used to 
determine the diffusion tensor. The program fits the relaxation data in an 
isotropic, axially symmetric and fully anisotropic model using increasing 
number of fitting parameters. In order to fit the relaxation data to an isotropic 
model, only one parameter is used, Diso, since Dz=Dx=Dy. Fitting the relaxation 
data to an axially symmetric model requires four parameters: two rotation 
angles (θ and φ) that re-orient the molecule to its principal axis system and two 
diffusion coefficients Dparallel (Dǁ) and Dperperdicular (Dￌ).  Dǁ      corresponds to Dz, and  
Dￌ to Dx=Dy. Fitting to a fully anisotropic tensor requires 6 parameters: three 
rotation angles (θ, φ and γ) and three diffusion coefficients (Dz, Dx, Dy) since in 
anisotropic tumbling Dz ≠Dx ≠Dy.  
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In order to assess the validity of the model, the program calculates the χ2.  The 
more parameters are used to fit the data, the lower value of χ2 is expected. The 







Where σ2 is the error associated with the data, yi is the experimentally derived 
values, and y(p) is the value calculated from the model, using n parameters p= 
p1, p2, …pn. . As more parameters are used to fit the data the χ2 will naturally 
decrease. Thus, fitting the data to an axially symmetric model will give a χ2 
value smaller than fitting to an isotropic model. The program quadric_diffusion 
gave the following results for KlcA: 
 
Type of diffusion χ2 value 
Isotropic 63293 
Axially Symmetric 61977 
Anisotropic 61038 
 
The differences in the χ2 values between isotropic and axially symmetric and 
axially symmetric vs. anisotropic were very small. In order to test whether the 
difference in the χ2 values is actually significant, a statistical test called the 
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In this formula, N data points (residues) are initially fit to m parameters and 
then subsequently fit to n parameters. Since 92 residues were used for the 
analysis of relaxation data, the F-test for isotropic vs. axially symmetric fitting 
will be F(3, 88). Similarly, for axially symmetric vs. anisotropic: F(2, 86). The quadric-
diffusion program gave the following partial F-test values: F(3, 88) = 0.622 and F(2, 
86) = 0.661. These F-values derived using a partial F-test with a 95% confidence 
are statistically non-significant, which implies that adoption of the more 
complicated diffusion models does not significantly improve the fitting of the 
data. As a result, the isotropic diffusion tensor with a Diso = 1.8 x 107 s-1 was 
adopted. The average rotational correlation time (τm) calculated using the 
program “r2r1_tm” from Palmer Group, Columbia University. The τm was 
found to be 8.83 ns ± 0.01, a value that is expected for a protein of this size.  
 
 
In order to extract microscopic parameters of motion from the relaxation data a 
model-free approach was used with the help of the program Tensor2 (Dosset et 
al., 2000). In this analysis, the overall and internal motions of the molecule are 
assumed to be independent.  Based on the above analysis of the relaxation data, 
the isotropic model was selected for further consideration. Relaxation analysis 
data were fitted using models 1-5, where model 1 fits only the generalised order 
parameter (S2); model 2 fits S2 and the effective internal correlation time (τe); 
model 3 fits S2 and the chemical exchange term (Rex) and model 5 is an external 
Lipari-Szabo model, which includes a very fast (Sf2) and slow (Ss2) time scales 
along with τe. The program Tensor2 tests the models (1-5) against the 
experimental relaxation data for each residue selected.  
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Relaxation data for most residues (73%) were adequately described by the 
generalised order parameter S2 (model 1) suggesting an overall rigid molecule.  
Eleven residues (4Glu, 31Met, 38Val, 41Trp, 47Glu, 56Tyr, 64Phe, 99Phe, 103Gln, 
123Phe and 128Ala) did not fit any model. An additional parameter (Rex) was 
required to fit 17 residues, with residues 14Ala, 16Ala, 91Ala, 107Glu, 108Ile, 
117Leu and 121Tyr showing significant Rex values (>2 Hz), suggesting that these 
N-H sites experience multiple environments interconverting on the micro- to 
millisecond time scale. The order parameter S2 as a function of the residue 


















Fig. 60 S2 values calculated with the program Tensor2 as a function of residue number 
 - 168 -
The order parameter is a measure of the degree of spatial motion of the N-H 
bond where a value of 0 means that the bond vector has unrestricted motion 
while 1 implies a completely rigid bond. The distribution of S2 values visualised 
on the ribbon structure is shown in Fig. 61. This graph shows that the mobility 
on the nano second time scale is slightly restricted in secondary structure 
elements when compared to the loops. The largest mobility indicated by the 
smallest S2 values (excluding the termini) was observed starting with the 























Fig. 61 The order parameter S2 visualised on the KlcA ribbon structure (beta-sheets are 
not shown). Blue denotes high flexibility, whereas residues coloured yellow are the most 
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5.4 Antirestriction activity of KlcA 
 
In the restriction assay, E. coli strains harbouring different Type I R-M systems 
were infected with unmodified, virulent λv.0. phage. A restriction-modification 
deficient (r-m-) strain was also tested as a control (NM1261). For the r-m- strain, 
no difference in plaque formation should be observed in strains harbouring 
either the KlcA expression construct or vector alone. However, assuming KlcA 
confers restriction alleviation, r+m+ strains harbouring the KlcA expression 
construct will give a greater number of plaques than r+m+ strains harbouring 
vector alone. The efficiency of plating of unmodified test phage λv.0. was 
determined by measuring the ratio of phage titre on the restricting strains (r+m+) 
to the titre on the nonrestricting strain (r-m-). The ratio of the two e.o.p. 
measurements shows the restriction alleviation potential of KlcA (Table 3). KlcA 
expression provided between 1 and 3 orders of magnitude of protection to the 
unmodified phage. The greatest restriction alleviation was for the Type IA 
system and the lowest for the Type IB. 
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Table 3: KlcA antirestriction against Type IA-ID Restriction-Modification systems as 
determined in vivo 
 
In the modification assay, phage were recovered from plates of restriction-
modification proficient strains harbouring the KlcA expression construct or 
vector only. When these phage were subsequently used to infect the same 
strains two possible outcomes could be envisaged. If KlcA was capable of 
inhibiting modification, phage DNA would not be modified and therefore 
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remain vulnerable to restriction. This would result in a reduced number of 
plaque forming units. If, however, KlcA was unable to inhibit modification, the 
phage DNA would be modified and rendered immune to restriction. Thus, the 
phage would survive and the number of plaque forming units would increase. 
The modification test revealed that KlcA cannot inhibit modification by any of 
the four Type I systems. A similar result was reported for the ArdB from 
pKM101, which showed efficient antirestriction activity of Type I enzymes but 
no antimodification activity (Belogurov et al., 1993).  
 
 
5.5 Expression of KlcA is not lethal to E. coli 
 
It has been shown that unregulated expression of the kil genes leads to killing of 
the host cells. The cells become elongated with distorted outer membranes and 
macromolecular synthesis ceases (Saltman et al., 1991). Interestingly, previous 
studies of the kilC operon in plasmid RK2 showed that the klcB gene is not 
required for the Kil+ phenotype and that klcA is responsible for the lethality of E. 
coli host cells in the absence of korA and korC (Larsen & Figurski, 1994). 
However, as shown in this work, it was possible to overexpress the klcA gene in 
a pET24 vector in the absence of kor determinants with no apparent harmful 
effects. Furthermore, in vivo antirestriction experiments performed on the KlcA 
from RK2 failed to identify any signs of antirestriction function, whereas the 
KlcA from B. pertussis clearly functions as an antirestriction protein as it showed 
efficient antirestriction activity against all four families of Type I restriction 
systems. Despite these differences, the two KlcAs are homologous (71% 
identity). 
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5.6 KlcA does not bind to MTase 
 
Biophysical characterisation using isothermal titration calorimetry (ITC) and 
fluorescence spectroscopy performed on two other antirestriction proteins, Ocr 
and orf18, have shown clear interaction of the MTase subunit of EcoKI with 
these proteins (Serfiotis-Mitsa et al., 2008;  Atanasiu et al., 2001). Both 
antirestriction proteins exhibited strong binding with the methyltransferase. 
However, ITC experiments performed at different temperatures ranging from 
10-25°C showed no apparent binding of MTase to KlcA.  This result agrees with 




5.7 KlcA antirestriction function does not involve the ClpXP protease 
 
It has been shown that ClpXP-dependent regulation of the endonuclease 
activity enables bacteria that acquire unmodified chromosomal target sequences 
to survive. The restriction subunit of the nuclease (HsdR) is degraded in the 
presence of ClpXP (Makovets et al., 1999). ClpXP is a two-component system 
consisting of an activator ATPase (ClpX), which recognises, unfolds and 
translocates the target to be degraded, and a proteolytic core (ClpP), which 
degrades the substrate (Gottesman et al., 1993). When cells are under stress after 
prolonged exposure to treatments that damage DNA, such as exposure to 2-
aminopurine, the ClpXP-dependent pathway is essential in preventing EcoKI 
from causing DNA damage.  
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Since no direct interaction of KlcA with the EcoKI was observed in vitro (Dr. 
Gareth Roberts, Edinburgh University, personal communication), the 
hypothesis that the antirestriction activity of KlcA may be dependent on the 
ClpXP pathway was tested. A ClpX- mutant (strain NM1041(DE3), kind gift of 
Noreen Murray) was plated in the presence and absence of 40 μg/ml 2-AP. The 
ClpX- mutant was also transformed with a pET-20b vector carrying the klcA 
gene and tested under the same conditions. The klcA was subcloned into the 
NdeI and HindIII of the polylinker region of pET20-b. The use of a different 
vector other than pET24-a was necessary for this assay because the ClpX- 
mutant is kanamycin sensitive. pET20-b provides the necessary second 
antibiotic selection (ampicillin). As expected, the ClpX- with no antirestriction 
determinant present, grew well in the absence of 2-AP, but no growth was 
observed in the presence of 40 μg/ml 2-AP. (Fig. 62) By contrast, the ClpX- 
carrying the klcA grew equally well in both the presence and absence of 2-AP. 








































Fig. 62  The presence of 2-AP hindered the growth of the ClpX- mutant containing only 
vector (pET20-b) (a), whereas in the presence of pET20-b +klcA, growth of the mutant 
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5.8 Blue Native (BN)/SDS-PAGE  
 
 
BN/SDS-PAGE is a 2D PAGE technique technique for the identification of 
protein complexes developed in the early 90’s (Schagger & von Jagow, 1991) in 
order to investigate the individual components of protein complexes forming 
the respiratory chain of various organisms. The technique has been used 
primarily to investigate plant proteomes (Eubel et al., 2004), however, it has been 
used to study multiprotein complexes in human HeLa cell cultures (Camancho-
Carvajal et al., 2004), in yeast (Grandier-Vazeille & Guérin, 1996) and in E. coli 
(Barrett et al., 2005). 
 
Blue native polyacrylamide gel electrophoresis is a charge-shift method. In this 
method, negative charges are not attached to the proteins by detergents such as 
in the SDS-PAGE, but by addition and binding of the negatively charged 
Coomassie Blue G250. When the negatively-charged dye is added to the native 
proteins it induces a charge-shift as it binds to surface hydrophobic patches on 
proteins. The electrophoretic motility of the proteins is determined by the 
negative charge due to the binding of the dye making even very basic proteins 
migrate to the anode.  A major difference between BN-PAGE and SDS-PAGE is 
that the Coomassie dye binds to the surface of the proteins and not the interior 
and as a consequence, the dye does not denature the proteins. 
 
After the cells are lysed by sonication, the mixture of different protein 
complexes is separated by BN-PAGE based on molecular weight. The lane of the 
blue native gel is excised and subjected to a denaturation solution containing 
1% SDS and 1% 2-mercaptoethanol. Following denaturation, the native protein 
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complexes dissociate to their constituent polypeptides. The subunits of the 
protein complexes remain in position until they are forced electrophoretically 
into the second dimension gel, this time an SDS polyacrylamide gel.  The 
subunits of the protein complex will form a vertical row on the second 






Fig. 63 The working principle of BN/SDS-PAGE. The solubilised sample is run on a 
blue native polyacrylamide gel. The non-denaturing condition in the gel allows the 
various protein complexes to remain intact. The gel slice form the BN polyacrylamide gel 
is cut and incubated in a denaturation solution (1% SDS and 1% 2-mercaptoethanol) 
and then placed on top of a SDS polyacrylamide gel. The dissociated complexes now run 
in the second dimension. Subunits of each protein complex form a vertical column on the 
second dimension gel. (Image adapted from Eubel et al., 2005). 
 
A sample of BL21(DE3) cells containing the pDMKlcA vector was induced and 
subsequently sonicated as described in the Methods. The supernatant was 
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loaded on a BN gel and after the run the gel slice was excided treated with SDS 
and 2-meractoethanol and subsequently placed horizontally on top of an SDS 





Fig. 64 BN/SDS-PAGE of cell lysate containing overexpressed KlcA. The BN strip was 
placed horizontally on top of an SDS polyacrylamide gel with the high to low molecular 
weight from left to right. The bands with numbers correspond to bands that were 
analysed by MALDI-TOF-MS. 
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All protein spots which are situated vertically below each other after BN/SDS-
PAGE are potential subunits of protein complexes. Spots which are located side 
by side in a horizontal row potentially represent the same protein which is 
localised in protein complexes of different molecular mass. Caution, however, 
has to employed because it can be the case that more than one protein complex 
can separate to the same molecular mass during BN-PAGE and more than one 
protein subunit may be resolved during SDS-PAGE to the same molecular mass. 
 
A streak of bands corresponding to the expected molecular weight of KlcA (15.6 
kDa) appeared on the SDS-PAGE. Some bands appeared in a vertical position of 
that streak, however, most of the bands on the gel were grouped in a cluster 
towards the middle of the gel making it difficult to identify which bands had 
run vertically with the KlcA bands. The fact that a horizontal streak of KlcA 
bands appeared in the SDS-PAGE implied that the protein may be associated 
with a very large complex (thus a band of KlcA appearing at position 4, and 
“free” KlcA at position 3). 
 
The molecular mass of a complex is increasing during assembly of the structural 
subunits of this complex, thus in the case of a “supercomplex”, the analysis of 
the protein pattern resolves the direction of the stepwise subunit assembly from 
the lower towards the higher molecular mass of the protein complexes from the 
right side of the gel towards the left side (Fig. 65). The subunit composition of a 
protein complex is directly presented in the 2D BN/SDS-PAGE as proteins are 
arranged in a vertical line. In contrast, the assembly of the protein subunits into 
one supercomplex can be analysed from the horizontal appearance of one 
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subunit together with other partner protein subunits at a specific molecular 






Fig. 65 When the protein of interest binds to a large complex that involves many protein 
partners, the analysis of the horizontal “streak” on the SDS-PAGE resolves the 
direction of the stepwise subunit assembly from the lower to the higher molecular mass 
of the protein complexes (image reprinted from Reisinger & Eichaker, 2007). 
 
Two bands (6 and 7) that run vertically with the KlcA band (4) as well as a few 
other intense bands from the gel were digested with trypsin and analysed by 
MALDI-TOF-MS as described in the Methods. In order to confirm that the 
bands in the streak were all KlcA, more than one band was analysed (4, 1, 3). 
After the MS spectra were collected, peptide mass fingerprinting was performed 
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with the online server MASCOT. All nine bands came with a significant score 
and the identities of the bands are summarised in Table 4. 
 
Table 4.  Results of the peptide mass search (PMS) of selected bands from the BN/SDS-
PAGE using MASCOT. 
 
Band Number Protein Identified Function 
1 KlcA from B. pertussis Antirestriction 
2 50 S ribosomal protein L4 Part of the 50 S ribosomal 
subunit 
3 KlcA from B. pertussis Antirestriction 
4 KlcA from B. pertussis Antirestriction 
5 50 S ribosomal protein L4 Part of the 50 S ribosomal 
subunit 
6 Dihydrolipoamide succinyltransferase Part of the 2-oxoglutarate 
dehydrogenase complex, 
involved in oxidative 
decarboxylation of2-
oxoglutarate, part of Krebs 
cycle 
7 30 S ribosomal protein S1 Part of the 30 S ribosomal 
subunit 
8 Chaperonin 1 Involved in the folding 
process of nascent proteins 
9 Elongation factor Tu 1 Elongates the protein chain 
during protein synthesis 
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PMS confirmed that the streak of bands 1, 3 and 4 belonged to the KlcA protein. 
The bands 6 and 7 which run vertically with band 4 do not belong to the same 
complex but there was rather a co-migration of proteins from different 
complexes (2-oxoglutarate dehydrogenase complex and 30 S ribosomal subunit) 
making it difficult to identify which could be forming a complex with KlcA. The 
rest of the bands revealed proteins that are involved in the protein machinery of 
E. coli (ribosome, elongation factor, chaperonin). The strong appearance of 
bands on the gel belonging to proteins involved in the protein machinery of the 
cell could simply be due to the fact that the lysate used for the experiment 
contained an overexpressed protein, thus more ribosomes, elongation factors 
etc. are necessary for the overexpression to take place. As a result, no other 
assumptions can be made about the result of this experiment apart from the fact 
that KlcA appeared to be associating with a complex of very high molecular 
mass. However, co-migration of proteins on BN gels is not a final proof of native 
association as physically distinct complexes may have similar molecular masses 
and appear in the same protein bands. One other thing to take into 
consideration for this experiment is the concentration of KlcA versus the 
concentration of the rest of the cellular proteins. Overproduction of the protein 
of interest may cause the protein to adopt a “sticky” nature that favours 
interactions that would not be normally observed at endogenous levels of 
abundance. A complementary experiment to the BN/SDS-PAGE technique is the 
pull-down assay where co-immunoprecipitation of the protein of interest along 
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5.9 c-myc tagged KlcA co-IP assay 
 
Identifying novel proteins that could potentially interact with KlcA was also 
tested by the co-imunoprecipitation (co-IP) method. Co-IP is a method that 
utilizes antibody-mediated precipitation of antigens to analyse antigen-
associated proteins. When an antibody against the protein of interest is not 
available, co-IP can still be performed using a tagged version of the protein. 
There are five steps involved in a co-IP process: preparation of protein extract, 
coupling of the antibody to the antigen, isolation of protein complexes, analysis 
of the proteins involved in the complexes by SDS-PAGE and identification of the 
proteins involved in the complex by MALDI-TOF-MS. 
 
A rapid method for capturing an antigen on the antibody-bead matrix is to mix 
the antigen solution with the beads and rotate or rock the slurry, allowing 
maximum contact between the antigen and the immobilized antibody. After the 
binding reaction has been completed, the slurry is passed into a column for 
collection of the beads, and then the antigen is eluted. Epitope tags are useful for 
labeling proteins since their small size (5-15 amino acids) is less likely to affect 
the protein’s function compared to larger tags such as the GFP or GST tag for 
example. For this study, the c-myc epitope was used which is a 10 amino acid 
sequence (EQKLISEEDL) derived from the human c-myc gene. This polypeptide 
is specifically recognized by the monoclonal antibody Mycl-9E10 (Evan et al., 
1985). This allows for sensitive detection and immunoprecipitation of expressed 
proteins with the anti-c-myc antibody. 
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Since the region of the protein which is responsible for antirestriction was not 
known, two constructs were created in case one of the constructs interfered with 
antirestriction activity: KlcA tagged with c-myc at the N-terminus and KlcA 
tagged with c-myc at the C-terminus as follows: 
 












To assess if the required recombinant was successful, the DNA was cleaved 
with NdeI and HindIII in order to release the insert from the vector. An example 












Fig. 66 The sequence coding for the N-terminus c-myc 
tagged KlcA was cloned between NdeI and HindIII 
restriction sites of the pET24-a vector. To test whether 
ligation was successful, a digestion was performed with 
NdeI and HindIII enzymes in order to release the insert. 
Lane 1: 1 kb DNA ladder, lane 2: 100 bp DNA ladder 
Lane 3: digestion of N-terminus c-myc tagged KlcA 
construct. A band corresponding to linearised vector (~5.3 
kb) and a band corresponding to the insert (~500 bp) can 
be seen. 
 
1 2 3 
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 After the two constructs were made, they were tested for antirestriction 
activity. The N-terminus c-myc tagged KlcA showed the same antirestriction 
activity as the wild type KlcA, whereas the C-terminus tagged KlcA showed 
almost no antirestriction, similar to the pET24-a vector alone. The fact that no 
antirestriction was observed for the C-terminus c-myc tagged KlcA did not 
necessarily mean that the C-terminus was responsible for antirestriction. In 
order to assess whether the constructs were expressed in the cell, an induction 




                                      
Fig. 67 Overproduction of N-terminus and C-
terminus -myc- tagged KlcA. Lane 1: Protein 
marker; Lane 2: N-terminus-myc-tagged-KlcA 
uninduced; Lane 3: N-terminus-myc-tagged-KlcA 
after 3 hr induction; Lane 4: C-terminus-myc-
tagged-KlcA uninduced; Lane 5: C-terminus-
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Very good expression was observed for the N-terminus c-myc tagged KlcA, 
whereas no expression can be seen from the gel for the C-terminus c-myc tagged 
KlcA, suggesting that the protein may not have been able to fold properly in the 
cell and it was degraded by the cell’s proteases. 
 
The N-terminus c-myc tagged KlcA construct was chosen for the co-IP assay. A 
high affinity anti-c-myc antibody coupled agarose provided in the Profound c-
myc tag IP/co-IP kit (Pierce) was used in order to co-purify the tagged KlcA and 
interacting proteins. As a positive control a c-myc-tagged glutathionine S-
transferase was used (Pierce provided), and as a negative control, a lysate 
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Fig. 68 An SDS-PAGE showing the result of the co-IP assay. Lane 1: protein marker; 
lane 3: elution of proteins from sample containing uninduced N-terminus myc tagged 
KlcA; lane 5:  elution of proteins from sample containing induced N-terminus myc 
tagged KlcA; lane7: elution of proteins from sample containing only vector pEt24-a; lane 
9: positive control (c-myc-GST protein) 
 
For this experiment, a 3 gr pellet was resuspended in only 1 ml of TBS buffer in 
order to have a lysate as concentrated as possible. Even so, the losses from the 
column have been so substantial, that only faint bands could be seen on the 
SDS-PAGE stained with Coomassie blue. The experiment was repeated several 
times with different incubation times (from 2 hr to overnight) in case longer 
incubation times would help the binding to the epitope to the antibody, but no 
difference was observed. 
 
The major problem, however, was the amount of non-specific binding. A band 
containing a potential binding partner can be masked in the gel by the 
appearance of non-specific binding. Since no resin is totally inert, several 
proteins bind to it confusing the interpretation of results. A preclearing step was 
used where the lysates were first mixed with mouse IgG agarose in order to 
reduce the background that is due to adhesion of sample components to resin. 
 
For the elution step, an elution buffer (Pierce provided) with a very low pH (2.8) 
was used instead of boiling the resin in a Laemli-buffer. This precaution 
prevents contamination of the sample by non-immobilised antibody fragments. 
Furthermore, extra washing steps were performed.  
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Ideally, the washing step should break all nonspecific interactions while 
preserving the specific interaction between antibody and antigen. Increasing the 
number of washing steps could be one solution as the washing buffer contains 
mild detergents that can help break nonspecific interactions. Also, increasing the 
stringency of the buffer can help reduce the background. The TBS buffer used 
for this experiment is a medium stringency buffer. A higher stringency buffer 
such as RIPA buffer could be used, however, because this buffer is partly 
denaturing due to the anionic detergent SDS, it was not considered ideal for co-
IP experiments. The non-specific binding, however, persisted and the same 
bands could be seen on lane 7 where there was no KlcA present as well as on 
lanes 3 and 5. Also, some non-specific binding can be seen on lane 9 where the c-
myc-tagged GST lysate was loaded. 
 
 
5.10 Conclusion for KlcA experiments  
  
In this study, the solution structure of KlcA, an antirestriction protein belonging 
to the ArdB family, was solved, and its antirestriction function confirmed.  The 
structure of KlcA is the first ArdB structure reported, and adopts a novel fold. 
Sequence comparison revealed 43 non-redundant related sequences. Although 
three distinct regions of charge are apparent from the electrostatic surface 
representation, only a handful of charged residues are conserved between the 
related sequences. These conserved residues, as well as residues that display 
potential chemical exchange and/or higher mobility identified during the 
relaxation analysis, will be the target for future mutational studies. The 
antirestriction proteins, such as Ocr (Walkinshaw et al., 2002) and ArdA from 
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Orf18 of Tn916 of Enterococcus faecalis, have been shown to comprise elongated 
structures that bind to the methyltransferase subunit of the endonuclease, 
thereby rendering the nuclease incapable of digesting DNA or methylating the 
DNA substrate. The structure of KlcA on the other hand, appears to be a rigid 
globular molecule. Genetic analysis shows that KlcA displays antirestriction but 
not antimodification activity. However, the antirestriction function of KlcA has 
only been demonstrated in vivo but not in vitro. Furthermore, there is no 
apparent interaction of KlcA with the ClpXP protease. Because no direct binding 
of KlcA to EcoKI was observed in vitro, the mechanism of the endonuclease 
blocking remains unclear. It is possible KlcA needs another protein partner, or 
simply a cofactor, for antirestriction to take place. Attempts to find the possible 
binding partner with BN/SDS-PAGE and co-IP precipitation experiments 
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Chapter 6: Final remarks and future work 
 
6.1 Final remarks  
 
The present work dealt with the characterisation of two antirestriction proteins, 
an ArdA and an ArdB homologue, KlcA. Even though the two proteins appear 
to have in common the antirestriction function, they differ in many respects. The 
structures of Ocr and ArdA revealed that these molecules belong to DNA 
mimics with a characteristic distribution of negatively charged residues 
imitating distribution of negatively charged phosphate groups along the DNA 
duplex. KlcA, on the other hand, is a globular protein, less acidic than ArdA and 
with no characteristic distribution of negative residues. Furthermore, no 
antimodification activity was observed for KlcA, a characteristic of ArdB 
proteins. A similarity of ArdA and KlcA however, is noteworthy. It has been 
shown that the closely linked ardA and ardB genes on pKM101 are controlled by 
conserved upstream elements containing a strong promoter. These promoters 
are regulated by two plasmid proteins, ArdK and ArdR, with at least ArdK 
acting as a repressor controlling antirestriction gene expression (Delver & 
Belogurov, 1997). Could this kind of regulation be linked with the korA and korC 
regulation of KlcA? Moreover, unlike ardA and ardB genes, klcA is located 
outside the plasmid leading region. If immediate transcription of the 
antirestriction genes is necessary for the efficient transfer of the plasmid to a 
new cell, then how klcA genes manage to achieve that? 
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Future work needs to be focused on the identification of the protein partner(s) of 
KlcA. This identification will help in the elucidation of its antirestriction mode 
of action and may give partial answers to the question above.  
 
 





In order test for any “sticky” behaviour of the overexpressed KlcA in the 2D BN-
PAGE/SDS-PAGE experiment, a mutant KlcA should be used which has a 
mutation that abolishes all antirestriction activity and thus no binding with the 
suspected partners would occur in that case. Furthermore, a BN-PAGE/Western 
can be done where a blue native gel of the lysate of the uninduced N-terminus –
myc-tagged KlcA is followed by a western blot.  The significant problem  of 
Coomassie transfer to the membrane (since Coomassie is negatively charged) of 
a blue native gel can be overcome  by changing the cathode dye containing 
Coomassie blue  at about 2/3 of the run by cathode buffer without dye in order 
to  reduce the amount of dye in the gel (the removal of excess dye also helps in 
protein transfer since the dye tends to migrate first on the membrane blocking 
some proteins from being transferred), and also destain the gel prior to transfer. 
The appearance of the tagged KlcA in the lysate can be detected on the 
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6.2.2 Far-Western Blotting 
 
A different type of western blotting, far-western blotting involves the separation 
of total cell lysates on an SDS-PAGE, transfer of the protein on a membrane, and 
then the proteins are first denatured and then renatured with different 
concentrations of guanidine hydrochloride. The idea is that the denatured 
proteins after separation in the SDS-PAGE gel, must be renatured in order to 
adopt their native state and be able for binding. After renaturation of the 
proteins, the “bait” protein (in this case the N-terminus-myc-tagged KlcA) is 
applied on the membrane. If the bait protein is involved in a protein complex, it 
will bind to the relevant proteins on the membrane. The membrane is then 
blocked as in a normal western and the antibody for the epitope tag is applied in 
order to visualise the bands where the binding took place.  
 
6.2.3 In vivo crosslinking 
 
 To stabilize transient complexes and weak interactions for analysis by Co-IP, or 
BN-PAGE/Western blot, in vivo crosslinking can be applied where the protein 
interaction is “frozen” in the cell. Traditionally, transient interactions were 
studied using chemical crosslinking with bifunctional NHS-ester crosslinkers. A 
recent advancement in protein crosslinking involves the incorporation of 
photoactivatable amino acids that act as zero length crosslinkers (Suchanek et 
al., 2005). Two such amino acids, photo-leucine and photo-methionine 
containing diazirine rings for photoactivation can substitute for their respective 
amino acids in endogenously expressed proteins. Photoactivation of the 
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diazirine rings by UV light creates reactive carbene intermediates that 
irreversibly crosslink proteins within protein interaction domains containing 
methionine and/or leucine with a zero-length bond. Photoreactive amino acids 
do not alter the cell’s metabolism and are essentially non-invasive. More 
importantly, as zero-length linkers they are very specific.  
 
6.2.4 Yeast-two-hybrid method 
 
Novel protein-protein interactions can be easily selected from a pool of potential 
interaction partners (e.g. a cDNA expression library). Genetic screening systems 
yield not only information on the interaction itself but also directly provide the 
cDNA encoding the novel interaction partner. The most widely used 
methodology of this type is the yeast two hybrid system (Fields & Song, 1989). 
In the yeast-two-hybrid system protein interactions are detected by their ability 
to reconstitute the function of a split transcriptional activator complex. The 
transcription factor can be divided in two domains: a DNA-binding domain and 
a transcriptional activation domain. These two domains must be in close 
proximity to each other in order for the transcription factor to active. The 
sequence coding for the protein of interest is cloned into a vector coding for the 
isolated DNA-binding domain creating a fusion protein that will act as bait in 
search for interacting protein partners. An E. coli cDNA library must then be 
created and cloned into a cDNA encoding the isolated transcriptional activation 
domain of the transcription factor. In this way, a large number of fusion proteins 
is created that will act as the “prey”. The plasmids that are created contain the 
fusion prey proteins and the fusion bait proteins. A yeat strain transformed with 
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these plasmids, contains a reporter gene that can only be transcribed in the 
presence of the whole transcription factor (DNA-binding domain and 
transcriptional activation domain). When there is an interaction between the bait 
and one of the prey proteins, the two domains of the transcription factor come 
together and the reporter gene is transcribed. The measurable output, can be 
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 M  D  D  M  Q  V  Y  I  A  N  L  G  K  Y  N  E  G  E  L  V  
GGTGCGTGGTTTACCTTTCCCATTGACTTTGAGGAAGTCAAAGAGAAAATCGGCTTGAAT 
 G  A  W  F  T  F  P  I  D  F  E  E  V  K  E  K  I  G  L  N  
GATGAATATGAGGAATACGCCATTCATGACTACGAGTTACCCTTTACGGTTGACGAATAC 
 D  E  Y  E  E  Y  A  I  H  D  Y  E  L  P  F  T  V  D  E  Y  
ACTTCCATTGGCGAACTCAATCGACTATGGGAAATGGTATCGGAATTACCCGAAGAATTA 
 T  S  I  G  E  L  N  R  L  W  E  M  V  S  E  L  P  E  E  L  
CAATCGGAGCTATCTGCTCTGCTCACTCATTTTTCAAGCATTGAAGAACTAAGCGAACAT 
 Q  S  E  L  S  A  L  L  T  H  F  S  S  I  E  E  L  S  E  H  
CAAGAGGATATTATCATTCATTCCGATTGTGATGATATGTATGACGTGGCACGCTACTAC 
 Q  E  D  I  I  I  H  S  D  C  D  D  M  Y  D  V  A  R  Y  Y  
ATTGAAGAAACGGGTGCTTTAGGCGAAGTACCAGCTAGTCTTCAAAACTATATTGATTAT 
 I  E  E  T  G  A  L  G  E  V  P  A  S  L  Q  N  Y  I  D  Y  
CAAGCCTATGGTCGGGATTTAGACCTTTCAGGAACGTTTATCTCAACCAATCATGGGATT 
 Q  A  Y  G  R  D  L  D  L  S  G  T  F  I  S  T  N  H  G  I  
TTTGAAATCGTCTAT 









 M  N  T  E  E  Q  P  V  T  A  S  L  V  A  E  A  Q  R  L  D  
TTTCTGCCGACCTATTTTGGCCCGCGTCTGATGATGCGTGGCGAAGCGCTGGTGTATGCG 
 F  L  P  T  Y  F  G  P  R  L  M  M  R  G  E  A  L  V  Y  A  
TGGATGCGTCGTCTGTGCGAACGTTACAACGGCGCGTATTGGCATTACTACGCCCTGAGC 
 W  M  R  R  L  C  E  R  Y  N  G  A  Y  W  H  Y  Y  A  L  S  
GATGGCGGCTTTTATATGGCGCCGGATCTGGCCGGTCGTCTGGAAATTGAAGTGAACGGC 
 D  G  G  F  Y  M  A  P  D  L  A  G  R  L  E  I  E  V  N  G  
AACGGCTTTCGTGGCGAACTGAGCGCGGATGCGGCGGGTATTGTGGCGACCCTGTTTGCG 
 N  G  F  R  G  E  L  S  A  D  A  A  G  I  V  A  T  L  F  A  
CTGGGTCAGCTGGCCGCGGAAATTGCGGATACCGATGCGGCGGATGCGCTGATTGATCGT 
 L  G  Q  L  A  A  E  I  A  D  T  D  A  A  D  A  L  I  D  R  
TATCATTTTCTGCGTGGCTTTGCGGCGGGTCATCCGGAAGCGGCAGCGATTTATCGTGCG 
 Y  H  F  L  R  G  F  A  A  G  H  P  E  A  A  A  I  Y  R  A  
ATTGAT 
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Fig. IV. Multiple sequence alignment of KlcA and ArdB (1/2) 
 
Multiple sequence alignment of 43 non-redundant sequences of ArdB and KlcA using 
PROMALS3D. The secondary structure (alpha-helices: red; beta-strands: yellow; 310-
helix: purple) from the consensus ensemble of NMR-derived structures is shown above 
the aligned sequences. Highly conserved amino acid positions that are exposed are 
shown within a green rectangular box, while highly conserved, buried positions are 
highlighted in a purple. KlcA from B.pertussis corresponds to Q08L07_BOR. 
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Fig. VI.  Genetic map of the 41 268 bp IncP-1b plasmid pBP136 (Kamachi et al., 2006).  
Grey arrows indicate directions of transcription. White arrows indicate positions of 
insertion (mobile genetic elements and phenotypic markers) inother IncP-1b plasmids. 
The position of klcA and klcB genes is marked by a red box. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
